АКАДИА Фармасьютикалс Инк.
Введение
На этой странице представлен всесторонний анализ известной истории инсайдерской торговли Baker Bros. Advisors (GP) LLC. Инсайдеры — это должностные лица, директора или крупные инвесторы компании. Инсайдерам запрещено совершать сделки в своих компаниях на основе конкретной, закрытой информации. Это не означает, что для них незаконно совершать какие-либо сделки в своих собственных компаниях. Однако они должны сообщать обо всех сделках в SEC по форме 4. Несмотря на эти ограничения, академические исследования показывают, что инсайдеры в целом имеют тенденцию опережать рынок в своих собственных компаниях.
Средняя прибыльность торговли
Средняя прибыльность торговли — это средний доход от всех покупок на открытом рынке, сделанных инсайдером за последние три года. Чтобы рассчитать это, мы проверяем каждую незапланированную покупку инсайдера на открытом рынке, исключая все сделки, которые были отмечены как часть торгового плана 10b5-1. Затем мы рассчитываем среднюю эффективность этих сделок за 3, 6 и 12 месяцев, усредняя каждую из этих продолжительностей, чтобы получить окончательный показатель эффективности для каждой сделки. Наконец, мы усредняем все показатели производительности, чтобы рассчитать показатель производительности для инсайдера. В этот список включены только инсайдеры, совершившие не менее трех сделок за последние два года.
Если прибыльность этой инсайдерской сделки равна «Н/Д», то инсайдер либо не совершал никаких покупок на открытом рынке за последние три года, либо совершенные им сделки слишком недавние, чтобы можно было рассчитать надежные показатели эффективности.
Частота обновлений: ежедневно
Компании с заявленной инсайдерской позицией
В документах SEC указано, что Baker Bros. Advisors (GP) LLC сообщил о владениях или сделках со следующими компаниями:
Как интерпретировать графики
На следующих диаграммах показаны динамика акций ценных бумаг после каждой незапланированной сделки на открытом рынке, совершенной Baker Bros. Advisors (GP) LLC. Незапланированная сделка — это сделка, которая не была совершена в рамках торгового плана 10b5-1. Динамика акций отображается как совокупное процентное изменение цены акций. Например, если инсайдерская сделка была совершена 1 января 2019 года, на графике будет показано дневное процентное изменение ценной бумаги к текущему дню. Если бы цена акций за это время выросла с 10 до 15 долларов, совокупное процентное изменение цены акций составило бы 50%. Изменение цены с 10 до 20 долларов составит 100%, а изменение цены с 10 до 5 долларов составит -50%.
В конечном счете, мы пытаемся определить, насколько тесно инсайдерские сделки коррелируют с избыточной доходностью (положительной или отрицательной) от цены акций, чтобы увидеть, рассчитывает ли инсайдер свои сделки для получения прибыли от инсайдерской информации. Рассмотрим ситуацию, когда это делал инсайдер. В этой ситуации мы ожидаем либо (а) положительной прибыли после покупок, либо (б) отрицательной прибыли после продажи. В случае (а) график ПОКУПКИ покажет серию восходящих кривых, указывающих на положительную доходность после каждой транзакции покупки. В случае (b) график ПРОДАЖИ будет отображать серию нисходящих кривых, указывающих на отрицательную доходность после каждой транзакции продажи.
Однако одного этого недостаточно, чтобы делать выводы. Если, например, цена акций компании росла нециклически в течение многих лет, то мы ожидаем, что все графики после покупки будут иметь наклон вверх. Аналогичным образом, нециклическое снижение на протяжении многих лет приведет к нисходящему наклону постторговых графиков. Ни один из этих графиков не указывает на инсайдерскую торговую активность.
Самым сильным индикатором была бы ситуация, когда цена акций была чрезвычайно цикличной, и были как положительные сигналы на графике ПОКУПКИ, так и отрицательные участки на графике ПРОДАЖИ. Эта ситуация весьма наводит на мысль о том, что инсайдер рассчитывает сделку в свою финансовую выгоду.
Инсайдерские покупки ACAD / ACADIA Pharmaceuticals Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи ACAD / ACADIA Pharmaceuticals Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки BCRX / BioCryst Pharmaceuticals, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи BCRX / BioCryst Pharmaceuticals, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки CELC / Celcuity Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Макс |
Цена в Макс |
Макс Прибыль ($) |
Макс. доход (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи CELC / Celcuity Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки HOOK / HOOKIPA Pharma Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи HOOK / HOOKIPA Pharma Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки KALA / KALA BIO, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи KALA / KALA BIO, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки KNSA / Kiniksa Pharmaceuticals, Ltd. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи KNSA / Kiniksa Pharmaceuticals, Ltd. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки KOD / Kodiak Sciences Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи KOD / Kodiak Sciences Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки KYMR / Kymera Therapeutics, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи KYMR / Kymera Therapeutics, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки MDGL / Madrigal Pharmaceuticals, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи MDGL / Madrigal Pharmaceuticals, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки NTLA / Intellia Therapeutics, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи NTLA / Intellia Therapeutics, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки PRLD / Prelude Therapeutics Incorporated – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи PRLD / Prelude Therapeutics Incorporated – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки REPL / Replimune Group, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Макс |
Цена в Макс |
Макс Прибыль ($) |
Макс. доход (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи REPL / Replimune Group, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки RYTM / Rhythm Pharmaceuticals, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи RYTM / Rhythm Pharmaceuticals, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки SERA / Sera Prognostics, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Макс |
Цена в Макс |
Макс Прибыль ($) |
Макс. доход (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи SERA / Sera Prognostics, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки SYRE / Spyre Therapeutics, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Макс |
Цена в Макс |
Макс Прибыль ($) |
Макс. доход (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи SYRE / Spyre Therapeutics, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки TCRX / TScan Therapeutics, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи TCRX / TScan Therapeutics, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки TLIS / Talis Biomedical Corporation – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи TLIS / Talis Biomedical Corporation – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки TRDA / Entrada Therapeutics, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи TRDA / Entrada Therapeutics, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки VTVT / vTv Therapeutics Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Макс |
Цена в Макс |
Макс Прибыль ($) |
Макс. доход (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи VTVT / vTv Therapeutics Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки XOMAO / XOMA Royalty Corporation - Preferred Stock – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи XOMAO / XOMA Royalty Corporation - Preferred Stock – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские покупки ZYME / Zymeworks Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Макс |
Цена в Макс |
Макс Прибыль ($) |
Макс. доход (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи ZYME / Zymeworks Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в ACAD / ACADIA Pharmaceuticals Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
| Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
|---|---|---|---|---|---|---|---|
| Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
История инсайдерской торговли
В этой таблице показан полный список инсайдерских сделок, совершенных Baker Bros. Advisors (GP) LLC, раскрытый Комиссии по ценным бумагам и биржам (SEC).
| Дата файла | Тран Дата | Форма | Бегущая строка | Безопасность | Код | Акции | Оставшиеся акции | Процент Изменять |
Делиться Цена |
Тран Ценить |
Оставшийся Ценить |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 46 692 | 135 946 | 52,31 | ||||
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 4 308 | 12 368 | 53,45 | ||||
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10 128 | 1 859 091 | 0,55 | 372,16 | 3 769 209 | 691 874 287 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 933 | 194 625 | 0,48 | 372,16 | 347 223 | 72 431 115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5 494 | 1 848 963 | 0,30 | 371,00 | 2 038 301 | 685 974 518 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 506 | 193 692 | 0,26 | 371,00 | 187 729 | 71 860 700 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 747 | 1 843 469 | 0,15 | 369,34 | 1 014 563 | 680 857 623 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 253 | 193 186 | 0,13 | 369,34 | 93 442 | 71 350 351 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 419 | 1 840 722 | 0,08 | 368,84 | 523 384 | 678 931 902 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 131 | 192 933 | 0,07 | 368,84 | 48 318 | 71 161 408 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 798 | 1 839 303 | 0,26 | 367,77 | 1 764 565 | 676 442 304 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 442 | 192 802 | 0,23 | 367,77 | 162 555 | 70 906 984 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 289 | 1 834 505 | 0,12 | 366,30 | 838 459 | 671 977 714 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 211 | 192 360 | 0,11 | 366,30 | 77 289 | 70 461 314 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 772 | 1 832 216 | 0,15 | 363,75 | 1 008 308 | 666 463 806 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 255 | 192 149 | 0,13 | 363,75 | 92 756 | 69 893 699 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5 587 | 1 829 444 | 0,31 | 362,39 | 2 024 662 | 662 968 735 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 191 894 | 0,27 | 362,39 | 186 630 | 69 540 102 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5 443 | 1 823 857 | 0,30 | 361,37 | 1 966 957 | 659 093 770 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 502 | 191 379 | 0,26 | 361,37 | 181 410 | 69 159 318 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8 514 | 1 818 414 | 0,47 | 359,39 | 3 059 873 | 653 525 445 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 784 | 190 877 | 0,41 | 359,39 | 281 764 | 68 599 877 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 472 | 1 809 900 | 0,14 | 358,21 | 885 495 | 648 324 279 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 228 | 190 093 | 0,12 | 358,21 | 81 672 | 68 093 214 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8 328 | 1 807 428 | 0,46 | 357,02 | 2 973 289 | 645 293 728 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 767 | 189 865 | 0,41 | 357,02 | 273 837 | 67 786 210 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 916 | 1 799 100 | 0,05 | 355,00 | 325 180 | 638 680 500 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 84 | 189 098 | 0,04 | 355,00 | 29 820 | 67 129 790 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 923 | 1 798 184 | 0,11 | 353,88 | 680 503 | 636 333 262 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 177 | 189 014 | 0,09 | 353,88 | 62 636 | 66 887 424 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9 362 | 1 947 968 | 0,48 | 392,24 | 3 672 178 | 764 076 617 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 862 | 202 813 | 0,43 | 392,24 | 338 113 | 79 551 959 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 506 | 1 938 606 | 0,13 | 389,89 | 977 059 | 755 838 828 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 231 | 201 951 | 0,11 | 389,89 | 90 064 | 78 738 231 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 366 | 1 936 100 | 0,02 | 389,00 | 142 374 | 753 142 900 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 34 | 201 720 | 0,02 | 389,00 | 13 226 | 78 469 080 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 441 | 1 935 734 | 0,23 | 387,07 | 1 718 969 | 749 260 688 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 409 | 201 686 | 0,20 | 387,07 | 158 311 | 78 066 197 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13 545 | 1 931 293 | 0,71 | 385,06 | 5 215 601 | 743 658 468 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 248 | 201 277 | 0,62 | 385,06 | 480 552 | 77 503 178 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 049 | 1 917 748 | 0,21 | 383,79 | 1 553 954 | 736 007 135 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 373 | 200 029 | 0,19 | 383,79 | 143 153 | 76 768 570 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 838 | 1 913 699 | 0,15 | 382,82 | 1 086 447 | 732 604 739 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 262 | 199 656 | 0,13 | 382,82 | 100 299 | 76 432 569 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 136 | 1 910 861 | 0,06 | 382,29 | 434 280 | 730 501 332 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 105 | 199 394 | 0,05 | 382,29 | 40 140 | 76 226 153 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9 477 | 1 909 725 | 0,50 | 381,12 | 3 611 889 | 727 837 448 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 873 | 199 289 | 0,44 | 381,12 | 332 719 | 75 953 343 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 919 | 1 900 248 | 0,10 | 380,78 | 730 717 | 723 576 433 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 198 416 | 0,09 | 380,78 | 67 017 | 75 552 844 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5 209 | 1 898 329 | 0,28 | 380,44 | 1 981 694 | 722 193 641 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 480 | 198 240 | 0,24 | 380,44 | 182 610 | 75 417 732 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 325 | 1 893 120 | 0,39 | 374,43 | 2 742 728 | 708 848 115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 675 | 197 760 | 0,34 | 374,43 | 252 743 | 74 048 028 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26 704 | 1 885 795 | 1,44 | 372,87 | 9 957 102 | 703 155 062 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 460 | 197 085 | 1,26 | 372,87 | 917 258 | 73 486 946 | |
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -3 763 362 | 0 | -100,00 | ||||
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -357 048 | 0 | -100,00 | ||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
689 944 | ||||||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
7 055 748 | ||||||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28 187 581 | 0,00 | ||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28 187 581 | 0,00 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3 763 362 | 0,03 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3 763 362 | 0,03 | ||||
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 600 309 | 6 117 295 | 10,88 | 44,00 | 26 413 596 | 269 160 980 | |
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 55 191 | 534 134 | 11,52 | 44,00 | 2 428 404 | 23 501 896 | |
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 430 | 1 796 261 | 0,08 | ||||
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 430 | 1 796 261 | 0,08 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2 518 | 28 187 089 | 0,01 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2 518 | 28 187 089 | 0,01 | ||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
326 302 | ||||||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
3 405 393 | ||||||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10 565 | 3 415 958 | 0,31 | ||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10 565 | 3 415 958 | 0,31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8 397 | 2 738 816 | 0,31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8 397 | 2 738 816 | 0,31 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16 214 | 39 365 965 | 0,04 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16 214 | 39 365 965 | 0,04 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21 970 | 148 069 | 17,42 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21 970 | 148 065 | 17,42 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 28 184 571 | 0,00 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 2 813 892 | 0,02 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3 762 409 | 0,03 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 356 095 | 0,27 | ||||
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 92 349 | 2 144 060 | 4,50 | 29,56 | 2 729 864 | 63 379 057 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 8 589 | 178 596 | 5,05 | 29,56 | 253 893 | 5 279 351 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 646 290 | 2 051 711 | 45,99 | 29,74 | 19 221 699 | 61 021 168 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 60 110 | 170 007 | 54,70 | 29,74 | 1 787 768 | 5 056 280 | |
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
929 241 | ||||||||
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
10 116 095 | ||||||||
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -671 976 | 8 068 411 | -7,69 | 260,00 | -174 713 760 | 2 097 786 860 | |
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -60 851 | 730 642 | -7,69 | 260,00 | -15 821 260 | 189 966 920 | |
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
432 434 | ||||||||
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
5 065 736 | ||||||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4 400 | 9 999 674 | 0,04 | ||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4 400 | 918 483 | 0,48 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28 184 084 | 0,00 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28 184 084 | 0,00 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1 994 | 3 761 456 | 0,05 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1 994 | 355 142 | 0,56 | ||||
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 279 939 | 1 083 398 | 34,84 | 6,44 | 1 802 807 | 6 977 083 | |
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 30 620 | 118 496 | 34,84 | 6,44 | 197 193 | 763 114 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 457 631 | 9 995 274 | 4,80 | 15,34 | 7 020 883 | 153 345 495 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 42 369 | 914 083 | 4,86 | 15,34 | 650 017 | 14 023 679 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 566 814 | 9 537 643 | 6,32 | 13,80 | 7 824 300 | 131 657 624 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 52 656 | 871 714 | 6,43 | 13,80 | 726 863 | 12 033 140 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 244 587 | 8 970 829 | 2,80 | 13,72 | 3 356 761 | 123 117 451 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 22 722 | 819 058 | 2,85 | 13,72 | 311 841 | 11 240 916 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 59 995 | 8 726 242 | 0,69 | 13,63 | 817 660 | 118 928 207 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 5 573 | 796 336 | 0,70 | 13,63 | 75 953 | 10 853 104 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 30 241 | 8 666 247 | 0,35 | 13,50 | 408 190 | 116 976 135 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 2 809 | 790 763 | 0,36 | 13,50 | 37 916 | 10 673 640 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -916 964 | 8 740 387 | -9,49 | 186,50 | -171 013 786 | 1 630 082 176 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -83 036 | 791 493 | -9,49 | 186,50 | -15 486 214 | 147 613 444 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -33 943 | 9 657 351 | -0,35 | 208,01 | -7 060 609 | 2 008 861 314 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -3 074 | 874 529 | -0,35 | 208,01 | -639 434 | 181 914 013 | |
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4 730 | 2 730 419 | 0,17 | ||||
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4 730 | 2 730 419 | 0,17 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 28 183 638 | 0,00 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 2 812 959 | 0,02 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1 994 | 3 759 462 | 0,05 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1 994 | 353 148 | 0,57 | ||||
| 2024-08-22 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1 | 5 516 986 | 0,00 | 46,41 | 46 | 256 043 320 | |
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28 183 142 | 0,00 | ||||
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28 183 142 | 0,00 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1 994 | 3 757 468 | 0,05 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1 994 | 3 757 468 | 0,05 | ||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
87 876 | ||||||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
803 459 | ||||||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 428 | 1 794 831 | 0,08 | ||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 428 | 1 794 831 | 0,08 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 2 186 686 | 8 636 006 | 33,91 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 196 098 | 787 954 | 33,13 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -5 283 206 | 28 182 605 | -15,79 | 60,00 | -316 992 360 | 1 690 956 300 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -175 977 | 2 811 926 | -5,89 | 60,00 | -10 558 620 | 168 715 560 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2 830 | 33 465 811 | 0,01 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2 830 | 33 465 811 | 0,01 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32 682 | 126 099 | 34,99 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32 682 | 126 099 | 34,99 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6 346 | 2 725 689 | 0,23 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6 346 | 2 725 689 | 0,23 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18 774 | 39 349 751 | 0,05 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18 774 | 39 349 751 | 0,05 | ||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
109 897 | ||||||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
1 405 421 | ||||||||
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15 000 | 33 462 981 | 0,04 | 49,01 | 735 150 | 1 640 020 699 | |
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15 000 | 2 985 073 | 0,51 | 49,01 | 735 150 | 146 298 428 | |
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12 000 | 6 449 320 | 0,19 | ||||
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12 000 | 6 449 320 | 0,19 | ||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
579 856 | ||||||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
6 437 320 | ||||||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1 994 | 3 755 474 | 0,05 | ||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1 994 | 3 755 474 | 0,05 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 33 447 981 | 0,00 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 2 970 073 | 0,02 | ||||
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 89 407 | 3 753 480 | 2,44 | 9,62 | 860 042 | 36 106 226 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8 066 | 347 166 | 2,38 | 9,62 | 77 590 | 3 339 529 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8 439 | 3 664 073 | 0,23 | 9,27 | 78 207 | 33 956 064 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 761 | 339 100 | 0,22 | 9,27 | 7 052 | 3 142 541 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17 101 | 3 655 634 | 0,47 | 9,22 | 157 683 | 33 707 504 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 1 543 | 338 339 | 0,46 | 9,22 | 14 228 | 3 119 722 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 247 656 | 3 638 533 | 7,30 | 8,26 | 2 046 159 | 30 061 923 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 22 344 | 336 796 | 7,11 | 8,26 | 184 608 | 2 782 642 | |
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
12 836 | ||||||||
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
142 135 | ||||||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -52 881 | 89 254 | -37,20 | ||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -4 776 | 8 060 | -37,21 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33 447 438 | 0,00 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33 447 438 | 0,00 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3 390 877 | 0,02 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3 390 877 | 0,02 | ||||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -42 977 301 | 0 | -100,00 | 229,00 | -9 841 801 929 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -1 731 202 | 0 | -100,00 | 229,00 | -396 445 258 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23 277 | 0 | -100,00 | 229,00 | -5 330 433 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23 280 | 0 | -100,00 | 229,00 | -5 331 120 | ||
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 214 025 | 3 390 323 | 6,74 | 6,60 | 1 412 565 | 22 376 132 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17 066 | 313 898 | 5,75 | 6,60 | 112 636 | 2 071 727 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 52 528 | 3 176 298 | 1,68 | 6,37 | 334 399 | 20 220 631 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 4 188 | 296 832 | 1,43 | 6,37 | 26 661 | 1 889 662 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 185 | 3 123 770 | 0,01 | 6,36 | 1 176 | 19 851 558 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 15 | 292 644 | 0,01 | 6,36 | 95 | 1 859 753 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 145 749 | 3 123 585 | 4,89 | 6,50 | 947 602 | 20 308 300 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 11 621 | 292 629 | 4,14 | 6,50 | 75 555 | 1 902 557 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 71 219 | 2 977 836 | 2,45 | 5,99 | 426 751 | 17 843 491 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 5 679 | 281 008 | 2,06 | 5,99 | 34 029 | 1 683 828 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 9 649 | 2 906 617 | 0,33 | 5,76 | 55 567 | 16 738 626 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 769 | 275 329 | 0,28 | 5,76 | 4 429 | 1 585 565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3 857 | 1 699 129 | 0,23 | 221,24 | 853 330 | 375 918 358 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 308 | 178 461 | 0,17 | 221,24 | 68 142 | 39 483 033 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 408 | 1 695 272 | 0,26 | 220,65 | 972 645 | 374 069 565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 352 | 178 153 | 0,20 | 220,65 | 77 670 | 39 310 279 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 005 | 1 690 864 | 0,90 | 219,24 | 3 289 711 | 370 706 714 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 195 | 177 801 | 0,68 | 219,24 | 261 993 | 38 981 269 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 873 | 1 675 859 | 0,17 | 217,91 | 626 049 | 365 182 748 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 229 | 176 606 | 0,13 | 217,91 | 49 901 | 38 483 825 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1 672 986 | 0,01 | 217,90 | 40 312 | 364 543 649 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176 377 | 0,01 | 217,90 | 3 268 | 38 432 548 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 769 | 1 672 801 | 0,11 | 216,67 | 383 286 | 362 442 949 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 141 | 176 362 | 0,08 | 216,67 | 30 550 | 38 212 055 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 668 | 1 671 032 | 0,04 | 214,72 | 143 434 | 358 807 834 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 176 221 | 0,03 | 214,72 | 11 380 | 37 838 578 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 1 670 364 | 0,03 | 213,80 | 110 107 | 357 122 821 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 41 | 176 168 | 0,02 | 213,80 | 8 766 | 37 664 613 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1 669 849 | 0,01 | 213,62 | 39 521 | 356 721 493 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176 127 | 0,01 | 213,62 | 3 204 | 37 625 130 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1 669 664 | 0,04 | 212,04 | 137 403 | 354 037 892 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176 112 | 0,03 | 212,04 | 11 026 | 37 343 035 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1 669 016 | 0,01 | 209,76 | 19 508 | 350 101 141 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 176 060 | 0,00 | 209,76 | 1 468 | 36 931 226 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 370 | 1 668 923 | 0,02 | 208,69 | 77 216 | 348 289 710 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 30 | 176 053 | 0,02 | 208,69 | 6 261 | 36 740 729 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1 668 553 | 0,04 | 206,93 | 134 092 | 345 277 176 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176 023 | 0,03 | 206,93 | 10 760 | 36 424 809 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 708 | 1 667 905 | 0,04 | 205,60 | 145 565 | 342 921 268 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 56 | 175 971 | 0,03 | 205,60 | 11 514 | 36 179 638 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1 667 197 | 0,01 | 205,32 | 19 095 | 342 308 888 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 175 915 | 0,00 | 205,32 | 1 437 | 36 118 868 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3 960 | 1 793 403 | 0,22 | 229,86 | 910 264 | 412 240 043 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 316 | 185 979 | 0,17 | 229,86 | 72 637 | 42 750 007 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 204 | 1 789 443 | 0,12 | 228,79 | 504 252 | 409 405 411 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 185 663 | 0,09 | 228,79 | 40 267 | 42 477 708 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 11 602 | 1 787 239 | 0,65 | 227,86 | 2 643 597 | 407 234 917 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 925 | 185 487 | 0,50 | 227,86 | 210 768 | 42 264 511 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 343 | 1 775 637 | 0,08 | 226,97 | 304 822 | 403 018 106 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 107 | 184 562 | 0,06 | 226,97 | 24 286 | 41 890 222 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5 594 | 1 774 294 | 0,32 | 224,91 | 1 258 156 | 399 059 480 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 446 | 184 455 | 0,24 | 224,91 | 100 311 | 41 486 088 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 363 | 1 768 700 | 0,02 | 223,94 | 81 289 | 396 078 079 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29 | 184 009 | 0,02 | 223,94 | 6 494 | 41 206 497 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9 262 | 1 768 337 | 0,53 | 222,68 | 2 062 425 | 393 766 210 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 738 | 183 980 | 0,40 | 222,68 | 164 335 | 40 967 930 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 532 | 1 759 075 | 0,26 | 221,78 | 1 005 101 | 390 125 367 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 361 | 183 242 | 0,20 | 221,78 | 80 062 | 40 639 173 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 518 | 1 754 543 | 0,26 | 219,87 | 993 351 | 385 762 948 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 360 | 182 881 | 0,20 | 219,87 | 79 151 | 40 209 168 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29 738 | 1 750 025 | 1,73 | 218,46 | 6 496 513 | 382 307 486 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 373 | 182 521 | 1,32 | 218,46 | 518 402 | 39 873 227 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10 894 | 1 720 287 | 0,64 | 217,52 | 2 369 611 | 374 188 571 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 869 | 180 148 | 0,48 | 217,52 | 189 021 | 39 184 928 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10 264 | 1 709 393 | 0,60 | 216,70 | 2 224 203 | 370 424 437 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 818 | 179 279 | 0,46 | 216,70 | 177 260 | 38 849 652 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 1 941 607 | 2 168 818 | 854,54 | 0,00 | 194 | 217 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 174 742 | 196 654 | 797,47 | 0,00 | 17 | 20 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 917 | 1 667 104 | 0,48 | 190,14 | 1 505 308 | 316 976 653 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 655 | 175 908 | 0,37 | 190,14 | 124 539 | 33 446 461 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 620 | 1 659 187 | 0,95 | 188,70 | 2 947 539 | 313 093 399 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 291 | 175 253 | 0,74 | 188,70 | 243 615 | 33 070 749 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13 505 | 1 643 567 | 0,83 | 188,46 | 2 545 218 | 309 754 690 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 117 | 173 962 | 0,65 | 188,46 | 210 515 | 32 785 731 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13 011 | 1 630 062 | 0,80 | 188,32 | 2 450 273 | 306 978 492 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 076 | 172 845 | 0,63 | 188,32 | 202 636 | 32 550 724 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 712 | 1 617 051 | 0,29 | 187,27 | 882 420 | 302 826 273 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 388 | 171 769 | 0,23 | 187,27 | 72 661 | 32 167 301 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 124 | 1 612 339 | 0,13 | 187,24 | 397 706 | 301 900 642 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 171 381 | 0,10 | 187,24 | 32 955 | 32 090 047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 385 | 1 610 215 | 0,09 | 186,59 | 258 431 | 300 454 847 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 115 | 171 205 | 0,07 | 186,59 | 21 458 | 31 945 655 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 647 | 1 608 830 | 0,04 | 186,32 | 120 547 | 299 752 540 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 171 090 | 0,03 | 186,32 | 9 875 | 31 876 993 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 369 | 1 608 183 | 0,02 | 183,16 | 67 586 | 294 554 798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31 | 171 037 | 0,02 | 183,16 | 5 678 | 31 327 137 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 146 | 1 607 814 | 0,01 | 185,94 | 27 148 | 298 963 688 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 | 171 006 | 0,01 | 185,94 | 2 231 | 31 797 574 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3 022 | 1 607 668 | 0,19 | 189,70 | 573 267 | 304 971 083 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 250 | 170 994 | 0,15 | 189,70 | 47 424 | 32 437 186 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 147 | 1 604 646 | 0,07 | 188,84 | 216 595 | 303 014 772 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 95 | 170 744 | 0,06 | 188,84 | 17 939 | 32 242 597 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 895 | 1 603 499 | 0,31 | 187,34 | 917 054 | 300 407 520 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 405 | 170 649 | 0,24 | 187,34 | 75 875 | 31 970 237 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 206 | 1 598 604 | 0,08 | 185,86 | 224 153 | 297 124 532 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 100 | 170 244 | 0,06 | 185,86 | 18 586 | 31 642 401 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 010 | 1 597 398 | 0,44 | 183,40 | 1 285 633 | 292 962 633 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 579 | 170 144 | 0,34 | 183,40 | 106 189 | 31 204 393 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 847 | 1 590 388 | 0,12 | 181,93 | 336 025 | 289 339 289 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 153 | 169 565 | 0,09 | 181,93 | 27 835 | 30 848 960 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10 715 | 1 588 541 | 0,68 | 175,82 | 1 883 889 | 279 293 943 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 903 | 169 412 | 0,54 | 175,82 | 158 764 | 29 785 662 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 923 | 1 577 826 | 0,31 | 175,72 | 865 062 | 277 253 218 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 415 | 168 509 | 0,25 | 175,72 | 72 923 | 29 610 149 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 18 125 | 1 572 903 | 1,17 | 174,87 | 3 169 606 | 275 061 098 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 528 | 168 094 | 0,92 | 174,87 | 267 209 | 29 395 405 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 978 | 1 554 778 | 0,06 | 174,67 | 170 827 | 271 572 762 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 82 | 166 566 | 0,05 | 174,67 | 14 323 | 29 094 050 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 660 | 1 553 800 | 0,11 | 173,75 | 288 422 | 269 969 798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 140 | 166 484 | 0,08 | 173,75 | 24 325 | 28 926 279 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 151 | 1 552 140 | 0,27 | 173,20 | 718 960 | 268 833 131 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 350 | 166 344 | 0,21 | 173,20 | 60 621 | 28 811 047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 461 | 1 547 989 | 0,03 | 171,79 | 79 195 | 265 929 030 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 39 | 165 994 | 0,02 | 171,79 | 6 700 | 28 516 109 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 107 | 1 547 528 | 0,07 | 168,78 | 186 842 | 261 195 645 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 165 955 | 0,06 | 168,78 | 15 697 | 28 010 300 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1 546 421 | 0,04 | 167,63 | 108 289 | 259 226 552 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 165 862 | 0,03 | 167,63 | 9 052 | 27 803 447 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13 548 | 1 500 227 | 0,91 | 154,78 | 2 096 961 | 232 205 285 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 142 | 161 969 | 0,71 | 154,78 | 176 759 | 25 069 578 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8 098 | 1 486 679 | 0,55 | 153,97 | 1 246 878 | 228 909 318 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 683 | 160 827 | 0,43 | 153,97 | 105 164 | 24 763 112 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 877 | 1 478 581 | 0,19 | 153,25 | 440 907 | 226 595 939 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 242 | 160 144 | 0,15 | 153,25 | 37 087 | 24 542 436 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1 475 704 | 0,04 | 152,21 | 98 330 | 224 621 185 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 159 902 | 0,03 | 152,21 | 8 219 | 24 339 147 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6 022 | 1 475 058 | 0,41 | 152,48 | 918 235 | 224 916 844 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 507 | 159 848 | 0,32 | 152,48 | 77 307 | 24 373 623 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3 542 | 1 469 036 | 0,24 | 154,60 | 547 582 | 227 108 412 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 299 | 159 341 | 0,19 | 154,60 | 46 224 | 24 633 625 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26 426 | 1 465 494 | 1,84 | 146,21 | 3 863 756 | 214 270 464 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 228 | 159 042 | 1,42 | 146,21 | 325 757 | 23 253 594 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 994 | 1 439 068 | 0,21 | 145,98 | 437 057 | 210 071 549 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 252 | 156 814 | 0,16 | 145,98 | 36 786 | 22 891 316 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6 369 | 1 436 074 | 0,45 | 145,46 | 926 430 | 208 890 175 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 537 | 156 562 | 0,34 | 145,46 | 78 112 | 22 773 383 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 291 | 1 429 705 | 0,09 | 142,86 | 184 429 | 204 244 082 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 109 | 156 025 | 0,07 | 142,86 | 15 571 | 22 289 341 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10 790 | 1 428 414 | 0,76 | 141,44 | 1 526 192 | 202 042 018 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 910 | 155 916 | 0,59 | 141,44 | 128 715 | 22 053 539 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5 072 | 1 417 624 | 0,36 | 140,90 | 714 657 | 199 746 624 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 427 | 155 006 | 0,28 | 140,90 | 60 165 | 21 840 717 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 631 | 1 412 552 | 0,33 | 137,69 | 637 622 | 194 487 928 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 390 | 154 579 | 0,25 | 137,69 | 53 697 | 21 283 287 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3 693 | 1 407 921 | 0,26 | 136,91 | 505 605 | 192 756 915 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 311 | 154 189 | 0,20 | 136,91 | 42 579 | 21 109 846 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3 144 | 1 404 228 | 0,22 | 136,18 | 428 151 | 191 228 471 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 265 | 153 878 | 0,17 | 136,18 | 36 088 | 20 955 183 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14 018 | 1 545 775 | 0,92 | 161,97 | 2 270 439 | 250 362 994 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 181 | 165 808 | 0,72 | 161,97 | 191 282 | 26 855 259 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31 530 | 1 531 757 | 2,10 | 156,42 | 4 932 061 | 239 604 170 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 658 | 164 627 | 1,64 | 156,42 | 415 776 | 25 751 680 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1 008 660 | 9 691 294 | -9,43 | 180,50 | -182 063 130 | 1 749 278 567 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -91 340 | 877 603 | -9,43 | 180,50 | -16 486 870 | 158 407 342 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -251 902 | 2 971 128 | -7,82 | 0,40 | -101 391 | 1 195 879 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -22 837 | 286 893 | -7,37 | 0,40 | -9 192 | 115 474 | |
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 535 601 | 1 658 190 | 47,71 | ||||
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 57 049 | 155 874 | 57,73 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 33 446 882 | 0,00 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 2 968 974 | 0,02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2 896 968 | 0,02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 274 560 | 0,20 | ||||
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 61 134 | 5 612 949 | 1,10 | 0,69 | 42 354 | 3 888 651 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 5 041 | 494 133 | 1,03 | 0,69 | 3 492 | 342 335 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 93 091 | 5 551 815 | 1,71 | 0,69 | 64 456 | 3 844 077 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 7 676 | 489 092 | 1,59 | 0,69 | 5 315 | 338 647 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4 434 | 5 458 724 | 0,08 | 0,68 | 3 028 | 3 727 217 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 366 | 481 416 | 0,08 | 0,68 | 250 | 328 711 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 207 676 | 5 454 290 | 3,96 | 0,68 | 141 324 | 3 711 644 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 17 124 | 481 050 | 3,69 | 0,68 | 11 653 | 327 355 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4 342 | 5 246 614 | 0,08 | 0,66 | 2 887 | 3 488 998 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 358 | 463 926 | 0,08 | 0,66 | 238 | 308 511 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 1 740 581 | 5 242 272 | 49,71 | 0,63 | 1 097 958 | 3 306 825 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 143 519 | 463 568 | 44,84 | 0,63 | 90 532 | 292 419 | |
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33 446 372 | 0,00 | ||||
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33 446 372 | 0,00 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2 896 414 | 0,02 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2 896 414 | 0,02 | ||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
148 821 | ||||||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
1 396 292 | ||||||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4 792 | 1 401 084 | 0,34 | ||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4 792 | 1 401 084 | 0,34 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25 844 | 93 417 | 38,25 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25 844 | 93 417 | 38,25 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2 505 | 33 445 860 | 0,01 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2 505 | 33 445 860 | 0,01 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8 746 | 2 719 343 | 0,32 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8 746 | 2 719 343 | 0,32 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13 304 | 39 330 977 | 0,03 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13 304 | 39 330 977 | 0,03 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2 044 | 42 977 301 | 0,00 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2 044 | 42 977 301 | 0,00 | ||||
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 259 109 | 39 317 673 | 0,66 | 25,65 | 6 646 146 | 1 008 498 312 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24 113 | 3 610 443 | 0,67 | 25,65 | 618 498 | 92 607 863 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28 878 | 39 058 564 | 0,07 | 25,51 | 736 788 | 996 532 390 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 688 | 3 586 330 | 0,08 | 25,51 | 68 581 | 91 500 906 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218 171 | 39 029 686 | 0,56 | 25,27 | 5 513 683 | 986 369 933 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 20 304 | 3 583 642 | 0,57 | 25,27 | 513 129 | 90 566 876 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 74 582 | 38 811 515 | 0,19 | 25,54 | 1 904 824 | 991 246 093 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6 941 | 3 563 338 | 0,20 | 25,54 | 177 273 | 91 007 653 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 116 672 | 38 736 933 | 0,30 | 25,33 | 2 955 325 | 981 214 260 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10 858 | 3 556 397 | 0,31 | 25,33 | 275 035 | 90 084 247 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 500 | 38 620 261 | 0,03 | 17,01 | 212 625 | 656 930 640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 500 | 38 620 261 | 0,03 | 17,01 | 212 625 | 656 930 640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 40 632 | 38 607 761 | 0,11 | 24,80 | 1 007 674 | 957 472 473 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 781 | 3 533 039 | 0,11 | 24,80 | 93 769 | 87 619 367 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 82 148 | 38 567 129 | 0,21 | 24,46 | 2 009 373 | 943 367 402 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7 645 | 3 529 258 | 0,22 | 24,46 | 187 000 | 86 327 062 | |
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
21 912 | ||||||||
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
227 211 | ||||||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209 175 | 23 277 | -89,99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209 175 | 23 277 | -89,99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209 175 | 232 452 | 898,63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209 175 | 232 452 | 898,63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | -2 368 357 | 1 729 158 | -57,80 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8 750 | 42 975 257 | 0,02 | 36,70 | 321 125 | 1 577 191 932 | |
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8 750 | 42 975 257 | 0,02 | 36,70 | 321 125 | 1 577 191 932 | |
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33 443 355 | 0,00 | ||||
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33 443 355 | 0,00 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2 895 860 | 0,02 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2 895 860 | 0,02 | ||||
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 33 442 926 | 0,06 | 22,74 | 454 800 | 760 492 137 | |
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 33 442 926 | 0,06 | 22,74 | 454 800 | 760 492 137 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 000 | 38 484 981 | 0,04 | 5,22 | 78 300 | 200 891 601 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 000 | 38 484 981 | 0,04 | 5,22 | 78 300 | 200 891 601 | |
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33 422 926 | 0,00 | ||||
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33 422 926 | 0,00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33 422 529 | 0,00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33 422 529 | 0,00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33 422 072 | 0,00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33 422 072 | 0,00 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10 000 | 2 710 597 | 0,37 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10 000 | 2 710 597 | 0,37 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33 384 | 67 573 | 97,65 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33 384 | 67 569 | 97,66 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2 144 | 33 421 639 | 0,01 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2 144 | 33 421 639 | 0,01 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 10 622 568 | 14 575 984 | 268,69 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 1 252 432 | 1 585 054 | 376,53 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17 104 | 38 469 981 | 0,04 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17 104 | 38 469 981 | 0,04 | ||||
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 26 450 | 4 501 658 | 0,59 | 6,42 | 169 849 | 28 907 397 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3 118 | 364 161 | 0,86 | 6,42 | 20 022 | 2 338 460 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7 815 | 4 475 208 | 0,17 | 6,35 | 49 654 | 28 434 129 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 921 | 361 043 | 0,26 | 6,35 | 5 852 | 2 293 959 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2 364 | 4 467 393 | 0,05 | 5,82 | 13 759 | 26 001 121 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 279 | 360 122 | 0,08 | 5,82 | 1 624 | 2 095 982 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 170 549 | 15 967 504 | 1,08 | 7,78 | 1 327 008 | 124 239 955 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 20 108 | 1 342 986 | 1,52 | 7,78 | 156 456 | 10 449 505 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 101 315 | 15 796 955 | 0,65 | 7,75 | 785 070 | 122 407 445 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11 945 | 1 322 878 | 0,91 | 7,75 | 92 559 | 10 250 717 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 78 271 | 15 695 640 | 0,50 | 7,95 | 622 466 | 124 822 716 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9 224 | 1 310 933 | 0,71 | 7,95 | 73 356 | 10 425 457 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13 155 | 15 617 369 | 0,08 | 7,93 | 104 363 | 123 897 273 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 550 | 1 301 709 | 0,12 | 7,93 | 12 297 | 10 326 848 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 138 122 | 15 604 214 | 0,89 | 7,68 | 1 060 680 | 119 829 441 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16 278 | 1 300 159 | 1,27 | 7,68 | 125 004 | 9 984 311 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10 585 | 15 466 092 | 0,07 | 7,51 | 79 540 | 116 218 402 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 247 | 1 283 881 | 0,10 | 7,51 | 9 370 | 9 647 595 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 88 046 | 15 455 507 | 0,57 | 6,92 | 609 278 | 106 952 108 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10 386 | 1 282 634 | 0,82 | 6,92 | 71 871 | 8 875 827 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 51 082 | 15 367 461 | 0,33 | 6,78 | 346 367 | 104 200 606 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6 026 | 1 272 248 | 0,48 | 6,78 | 40 860 | 8 626 605 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 358 | 15 316 379 | 0,00 | 6,64 | 2 375 | 101 624 175 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 | 1 266 222 | 0,00 | 6,64 | 279 | 8 401 383 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 984 | 15 316 021 | 0,01 | 6,76 | 6 647 | 103 459 722 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 | 1 266 180 | 0,01 | 6,76 | 784 | 8 553 046 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 53 401 | 15 315 037 | 0,35 | 6,75 | 360 521 | 103 394 878 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6 299 | 1 266 064 | 0,50 | 6,75 | 42 526 | 8 547 451 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29 090 | 15 261 636 | 0,19 | 6,71 | 195 089 | 102 350 636 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3 432 | 1 259 765 | 0,27 | 6,71 | 23 016 | 8 448 488 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 250 | 15 232 546 | 0,28 | 6,60 | 279 002 | 100 589 641 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4 984 | 1 256 333 | 0,40 | 6,60 | 32 912 | 8 296 321 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 48 222 | 15 190 296 | 0,32 | 6,53 | 315 058 | 99 245 799 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5 688 | 1 251 349 | 0,46 | 6,53 | 37 163 | 8 175 689 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 19 789 | 4 465 029 | 0,45 | 5,74 | 113 619 | 25 635 964 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2 334 | 359 843 | 0,65 | 5,74 | 13 401 | 2 066 039 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1 521 | 4 445 240 | 0,03 | 5,93 | 9 020 | 26 360 273 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 179 | 357 509 | 0,05 | 5,93 | 1 061 | 2 120 028 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7 010 | 4 443 719 | 0,16 | 5,99 | 41 972 | 26 606 323 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 827 | 357 330 | 0,23 | 5,99 | 4 952 | 2 139 478 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7 772 | 4 436 709 | 0,18 | 5,84 | 45 405 | 25 919 698 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 946 | 356 503 | 0,27 | 5,84 | 5 527 | 2 082 726 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7 248 | 4 428 937 | 0,16 | 5,84 | 42 335 | 25 868 978 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 883 | 355 557 | 0,25 | 5,84 | 5 158 | 2 076 773 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7 489 | 15 142 074 | 0,05 | 5,97 | 44 701 | 90 381 525 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 1 245 661 | 0,07 | 5,97 | 5 444 | 7 435 226 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 182 827 | 15 134 585 | 1,22 | 5,97 | 1 091 221 | 90 332 284 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22 266 | 1 244 749 | 1,82 | 5,97 | 132 897 | 7 429 409 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9 157 | 14 951 758 | 0,06 | 5,95 | 54 518 | 89 018 282 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 115 | 1 222 483 | 0,09 | 5,95 | 6 638 | 7 278 297 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 90 674 | 14 942 601 | 0,61 | 5,99 | 542 929 | 89 471 812 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11 043 | 1 221 368 | 0,91 | 5,99 | 66 122 | 7 313 185 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 118 | 14 851 927 | 0,05 | 5,99 | 48 599 | 88 912 546 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 989 | 1 210 325 | 0,08 | 5,99 | 5 921 | 7 245 732 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 154 | 14 843 809 | 0,10 | 5,75 | 87 098 | 85 314 792 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 846 | 1 209 336 | 0,15 | 5,75 | 10 610 | 6 950 659 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 93 690 | 14 828 655 | 0,64 | 5,71 | 534 979 | 84 673 103 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11 410 | 1 207 490 | 0,95 | 5,71 | 65 152 | 6 894 889 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30 003 | 4 421 689 | 0,68 | 6,00 | 180 018 | 26 530 134 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3 654 | 354 674 | 1,04 | 6,00 | 21 924 | 2 128 044 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 692 | 4 391 686 | 0,02 | 5,92 | 4 095 | 25 989 998 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 84 | 351 020 | 0,02 | 5,92 | 497 | 2 077 336 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16 501 | 4 390 994 | 0,38 | 6,13 | 101 153 | 26 917 232 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2 010 | 350 936 | 0,58 | 6,13 | 12 322 | 2 151 273 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16 937 | 4 374 493 | 0,39 | 5,83 | 98 673 | 25 485 359 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2 063 | 348 926 | 0,59 | 5,83 | 12 019 | 2 032 808 | |
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3 676 | 3 676 | |||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1 503 | 42 966 507 | 0,00 | ||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1 503 | 42 966 507 | 0,00 | ||||
| 2022-05-16 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 22 983 | 2 528 583 | 0,92 | 1,99 | 45 628 | 5 019 996 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 2 882 | 256 209 | 1,14 | 1,99 | 5 722 | 508 652 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 758 094 | 2 505 600 | 43,38 | 1,95 | 1 478 283 | 4 885 920 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 95 060 | 253 327 | 60,06 | 1,95 | 185 367 | 493 988 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 101 831 | 1 747 506 | 6,19 | 1,93 | 196 962 | 3 380 026 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 12 769 | 158 267 | 8,78 | 1,93 | 24 698 | 306 120 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 325 373 | 1 645 675 | 24,64 | 1,70 | 553 134 | 2 797 648 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 40 800 | 145 498 | 38,97 | 1,70 | 69 360 | 247 347 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 2 592 497 | 4 674 392 | 124,53 | 23,00 | 59 627 431 | 107 511 016 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 233 590 | 421 532 | 124,29 | 23,00 | 5 372 570 | 9 695 236 | |
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33 419 495 | 0,00 | ||||
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33 419 495 | 0,00 | ||||
| 2022-03-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 29 497 | 29 497 | |||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17 500 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17 500 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17 500 | 42 965 004 | 0,04 | 20,06 | 351 050 | 861 877 980 | |
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17 500 | 42 965 004 | 0,04 | 20,06 | 351 050 | 861 877 980 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 175 795 | 33 419 055 | 0,53 | 73,31 | 12 887 303 | 2 449 907 477 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 14 490 | 2 941 147 | 0,50 | 73,31 | 1 062 243 | 215 611 663 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 017 | 33 243 260 | 0,00 | 71,95 | 73 177 | 2 391 975 557 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 84 | 2 926 657 | 0,00 | 71,95 | 6 044 | 210 583 800 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25 107 | 33 242 243 | 0,08 | 71,90 | 1 805 126 | 2 390 027 518 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 070 | 2 926 573 | 0,07 | 71,90 | 148 827 | 210 412 697 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65 147 | 33 217 136 | 0,20 | 71,72 | 4 672 408 | 2 382 366 211 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5 370 | 2 924 503 | 0,18 | 71,72 | 385 142 | 209 748 280 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92 385 | 33 151 989 | 0,28 | 70,68 | 6 529 310 | 2 343 016 823 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7 615 | 2 919 133 | 0,26 | 70,68 | 538 190 | 206 309 725 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 33 059 604 | 0,06 | 22,05 | 441 000 | 728 964 268 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 33 059 604 | 0,06 | 22,05 | 441 000 | 728 964 268 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92 234 | 33 039 604 | 0,28 | 68,07 | 6 278 507 | 2 249 055 404 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7 566 | 2 891 518 | 0,26 | 68,07 | 515 029 | 196 829 968 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 22 178 | 32 947 370 | 0,07 | 68,43 | 1 517 656 | 2 254 611 592 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 827 | 2 883 952 | 0,06 | 68,43 | 125 023 | 197 350 854 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 100 731 | 32 925 192 | 0,31 | 68,37 | 6 886 696 | 2 251 003 187 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8 296 | 2 882 125 | 0,29 | 68,37 | 567 174 | 197 042 816 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 285 672 | 32 824 461 | 0,88 | 67,74 | 19 352 821 | 2 223 689 828 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7 300 | 32 538 789 | 0,02 | 67,40 | 491 984 | 2 192 951 685 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 271 997 | 14 734 965 | 1,88 | 54,57 | 14 843 883 | 804 141 559 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22 403 | 1 196 080 | 1,91 | 54,57 | 1 222 615 | 65 274 511 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5 174 | 14 462 968 | 0,04 | 53,82 | 278 457 | 778 376 690 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 426 | 1 173 677 | 0,04 | 53,82 | 22 927 | 63 165 653 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 64 119 | 14 457 794 | 0,45 | 54,26 | 3 479 200 | 784 503 035 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5 281 | 1 173 251 | 0,45 | 54,26 | 286 556 | 63 662 476 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 23 804 | 14 393 675 | 0,17 | 53,73 | 1 279 048 | 773 408 142 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 961 | 1 167 970 | 0,17 | 53,73 | 105 369 | 62 757 948 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5 359 | 14 369 871 | 0,04 | 54,16 | 290 217 | 778 200 364 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 441 | 1 166 009 | 0,04 | 54,16 | 23 882 | 63 145 217 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 182 326 | 32 531 489 | 0,56 | 66,04 | 12 040 390 | 2 148 304 711 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 320 526 | 32 349 163 | 1,00 | 66,02 | 21 159 973 | 2 135 575 284 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10 985 | 32 028 637 | 0,03 | 66,95 | 735 433 | 2 144 278 813 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 265 522 | 32 017 652 | 0,84 | 66,81 | 17 740 295 | 2 139 192 181 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 772 751 | 31 752 130 | 2,49 | 67,54 | 52 192 839 | 2 144 589 664 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6 100 | 30 979 379 | 0,02 | 67,20 | 409 899 | 2 081 705 841 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 40 164 | 30 973 279 | 0,13 | 66,57 | 2 673 577 | 2 061 782 777 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 27 841 | 14 364 512 | 0,19 | 57,22 | 1 593 076 | 821 944 559 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 307 | 1 165 568 | 0,20 | 57,22 | 132 008 | 66 694 384 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11 526 | 14 336 671 | 0,08 | 51,61 | 594 898 | 739 967 202 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 953 | 1 163 261 | 0,08 | 51,61 | 49 188 | 60 040 088 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17 119 | 14 325 145 | 0,12 | 50,56 | 865 460 | 724 214 868 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 414 | 1 162 308 | 0,12 | 50,56 | 71 485 | 58 761 062 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22 395 | 14 308 026 | 0,16 | 49,70 | 1 113 056 | 711 124 631 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 851 | 1 160 894 | 0,16 | 49,70 | 91 997 | 57 697 709 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 54 024 | 14 285 631 | 0,38 | 51,67 | 2 791 490 | 738 157 125 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4 465 | 1 159 043 | 0,39 | 51,67 | 230 712 | 59 889 259 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 117 291 | 14 231 607 | 0,83 | 51,59 | 6 050 820 | 734 181 565 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86 479 | 14 114 316 | 0,62 | 52,04 | 4 500 497 | 734 530 176 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5 500 | 14 027 837 | 0,04 | 58,90 | 323 934 | 826 198 919 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 57 547 | 14 022 337 | 0,41 | 58,87 | 3 387 844 | 825 507 599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9 350 | 13 964 790 | 0,07 | 58,76 | 549 368 | 820 513 805 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 132 367 | 13 955 440 | 0,96 | 58,13 | 7 693 938 | 811 171 114 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 25 900 | 13 823 073 | 0,19 | 57,59 | 1 491 519 | 796 037 599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 083 | 13 797 173 | 0,85 | 56,86 | 6 601 060 | 784 576 243 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 200 | 13 681 090 | 0,01 | 56,60 | 67 914 | 774 281 289 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19 750 | 13 679 890 | 0,14 | 56,39 | 1 113 649 | 771 372 061 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 31 207 | 13 660 140 | 0,23 | 57,53 | 1 795 292 | 785 847 364 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 102 207 | 13 628 933 | 0,76 | 56,57 | 5 782 279 | 771 045 981 | |
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30 933 115 | 0,00 | ||||
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30 933 115 | 0,00 | ||||
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 193 997 | 30 932 696 | 0,63 | 72,91 | 14 144 224 | 2 255 287 399 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 881 875 | 30 738 699 | 2,95 | 72,77 | 64 177 924 | 2 236 990 377 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 29 703 | 29 856 824 | 0,10 | 72,00 | 2 138 616 | 2 149 691 328 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 139 612 | 29 827 121 | 0,47 | 71,96 | 10 045 795 | 2 146 213 474 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 288 368 | 29 687 509 | 0,98 | 71,91 | 20 736 197 | 2 134 793 147 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5 382 | 29 399 141 | 0,02 | 71,03 | 382 302 | 2 088 323 882 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9 893 | 29 393 759 | 0,03 | 70,24 | 694 840 | 2 064 485 360 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 36 476 | 29 383 866 | 0,12 | 69,63 | 2 539 700 | 2 045 898 684 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9 352 | 29 347 390 | 0,03 | 68,52 | 640 841 | 2 011 015 226 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 861 | 29 338 038 | 0,00 | 67,90 | 58 460 | 1 991 999 972 | |
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
346 863 | ||||||||
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
4 357 556 | ||||||||
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -51 399 | 42 947 504 | -0,12 | 161,39 | -8 295 146 | 6 931 181 712 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -4 738 | 4 069 762 | -0,12 | 161,39 | -764 653 | 656 807 901 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -8 332 | 42 998 903 | -0,02 | 161,34 | -1 344 327 | 6 937 658 005 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -768 | 4 074 500 | -0,02 | 161,34 | -123 913 | 657 400 202 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -25 833 | 43 007 235 | -0,06 | 160,80 | -4 154 029 | 6 915 701 011 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2 381 | 4 075 268 | -0,06 | 160,80 | -382 872 | 655 316 135 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1 007 | 43 033 068 | 0,00 | 165,68 | -166 844 | 7 129 895 142 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -93 | 4 077 649 | 0,00 | 165,68 | -15 409 | 675 601 605 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -9 618 | 43 034 075 | -0,02 | 164,82 | -1 585 266 | 7 092 996 737 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -886 | 4 077 742 | -0,02 | 164,82 | -146 033 | 672 104 854 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1 337 | 43 043 693 | 0,00 | 163,39 | -218 449 | 7 032 809 999 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -123 | 4 078 628 | 0,00 | 163,39 | -20 097 | 666 397 648 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -20 154 | 43 045 030 | -0,05 | 160,96 | -3 243 986 | 6 928 523 724 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1 858 | 4 078 751 | -0,05 | 160,96 | -299 063 | 656 515 353 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -29 432 | 43 065 184 | -0,07 | 160,53 | -4 724 631 | 6 913 124 792 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2 713 | 4 080 609 | -0,07 | 160,53 | -435 510 | 655 047 921 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -5 860 | 43 094 616 | -0,01 | 160,08 | -938 044 | 6 898 400 822 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -540 | 4 083 322 | -0,01 | 160,08 | -86 441 | 653 640 627 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -208 597 | 43 100 476 | -0,48 | 160,00 | -33 375 520 | 6 896 076 160 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -19 226 | 4 083 862 | -0,47 | 160,00 | -3 076 160 | 653 417 920 | |
| 2021-11-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 50 000 | 7 053 176 | 0,71 | 4,36 | 218 250 | 30 787 113 | |
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29 337 177 | 0,00 | ||||
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29 337 177 | 0,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86 932 | 13 526 726 | 0,65 | 95,83 | 8 330 572 | 1 296 247 215 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -138 815 | 0 | -100,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -11 184 | 0 | -100,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -14 | 13 439 794 | 0,00 | 102,00 | -1 428 | 1 370 858 988 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 138 815 | 13 439 808 | 1,04 | 0,01 | 1 388 | 134 398 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -2 | 1 154 578 | 0,00 | 102,00 | -204 | 117 766 956 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 11 184 | 1 154 580 | 0,98 | 0,01 | 112 | 11 546 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 153 | 13 300 993 | 0,01 | 94,59 | 109 064 | 1 258 164 870 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13 299 840 | 0,00 | 94,48 | 37 791 | 1 256 535 634 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30 285 | 13 299 440 | 0,23 | 94,38 | 2 858 425 | 1 255 257 005 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 52 201 | 13 269 155 | 0,39 | 93,35 | 4 872 948 | 1 238 671 639 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5 300 | 13 216 954 | 0,04 | 92,88 | 492 279 | 1 227 629 017 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 73 635 | 13 211 654 | 0,56 | 87,61 | 6 451 464 | 1 157 527 175 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 396 | 13 138 019 | 0,02 | 87,48 | 209 607 | 1 149 341 492 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4 649 | 13 135 623 | 0,04 | 87,07 | 404 793 | 1 143 731 830 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 968 | 13 130 974 | 0,02 | 86,94 | 258 033 | 1 141 587 183 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13 128 006 | 0,00 | 89,66 | 35 863 | 1 177 008 444 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 100 | 13 127 606 | 0,01 | 88,16 | 96 982 | 1 157 395 383 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 186 | 13 126 506 | 0,06 | 87,91 | 719 659 | 1 153 995 773 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12 898 | 13 118 320 | 0,10 | 87,79 | 1 132 303 | 1 151 644 194 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7 764 | 13 105 422 | 0,06 | 85,95 | 667 333 | 1 126 439 853 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13 097 658 | 0,00 | 84,80 | 33 921 | 1 110 714 143 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13 097 258 | 0,00 | 88,82 | 35 526 | 1 163 232 969 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16 269 | 13 096 858 | 0,12 | 88,76 | 1 444 017 | 1 162 461 400 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21 595 | 13 080 589 | 0,17 | 88,59 | 1 913 036 | 1 158 770 138 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6 086 | 13 058 994 | 0,05 | 88,01 | 535 634 | 1 149 333 815 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4 600 | 13 052 908 | 0,04 | 86,44 | 397 646 | 1 128 354 716 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 300 | 13 048 308 | 0,00 | 85,58 | 25 674 | 1 116 674 199 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4 500 | 13 048 008 | 0,03 | 88,00 | 395 990 | 1 148 195 998 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 44 700 | 13 043 508 | 0,34 | 86,07 | 3 847 481 | 1 122 699 081 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 600 | 12 998 808 | 0,00 | 85,72 | 51 434 | 1 114 295 518 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3 723 | 12 998 208 | 0,03 | 84,39 | 314 185 | 1 096 922 673 | |
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 3 960 811 | 3 960 811 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -3 960 811 | 0 | -100,00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 315 777 | 315 777 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -315 777 | 0 | -100,00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 1 320 302 | 1 320 302 | 15,00 | 19 804 530 | 19 804 530 | ||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 104 698 | 104 698 | 15,00 | 1 570 470 | 1 570 470 | ||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29 336 784 | 0,00 | ||||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29 336 784 | 0,00 | ||||
| 2021-07-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 66 474 | 66 474 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7 368 | 7 368 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 121 612 | 12 994 485 | 0,94 | 92,75 | 11 279 014 | 1 205 185 206 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7 009 | 12 872 873 | 0,05 | 91,64 | 642 276 | 1 179 617 303 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22 353 | 12 865 864 | 0,17 | 90,20 | 2 016 332 | 1 160 553 683 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4 603 | 12 843 511 | 0,04 | 89,74 | 413 070 | 1 152 566 402 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30 221 | 12 838 908 | 0,24 | 90,70 | 2 741 157 | 1 164 536 460 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 200 | 12 808 687 | 0,01 | 90,40 | 108 474 | 1 157 841 261 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11 731 | 12 807 487 | 0,09 | 90,39 | 1 060 378 | 1 157 682 838 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3 847 | 12 795 756 | 0,03 | 89,90 | 345 828 | 1 150 282 163 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7 079 | 12 791 909 | 0,06 | 89,87 | 636 196 | 1 149 620 375 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10 459 | 12 784 830 | 0,08 | 91,87 | 960 845 | 1 174 514 205 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22 445 | 12 774 371 | 0,18 | 91,80 | 2 060 393 | 1 172 654 044 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10 170 | 12 751 926 | 0,08 | 90,76 | 923 046 | 1 157 386 482 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5 200 | 12 741 756 | 0,04 | 90,27 | 469 420 | 1 150 237 814 | |
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 23 274 | 23 274 | |||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12 782 | 38 452 877 | 0,03 | ||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12 782 | 38 452 877 | 0,03 | ||||
| 2021-06-22 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
A - Award | 23 344 | 23 344 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34 996 | 34 996 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15 600 | 34 189 | 83,92 | ||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15 600 | 34 189 | 83,92 | ||||
| 2021-06-10 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 8 010 | 8 010 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 923 | 29 336 439 | 0,01 | ||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 923 | 29 336 439 | 0,01 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3 462 | 3 462 | |||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17 500 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17 500 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1 402 | 43 309 073 | 0,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1 402 | 43 309 073 | 0,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17 500 | 43 307 671 | 0,04 | 19,02 | 332 850 | 823 711 902 | |
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17 500 | 43 307 671 | 0,04 | 19,02 | 332 850 | 823 711 902 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 29 334 516 | 0,07 | 18,97 | 379 400 | 556 475 769 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 2 870 749 | 0,70 | 18,97 | 379 400 | 54 458 109 | |
| 2021-05-13 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29 314 516 | 0,00 | ||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29 314 516 | 0,00 | ||||
| 2021-02-25 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 47 200 | 47 200 | |||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
315 516 | ||||||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
3 094 590 | ||||||||
| 2021-02-23 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 6 423 | 6 423 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6 427 576 | 27 511 741 | 30,49 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536 438 | 2 345 481 | 29,65 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7 286 794 | 21 084 165 | 52,81 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536 414 | 1 809 043 | 42,15 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 1 941 | 5 420 | 55,79 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6 654 603 | 13 797 371 | 93,17 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 598 860 | 1 272 629 | 88,88 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7 142 768 | 7 142 768 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 673 769 | 673 769 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 3 479 | 3 479 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -9 191 433 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -767 106 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -10 420 117 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -767 072 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Convertible Preferred Stock |
M - Exercise | -2 776 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -9 516 082 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -856 370 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -10 214 159 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -963 490 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -4 975 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 5 792 538 | 7 003 176 | 478,47 | 16,00 | 92 680 608 | 112 050 816 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 457 462 | 571 659 | 400,59 | 16,00 | 7 319 392 | 9 146 544 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 9 191 433 | 9 191 433 | 8,55 | 78 586 752 | 78 586 752 | ||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 767 106 | 767 106 | 8,55 | 6 558 756 | 6 558 756 | ||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158 456 | 23 277 | -87,19 | ||||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158 460 | 23 280 | -87,19 | ||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
590 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
114 197 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
1 210 638 | ||||||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5 188 | 41 500 | -11,11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5 188 | 41 500 | -11,11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5 188 | 9 252 951 | 0,06 | 12,85 | 66 666 | 118 900 420 | |
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5 188 | 9 252 951 | 0,06 | 12,85 | 66 666 | 118 900 420 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5 833 | 2 527 | -69,77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5 833 | 2 527 | -69,77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5 377 | 6 723 | -44,44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5 377 | 6 723 | -44,44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5 833 | 2 895 306 | 0,20 | 40,27 | 234 895 | 116 593 973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5 833 | 2 895 306 | 0,20 | 40,27 | 234 895 | 116 593 973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5 377 | 2 889 473 | 0,19 | 16,00 | 86 032 | 46 231 568 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5 377 | 2 889 473 | 0,19 | 16,00 | 86 032 | 46 231 568 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 154 222 | 5 212 371 | 3,05 | 60,00 | 9 253 320 | 312 742 260 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 12 444 | 509 480 | 2,50 | 60,00 | 746 640 | 30 568 800 | |
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
332 622 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
3 953 416 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
1 200 369 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
13 413 895 | ||||||||
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -111 094 | 10 699 954 | -1,03 | 220,50 | -24 496 227 | 2 359 339 857 | |
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -10 060 | 968 943 | -1,03 | 220,50 | -2 218 230 | 213 651 932 | |
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2 884 096 | 0,01 | ||||
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2 884 096 | 0,01 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29 314 152 | 0,00 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29 314 152 | 0,00 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 518 555 | 10 283 888 | 5,31 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 38 974 | 1 199 122 | 3,36 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 394 360 | 3 501 691 | 12,69 | 15,25 | 6 013 990 | 53 400 788 | |
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 29 640 | 320 049 | 10,21 | 15,25 | 452 010 | 4 880 747 | |
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 616 846 | 616 846 | 89,99 | 55 509 972 | 55 509 972 | ||
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 49 820 | 49 820 | 89,99 | 4 483 302 | 4 483 302 | ||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1 386 033 | 10 811 048 | -11,36 | 220,50 | -305 620 276 | 2 383 836 084 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -125 513 | 979 003 | -11,36 | 220,50 | -27 675 616 | 215 870 162 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13 516 | 10 418 | -56,47 | ||||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13 516 | 10 418 | -56,47 | ||||
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 411 619 | 12 736 556 | 12,46 | 108,00 | 152 454 852 | 1 375 548 048 | |
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 158 | 1 143 396 | 11,31 | 108,00 | 12 545 064 | 123 486 768 | |
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2 883 873 | 0,01 | ||||
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2 883 873 | 0,01 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29 313 809 | 0,00 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29 313 809 | 0,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 382 884 | 5 058 149 | 8,19 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -382 884 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 30 349 | 497 036 | 6,50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -30 349 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -574 327 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -45 524 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 2 698 424 | 4 675 265 | 136,50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -2 698 424 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 247 034 | 466 687 | 112,47 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -247 034 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -4 047 634 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -370 552 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 1 976 841 | 1 976 841 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -1 976 841 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 219 653 | 219 653 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -219 653 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -2 965 263 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -329 478 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 1 474 319 | 9 247 763 | 18,97 | 19,00 | 28 012 061 | 175 707 497 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 104 628 | 870 873 | 13,65 | 19,00 | 1 987 932 | 16 546 587 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 574 327 | 7 773 444 | 7,98 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 45 524 | 766 245 | 6,32 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 4 047 634 | 7 199 117 | 128,44 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 370 552 | 720 721 | 105,82 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 2 965 263 | 3 151 483 | 1 592,34 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 329 478 | 350 169 | 1 592,37 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Option (right to buy) |
A - Award | 46 688 | 46 688 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 957 211 | 957 211 | 14,52 | 13 898 321 | 13 898 321 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 75 873 | 75 873 | 14,52 | 1 101 646 | 1 101 646 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 3 373 029 | 3 373 029 | 3,93 | 13 264 099 | 13 264 099 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 308 793 | 308 793 | 3,93 | 1 214 298 | 1 214 298 | ||
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7 843 | 11 324 937 | 0,07 | 58,09 | 455 565 | 657 814 628 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 557 | 1 027 238 | 0,05 | 58,09 | 32 354 | 59 667 633 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19 235 | 11 317 094 | 0,17 | 56,92 | 1 094 854 | 644 167 859 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 365 | 1 026 681 | 0,13 | 56,92 | 77 696 | 58 438 580 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4 705 | 11 297 859 | 0,04 | 56,76 | 267 055 | 641 265 347 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 334 | 1 025 316 | 0,03 | 56,76 | 18 958 | 58 196 834 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13 153 | 11 293 154 | 0,12 | 55,35 | 728 057 | 625 108 824 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 933 | 1 024 982 | 0,09 | 55,35 | 51 644 | 56 735 726 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29 327 | 11 280 001 | 0,26 | 52,11 | 1 528 374 | 587 856 124 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 081 | 1 024 049 | 0,20 | 52,11 | 108 451 | 53 368 211 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4 306 | 11 250 674 | 0,04 | 51,41 | 221 368 | 578 388 150 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 306 | 1 021 968 | 0,03 | 51,41 | 15 731 | 52 538 557 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 74 381 | 11 246 368 | 0,67 | 52,44 | 3 900 235 | 589 713 428 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5 278 | 1 021 662 | 0,52 | 52,44 | 276 757 | 53 571 766 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10 467 | 11 171 987 | 0,09 | 52,40 | 548 468 | 585 408 767 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 743 | 1 016 384 | 0,07 | 52,40 | 38 933 | 53 258 217 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 120 | 11 161 520 | 0,01 | 51,97 | 58 206 | 580 064 194 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 80 | 1 015 641 | 0,01 | 51,97 | 4 158 | 52 782 863 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22 361 | 11 160 400 | 0,20 | 51,98 | 1 162 235 | 580 072 950 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 587 | 1 015 561 | 0,16 | 51,98 | 82 486 | 52 784 799 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 36 647 | 11 138 039 | 0,33 | 50,15 | 1 837 909 | 558 591 591 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 601 | 1 013 974 | 0,26 | 50,15 | 130 445 | 50 852 520 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10 983 | 11 101 392 | 0,10 | 49,72 | 546 102 | 551 988 964 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 779 | 1 011 373 | 0,08 | 49,72 | 38 734 | 50 287 994 | |
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
20 691 | ||||||||
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
186 220 | ||||||||
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 172 | 11 090 409 | 0,14 | 47,47 | 720 200 | 526 450 625 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 220 | 1 010 594 | 0,12 | 47,47 | 57 912 | 47 971 887 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 76 473 | 11 075 237 | 0,70 | 47,39 | 3 623 857 | 524 826 686 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6 151 | 1 009 374 | 0,61 | 47,39 | 291 480 | 47 831 609 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 807 | 10 998 764 | 0,14 | 47,04 | 743 482 | 517 326 865 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 272 | 1 003 223 | 0,13 | 47,04 | 59 829 | 47 186 594 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 10 982 957 | 0,00 | 45,88 | 8 487 | 503 843 152 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 | 1 001 951 | 0,00 | 45,88 | 688 | 45 964 502 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9 101 | 10 982 772 | 0,08 | 47,50 | 432 281 | 521 661 901 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 712 | 1 001 936 | 0,07 | 47,50 | 33 819 | 47 590 157 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 26 238 | 10 973 671 | 0,24 | 47,26 | 1 239 984 | 518 605 815 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 054 | 1 001 224 | 0,21 | 47,26 | 97 070 | 47 316 945 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29 319 | 10 947 433 | 0,27 | 46,62 | 1 366 767 | 510 337 579 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 295 | 999 170 | 0,23 | 46,62 | 106 986 | 46 578 408 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12 132 | 10 918 114 | 0,11 | 45,30 | 549 535 | 494 550 167 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 950 | 996 875 | 0,10 | 45,30 | 43 031 | 45 154 749 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 32 088 | 10 905 982 | 0,30 | 49,00 | 1 572 312 | 534 393 118 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 512 | 995 925 | 0,25 | 49,00 | 123 088 | 48 800 325 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 77 456 | 10 873 894 | 0,72 | 47,60 | 3 686 658 | 517 562 558 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6 062 | 993 413 | 0,61 | 47,60 | 288 532 | 47 283 280 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 987 | 10 796 438 | 0,03 | 47,45 | 141 725 | 512 260 753 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 234 | 987 351 | 0,02 | 47,45 | 11 103 | 46 847 040 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 359 | 10 793 451 | 0,02 | 46,97 | 110 798 | 506 947 886 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 987 117 | 0,02 | 46,97 | 8 689 | 46 363 010 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 83 832 | 10 791 092 | 0,78 | 49,08 | 4 114 734 | 529 660 248 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6 645 | 986 932 | 0,68 | 49,08 | 326 157 | 48 441 682 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 286 | 10 707 260 | 0,02 | 48,74 | 111 430 | 521 922 177 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 181 | 980 287 | 0,02 | 48,74 | 8 823 | 47 783 796 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 714 | 10 704 974 | 0,40 | 47,74 | 2 039 256 | 511 077 939 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3 386 | 980 106 | 0,35 | 47,74 | 161 655 | 46 792 319 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 754 | 10 662 260 | 0,01 | 47,82 | 36 058 | 509 896 995 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 60 | 976 720 | 0,01 | 47,82 | 2 869 | 46 709 290 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 41 155 | 10 661 506 | 0,39 | 47,72 | 1 963 970 | 508 780 926 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3 262 | 976 660 | 0,34 | 47,72 | 155 667 | 46 607 485 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10 640 | 10 620 351 | 0,10 | 46,50 | 494 716 | 493 802 778 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 843 | 973 398 | 0,09 | 46,50 | 39 196 | 45 259 016 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3 576 | 10 609 711 | 0,03 | 46,30 | 165 575 | 491 248 717 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 283 | 972 555 | 0,03 | 46,30 | 13 103 | 45 031 047 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3 585 | 10 606 135 | 0,03 | 46,99 | 168 447 | 498 345 162 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 284 | 972 272 | 0,03 | 46,99 | 13 344 | 45 683 658 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1 335 362 | 11 638 314 | 12,96 | 21,00 | 28 042 602 | 244 404 594 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 93 210 | 1 143 650 | 8,87 | 21,00 | 1 957 410 | 24 016 650 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728 370 | 6 173 327 | 13,38 | 16,00 | 11 653 920 | 98 773 232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52 880 | 542 114 | 10,81 | 16,00 | 846 080 | 8 673 824 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728 370 | 6 173 327 | 13,38 | 16,00 | 11 653 920 | 98 773 232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52 880 | 542 114 | 10,81 | 16,00 | 846 080 | 8 673 824 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 13 589 904 | 18 840 379 | 258,83 | 14,23 | 193 395 206 | 268 113 665 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 994 276 | 1 021 851 | 3 605,72 | 14,23 | 14 149 343 | 14 541 757 | |
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2 883 650 | 0,01 | ||||
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2 883 650 | 0,01 | ||||
| 2020-07-02 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7 106 | 7 106 | |||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29 313 492 | 0,00 | ||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29 313 492 | 0,00 | ||||
| 2020-07-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37 520 | 37 520 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 11 158 | 11 158 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6 118 | 38 440 095 | 0,02 | ||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6 118 | 38 440 095 | 0,02 | ||||
| 2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 90 766 | 90 766 | |||||
| 2020-06-10 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 4 135 | 4 135 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29 313 198 | 0,00 | 102,55 | 103 | 3 006 068 455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29 313 198 | 0,00 | 102,55 | 103 | 3 006 068 455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 10 514 | 10 514 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 282 | 29 313 197 | 0,00 | ||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 282 | 29 313 197 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 3 171 | 3 171 | |||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1 335 | 43 290 171 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1 335 | 43 290 171 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1 602 312 | 43 288 836 | -3,57 | 160,00 | -256 369 920 | 6 926 213 760 | |
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -147 688 | 4 082 851 | -3,49 | 160,00 | -23 630 080 | 653 256 160 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1 465 603 | 10 302 952 | 16,58 | 18,25 | 26 747 255 | 188 028 874 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 134 397 | 1 050 440 | 14,67 | 18,25 | 2 452 745 | 19 170 530 | |
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 189 | 7 846 213 | 0,02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 189 | 7 846 213 | 0,02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 468 | 7 845 024 | 0,04 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 468 | 7 845 024 | 0,04 | ||||
| 2020-05-12 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 9 000 | 9 000 | |||||
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -457 803 | 44 891 148 | -1,01 | 158,50 | -72 561 776 | 7 115 246 958 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -42 197 | 4 230 539 | -0,99 | 158,50 | -6 688 224 | 670 540 432 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4 343 | 45 348 951 | -0,01 | 166,15 | -721 610 | 7 534 941 349 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -400 | 4 272 736 | -0,01 | 166,15 | -66 462 | 709 935 168 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -48 880 | 45 353 294 | -0,11 | 164,96 | -8 063 118 | 7 481 361 460 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4 505 | 4 273 136 | -0,11 | 164,96 | -743 133 | 704 885 404 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -84 663 | 45 402 174 | -0,19 | 164,19 | -13 901 157 | 7 454 764 558 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -7 805 | 4 277 641 | -0,18 | 164,19 | -1 281 534 | 702 362 986 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16 159 | 45 486 837 | -0,04 | 163,41 | -2 640 610 | 7 433 195 079 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1 489 | 4 285 446 | -0,03 | 163,41 | -243 324 | 700 302 730 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -41 072 | 45 502 996 | -0,09 | 166,62 | -6 843 564 | 7 581 873 004 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -3 786 | 4 286 935 | -0,09 | 166,62 | -630 837 | 714 304 543 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -91 613 | 45 544 068 | -0,20 | 165,70 | -15 180 641 | 7 546 834 244 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -8 444 | 4 290 721 | -0,20 | 165,70 | -1 399 205 | 710 989 633 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -178 862 | 45 635 681 | -0,39 | 164,60 | -29 440 041 | 7 511 468 804 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16 485 | 4 299 165 | -0,38 | 164,60 | -2 713 372 | 707 627 082 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -45 606 | 45 814 543 | -0,10 | 164,06 | -7 482 107 | 7 516 320 180 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4 204 | 4 315 650 | -0,10 | 164,06 | -689 707 | 708 024 244 | |
| 2020-05-07 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 29 311 915 | 0,07 | 13,34 | 266 800 | 391 020 946 | |
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 29 311 915 | 0,07 | 13,34 | 266 800 | 391 020 946 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17 500 | 0 | -100,00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17 500 | 0 | -100,00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17 500 | 45 860 149 | 0,04 | 12,76 | 223 300 | 585 175 501 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17 500 | 45 860 149 | 0,04 | 12,76 | 223 300 | 585 175 501 | |
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2 883 427 | 0,01 | ||||
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2 883 427 | 0,01 | ||||
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29 291 915 | 0,00 | 73,23 | 28 706 | 2 145 046 935 | |
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29 291 915 | 0,00 | 73,23 | 28 706 | 2 145 046 935 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 42 473 | 38 433 977 | 0,11 | 34,47 | 1 463 896 | 1 324 684 668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 837 | 3 470 609 | 0,11 | 34,47 | 132 248 | 119 619 745 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 33 464 | 38 391 504 | 0,09 | 33,63 | 1 125 465 | 1 291 186 902 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 023 | 3 466 772 | 0,09 | 33,63 | 101 670 | 116 594 823 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 201 | 38 358 040 | 0,01 | 32,85 | 72 302 | 1 260 053 942 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 199 | 3 463 749 | 0,01 | 32,85 | 6 537 | 113 783 462 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 46 225 | 38 355 839 | 0,12 | 32,61 | 1 507 268 | 1 250 676 513 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 175 | 3 463 550 | 0,12 | 32,61 | 136 135 | 112 936 668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 275 | 38 309 614 | 0,00 | 31,94 | 8 782 | 1 223 417 523 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 | 3 459 375 | 0,00 | 31,94 | 798 | 110 475 141 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 93 006 | 38 309 339 | 0,24 | 33,86 | 3 149 406 | 1 297 246 161 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8 402 | 3 459 350 | 0,24 | 33,86 | 284 512 | 117 141 893 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24 223 | 38 216 333 | 0,06 | 32,32 | 782 873 | 1 235 128 953 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 188 | 3 450 948 | 0,06 | 32,32 | 70 715 | 111 532 569 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 29 624 | 38 192 110 | 0,08 | 32,19 | 953 620 | 1 229 434 575 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 676 | 3 448 760 | 0,08 | 32,19 | 86 143 | 111 018 343 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7 612 | 38 162 486 | 0,02 | 31,83 | 242 290 | 1 214 711 929 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 688 | 3 446 084 | 0,02 | 31,83 | 21 899 | 109 688 854 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43 212 | 38 154 874 | 0,11 | 31,74 | 1 371 359 | 1 210 867 819 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 903 | 3 445 396 | 0,11 | 31,74 | 123 864 | 109 341 709 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 913 | 38 111 662 | 0,01 | 31,00 | 121 285 | 1 181 290 020 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 353 | 3 441 493 | 0,01 | 31,00 | 10 941 | 106 670 796 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 631 281 | 38 107 749 | 1,68 | 31,51 | 19 893 937 | 1 200 912 359 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 57 022 | 3 441 140 | 1,68 | 31,51 | 1 796 968 | 108 442 710 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 503 | 37 476 468 | 0,01 | 31,19 | 171 613 | 1 168 714 898 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 497 | 3 384 118 | 0,01 | 31,19 | 15 499 | 105 534 735 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9 172 | 10 602 550 | 0,09 | 38,38 | 352 019 | 406 922 688 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 971 988 | 0,09 | 38,38 | 31 778 | 37 304 608 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6 237 | 10 593 378 | 0,06 | 37,75 | 235 433 | 399 876 714 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 563 | 971 160 | 0,06 | 37,75 | 21 252 | 36 659 153 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17 058 | 10 587 141 | 0,16 | 36,69 | 625 914 | 388 477 141 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 542 | 970 597 | 0,16 | 36,69 | 56 581 | 35 614 407 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9 172 | 10 570 083 | 0,09 | 38,98 | 357 570 | 412 074 686 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 969 055 | 0,09 | 38,98 | 32 280 | 37 778 609 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 95 934 | 10 560 911 | 0,92 | 39,97 | 3 834 588 | 422 131 230 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 666 | 968 227 | 0,90 | 39,97 | 346 390 | 38 701 098 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14 731 | 7 841 556 | 0,19 | 83,14 | 1 224 797 | 651 979 900 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 331 | 994 296 | 0,13 | 83,14 | 110 665 | 82 669 945 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 321 | 7 826 825 | 0,02 | 82,92 | 109 537 | 648 995 633 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 119 | 992 965 | 0,01 | 82,92 | 9 867 | 82 336 062 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 928 | 7 825 504 | 0,20 | 82,13 | 1 308 149 | 642 700 035 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 439 | 992 846 | 0,15 | 82,13 | 118 183 | 81 541 350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 25 640 | 7 809 576 | 0,33 | 81,79 | 2 097 003 | 638 717 107 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 314 | 991 407 | 0,23 | 81,79 | 189 254 | 81 083 609 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 203 | 7 783 936 | 0,05 | 81,47 | 342 438 | 634 193 850 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 380 | 989 093 | 0,04 | 81,47 | 30 960 | 80 586 055 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 815 | 7 779 733 | 0,16 | 81,09 | 1 039 177 | 630 863 995 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1 158 | 988 713 | 0,12 | 81,09 | 93 903 | 80 175 429 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3 298 | 7 766 918 | 0,04 | 80,91 | 266 845 | 628 431 432 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 298 | 987 555 | 0,03 | 80,91 | 24 112 | 79 904 359 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10 285 | 7 763 620 | 0,13 | 79,87 | 821 429 | 620 054 709 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 929 | 987 257 | 0,09 | 79,87 | 74 196 | 78 848 959 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26 022 | 7 753 335 | 0,34 | 79,72 | 2 074 362 | 618 062 527 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 351 | 986 328 | 0,24 | 79,72 | 187 412 | 78 625 827 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 888 | 7 727 313 | 0,04 | 79,29 | 228 980 | 612 673 148 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 261 | 983 977 | 0,03 | 79,29 | 20 694 | 78 016 289 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 191 | 7 724 425 | 0,05 | 79,16 | 331 760 | 611 467 028 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 379 | 983 716 | 0,04 | 79,16 | 30 002 | 77 871 155 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 565 | 7 720 234 | 0,01 | 78,66 | 44 443 | 607 273 606 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 51 | 983 337 | 0,01 | 78,66 | 4 012 | 77 349 288 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 65 505 | 7 719 669 | 0,86 | 76,67 | 5 022 445 | 591 887 865 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5 917 | 983 286 | 0,61 | 76,67 | 453 672 | 75 391 192 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 27 866 | 7 654 164 | 0,37 | 76,10 | 2 120 480 | 582 448 202 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 517 | 977 369 | 0,26 | 76,10 | 191 533 | 74 373 480 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 62 129 | 7 626 298 | 0,82 | 79,76 | 4 955 720 | 608 311 660 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5 612 | 974 852 | 0,58 | 79,76 | 447 641 | 77 759 070 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 133 042 | 7 564 169 | 1,79 | 79,14 | 10 529 170 | 598 641 194 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 017 | 969 240 | 1,26 | 79,14 | 951 046 | 76 707 301 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 612 | 7 431 127 | 0,10 | 77,94 | 593 260 | 579 163 461 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 688 | 957 223 | 0,07 | 77,94 | 53 621 | 74 603 568 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8 309 | 7 423 515 | 0,11 | 77,89 | 647 203 | 578 230 946 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 750 | 956 535 | 0,08 | 77,89 | 58 419 | 74 506 233 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 32 228 | 7 415 206 | 0,44 | 75,66 | 2 438 422 | 561 046 350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 911 | 955 785 | 0,31 | 75,66 | 220 251 | 72 316 222 | |
| 2020-03-16 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 18 000 | 18 000 | |||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1 876 724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3 248 692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1 876 724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3 248 692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1 876 724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3 248 692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1 876 724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3 248 692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1 876 724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3 248 692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1 876 724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3 248 692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1 876 724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3 248 692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1 876 724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3 248 692 | ||||||||
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 82 740 | 10 464 977 | 0,80 | 57,82 | 4 783 944 | 605 074 505 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7 460 | 959 561 | 0,78 | 57,82 | 431 330 | 55 480 857 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 989 | 10 382 237 | 0,09 | 59,61 | 535 824 | 618 873 727 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 811 | 952 101 | 0,09 | 59,61 | 48 343 | 56 753 693 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14 631 | 10 373 248 | 0,14 | 59,99 | 877 642 | 622 240 319 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 319 | 951 290 | 0,14 | 59,99 | 79 120 | 57 063 226 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 145 994 | 10 358 617 | 1,43 | 57,68 | 8 421 518 | 597 526 463 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13 164 | 949 971 | 1,41 | 57,68 | 759 352 | 54 798 127 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14 051 | 10 212 623 | 0,14 | 57,22 | 803 980 | 584 353 012 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 267 | 936 807 | 0,14 | 57,22 | 72 496 | 53 602 879 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14 402 | 10 198 572 | 0,14 | 58,80 | 846 819 | 599 662 775 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 298 | 935 540 | 0,14 | 58,80 | 76 321 | 55 008 536 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 623 | 10 184 170 | 0,08 | 60,77 | 524 043 | 618 919 508 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 777 | 934 242 | 0,08 | 60,77 | 47 220 | 56 776 409 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6 788 | 10 175 547 | 0,07 | 58,54 | 397 393 | 595 711 118 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 612 | 933 465 | 0,07 | 58,54 | 35 829 | 54 648 215 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7 122 | 10 168 759 | 0,07 | 58,39 | 415 826 | 593 714 180 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 642 | 932 853 | 0,07 | 58,39 | 37 484 | 54 465 649 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3 577 | 10 161 637 | 0,04 | 57,62 | 206 108 | 585 517 589 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 323 | 932 211 | 0,03 | 57,62 | 18 611 | 53 714 371 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21 301 | 10 158 060 | 0,21 | 56,69 | 1 207 513 | 575 841 121 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 921 | 931 888 | 0,21 | 56,69 | 108 898 | 52 826 960 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5 804 | 10 136 759 | 0,06 | 56,62 | 328 631 | 573 958 500 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 523 | 929 967 | 0,06 | 56,62 | 29 613 | 52 656 126 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10 121 | 10 130 955 | 0,10 | 56,25 | 569 277 | 569 836 839 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 929 444 | 0,10 | 56,25 | 51 297 | 52 278 530 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 92 | 10 120 834 | 0,00 | 55,45 | 5 102 | 561 225 547 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 | 928 532 | 0,00 | 55,45 | 444 | 51 489 421 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 813 | 10 120 742 | 0,02 | 55,77 | 101 117 | 564 468 192 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 164 | 928 524 | 0,02 | 55,77 | 9 147 | 51 786 940 | |
| 2020-02-07 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29 291 523 | 0,00 | 87,32 | 27 593 | 2 557 735 788 | |
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29 291 523 | 0,00 | 87,32 | 27 593 | 2 557 735 788 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 9 765 333 | 9 765 333 | |||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 1 160 148 | 1 161 048 | 128 905,33 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -9 765 333 | 3 107 331 | -75,86 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -1 160 148 | 290 409 | -79,98 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 2 767 505 | 12 872 664 | 27,39 | 8,40 | 23 247 042 | 108 130 378 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 250 037 | 1 450 557 | 20,83 | 8,40 | 2 100 311 | 12 184 679 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1 743 993 | 10 118 929 | 20,82 | 46,00 | 80 223 678 | 465 470 734 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 158 180 | 928 360 | 20,54 | 46,00 | 7 276 280 | 42 704 560 | |
| 2019-10-15 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 22 000 | 22 000 | |||||
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7 642 042 | 0,00 | 67,28 | 24 894 | 514 156 586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7 642 042 | 0,00 | 67,28 | 24 894 | 514 156 586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 1 217 279 | 0,03 | 67,28 | 24 894 | 81 898 531 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 244 595 | 0,15 | 67,28 | 24 894 | 16 456 352 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 160 223 | 0,23 | 67,28 | 24 894 | 10 779 803 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29 291 207 | 0,00 | 74,23 | 27 020 | 2 174 286 296 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29 291 207 | 0,00 | 74,23 | 27 020 | 2 174 286 296 | |
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 2 081 895 | 2 081 895 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -2 081 895 | 0 | -100,00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 187 942 | 187 942 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -187 942 | 0 | -100,00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 2 883 204 | 2 883 204 | 16,00 | 46 131 264 | 46 131 264 | ||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 260 796 | 260 796 | 16,00 | 4 172 736 | 4 172 736 | ||
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 494 025 | 37 470 965 | 4,15 | 40,00 | 59 761 000 | 1 498 838 600 | |
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 68 475 | 3 383 621 | 2,07 | 40,00 | 2 739 000 | 135 344 840 | |
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
X - Other | -1 | 138 815 | 0,00 | ||||
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
X - Other | 1 | 8 374 936 | 0,00 | 0,01 | 0 | 83 749 | |
| 2019-09-19 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 12 100 | 12 100 | |||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95 289 | 0 | -100,00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95 289 | 0 | -100,00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8 341 | 95 289 | 9,59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8 340 | 95 289 | 9,59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -8 866 | 43 361 | -16,98 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -7 815 | 165 610 | -4,51 | ||||
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 50 436 | 10 105 159 | 0,50 | 3,15 | 159 020 | 31 860 556 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4 564 | 1 200 520 | 0,38 | 3,15 | 14 390 | 3 785 120 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 209 382 | 10 054 723 | 2,13 | 3,02 | 633 255 | 30 409 504 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 18 943 | 1 195 956 | 1,61 | 3,02 | 57 291 | 3 617 049 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5 869 | 9 845 341 | 0,06 | 2,96 | 17 358 | 29 118 581 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 531 | 1 177 013 | 0,05 | 2,96 | 1 570 | 3 481 134 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 65 568 | 9 839 472 | 0,67 | 2,85 | 186 666 | 28 011 993 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5 932 | 1 176 482 | 0,51 | 2,85 | 16 888 | 3 349 327 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9 445 | 9 773 904 | 0,10 | 2,83 | 26 756 | 27 687 515 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 855 | 1 170 550 | 0,07 | 2,83 | 2 422 | 3 315 934 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7 641 672 | 0,01 | 58,86 | 24 957 | 449 788 814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7 641 672 | 0,01 | 58,86 | 24 957 | 449 788 814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 1 390 806 | 0,03 | 58,86 | 24 957 | 81 862 841 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 418 122 | 0,10 | 58,86 | 24 957 | 24 610 661 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 333 750 | 0,13 | 58,86 | 24 957 | 19 644 525 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 226 124 | 0,19 | 58,86 | 24 957 | 13 309 659 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 964 | 4 290 995 | 0,07 | 2,61 | 7 736 | 11 199 497 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 964 | 4 290 995 | 0,07 | 2,61 | 7 736 | 11 199 497 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29 290 843 | 0,00 | 84,96 | 26 338 | 2 488 550 021 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29 290 843 | 0,00 | 84,96 | 26 338 | 2 488 550 021 | |
| 2019-06-28 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 1 904 850 | 5 444 957 | 53,81 | 17,00 | 32 382 450 | 92 564 269 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 95 150 | 489 234 | 24,14 | 17,00 | 1 617 550 | 8 316 978 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 3 540 107 | 3 540 107 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -3 540 107 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 394 084 | 394 084 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -394 084 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -920 361 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -89 878 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -2 302 669 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -219 852 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 3 223 030 | 3 223 030 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 309 730 | 309 730 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 13 166 | 13 166 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 7 641 248 | 0,03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 7 641 248 | 0,03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 1 390 382 | 0,14 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 417 698 | 0,46 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 333 326 | 0,58 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1 910 | 225 700 | 0,85 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74 229 | 181 733 | 69,05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74 229 | 181 733 | 69,05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -1 002 483 | 4 302 354 | -18,90 | ||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14 840 | 14 840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14 840 | 14 840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | -200 423 | 98 980 | -66,94 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31 229 | 102 876 | 43,59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31 229 | 102 876 | 43,59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -421 756 | 3 315 146 | -11,29 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1 660 | 1 660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1 660 | 1 660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6 256 | 6 256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6 256 | 6 256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -6 009 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -11 337 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -42 724 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21 929 | 21 929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21 929 | 21 929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -59 267 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -178 967 | 347 757 | -33,98 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43 109 | 43 109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43 109 | 43 109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | -582 200 | 18 591 | -96,91 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13 516 | 20 618 | 190,31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13 516 | 20 618 | 190,31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -182 539 | 1 028 034 | -15,08 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Shares Option (Right to Buy) |
A - Award | 129 220 | 129 220 | |||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220 141 | 281 190 | 360,60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220 141 | 281 190 | 360,60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -692 706 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -1 603 238 | 2 826 766 | -36,19 | ||||
| 2019-06-05 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 24 747 | 24 747 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37 520 | 37 520 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37 520 | 37 520 | |||||
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22 720 | 7 382 978 | -0,31 | 120,77 | -2 743 928 | 891 653 328 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 729 | 952 874 | -0,29 | 120,77 | -329 585 | 115 080 022 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -13 213 | 7 405 698 | -0,18 | 122,31 | -1 616 054 | 905 775 370 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 587 | 955 603 | -0,17 | 122,31 | -194 103 | 116 877 796 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15 355 | 7 418 911 | -0,21 | 120,12 | -1 844 459 | 891 167 750 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 845 | 957 190 | -0,19 | 120,12 | -221 623 | 114 978 716 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -35 796 | 7 434 266 | -0,48 | 122,37 | -4 380 432 | 909 746 742 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4 300 | 959 035 | -0,45 | 122,37 | -526 200 | 117 359 127 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -30 766 | 7 470 062 | -0,41 | 123,06 | -3 786 036 | 919 259 107 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 696 | 963 335 | -0,38 | 123,06 | -454 826 | 118 547 138 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -39 732 | 7 500 828 | -0,53 | 121,37 | -4 822 189 | 910 359 743 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4 772 | 967 031 | -0,49 | 121,37 | -579 168 | 117 366 522 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -71 819 | 7 540 560 | -0,94 | 127,06 | -9 125 258 | 958 096 767 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -8 627 | 971 803 | -0,88 | 127,06 | -1 096 139 | 123 476 415 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22 886 | 7 612 379 | -0,30 | 125,05 | -2 861 901 | 951 930 278 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 749 | 980 430 | -0,28 | 125,05 | -343 763 | 122 603 066 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15 541 | 7 635 265 | -0,20 | 126,25 | -1 962 085 | 963 969 004 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 867 | 983 179 | -0,19 | 126,25 | -235 713 | 124 128 512 | |
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7 038 | 7 038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7 038 | 7 038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2 963 | 45 842 649 | 0,01 | ||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2 963 | 45 842 649 | 0,01 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 726 | 7 650 806 | 0,04 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 726 | 7 650 806 | 0,04 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 45 839 686 | 0,02 | 8,38 | 83 800 | 384 136 569 | |
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 45 839 686 | 0,02 | 8,38 | 83 800 | 384 136 569 | |
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12 472 | 12 472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12 472 | 12 472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12 472 | 12 472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 520 | 812 602 | 0,19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 520 | 812 602 | 0,19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1 520 | 812 602 | 0,19 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 529 758 | 529 758 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -529 758 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 60 194 | 60 194 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -60 194 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 2 905 359 | 2 905 359 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -2 905 359 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 324 421 | 324 421 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -324 421 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 820 729 | 820 729 | 14,00 | 11 490 206 | 11 490 206 | ||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 72 128 | 72 128 | 14,00 | 1 009 792 | 1 009 792 | ||
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 232 | 7 639 338 | -0,12 | 65,32 | -603 070 | 499 031 352 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 417 | 1 214 575 | -0,12 | 65,32 | -92 564 | 79 340 776 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -244 | 241 891 | -0,10 | 65,32 | -15 939 | 15 801 263 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -142 | 157 519 | -0,09 | 65,32 | -9 276 | 10 289 755 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 49 893 | -0,02 | 65,32 | -719 | 3 259 205 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -158 | 171 091 | -0,09 | 65,32 | -10 321 | 11 176 331 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 775 | 7 648 570 | -0,83 | 67,13 | -4 281 177 | 513 443 915 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 791 | 1 215 992 | -0,80 | 67,13 | -657 264 | 81 628 813 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 688 | 242 135 | -0,69 | 67,13 | -113 314 | 16 254 377 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -979 | 157 661 | -0,62 | 67,13 | -65 720 | 10 583 688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 49 904 | -0,15 | 67,13 | -4 968 | 3 350 026 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 093 | 171 249 | -0,63 | 67,13 | -73 372 | 11 495 843 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -173 085 | 7 712 345 | -2,19 | 64,62 | -11 184 701 | 498 369 420 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -26 575 | 1 225 783 | -2,12 | 64,62 | -1 717 269 | 79 209 730 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 581 | 243 823 | -1,84 | 64,62 | -296 023 | 15 755 769 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 656 | 158 640 | -1,65 | 64,62 | -171 630 | 10 251 269 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -202 | 49 978 | -0,40 | 64,62 | -13 053 | 3 229 563 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 966 | 172 342 | -1,69 | 64,62 | -191 662 | 11 136 688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106 054 | 7 885 430 | -1,33 | 66,61 | -7 063 981 | 525 227 990 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 282 | 1 252 358 | -1,28 | 66,61 | -1 084 502 | 83 416 310 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 807 | 248 404 | -1,12 | 66,61 | -186 967 | 16 545 545 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 628 | 161 296 | -1,00 | 66,61 | -108 437 | 10 743 507 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -124 | 50 180 | -0,25 | 66,61 | -8 259 | 3 342 359 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 817 | 175 308 | -1,03 | 66,61 | -121 026 | 11 676 810 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -60 618 | 7 991 484 | -0,75 | 67,42 | -4 086 914 | 538 792 244 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 307 | 1 268 640 | -0,73 | 67,42 | -627 485 | 85 532 724 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 604 | 251 211 | -0,63 | 67,42 | -108 143 | 16 936 847 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -930 | 162 924 | -0,57 | 67,42 | -62 701 | 10 984 466 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 50 304 | -0,14 | 67,42 | -4 787 | 3 391 536 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 039 | 177 125 | -0,58 | 67,42 | -70 050 | 11 941 909 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 832 | 8 052 102 | -0,13 | 69,12 | -748 735 | 556 581 420 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 663 | 1 277 947 | -0,13 | 69,12 | -114 951 | 88 334 892 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 252 815 | -0,11 | 69,12 | -19 838 | 17 475 205 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -166 | 163 854 | -0,10 | 69,12 | -11 474 | 11 325 998 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 50 375 | -0,03 | 69,12 | -899 | 3 482 046 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -185 | 178 164 | -0,10 | 69,12 | -12 788 | 12 315 141 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -102 618 | 8 062 934 | -1,26 | 68,70 | -7 049 918 | 553 928 404 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 755 | 1 279 610 | -1,22 | 68,70 | -1 082 378 | 87 909 975 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 716 | 253 102 | -1,06 | 68,70 | -186 591 | 17 388 259 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 575 | 164 020 | -0,95 | 68,70 | -108 203 | 11 268 272 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -120 | 50 388 | -0,24 | 68,70 | -8 244 | 3 461 686 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 758 | 178 349 | -0,98 | 68,70 | -120 776 | 12 252 683 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 543 | 8 165 552 | -0,19 | 67,68 | -1 051 888 | 552 611 897 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 386 | 1 295 365 | -0,18 | 67,68 | -161 475 | 87 665 122 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -411 | 255 818 | -0,16 | 67,68 | -27 815 | 17 312 739 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -239 | 165 595 | -0,14 | 67,68 | -16 175 | 11 206 807 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 50 508 | -0,04 | 67,68 | -1 218 | 3 418 179 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -266 | 180 107 | -0,15 | 67,68 | -18 002 | 12 188 921 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 813 | 8 181 095 | -0,02 | 67,87 | -123 047 | 555 244 373 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -278 | 1 297 751 | -0,02 | 67,87 | -18 868 | 88 077 322 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 256 229 | -0,02 | 67,87 | -3 258 | 17 390 057 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 165 834 | -0,02 | 67,87 | -1 900 | 11 255 021 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50 526 | 0,00 | 67,87 | -136 | 3 429 159 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31 | 180 373 | -0,02 | 67,87 | -2 104 | 12 241 771 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 661 | 8 182 908 | -0,23 | 67,90 | -1 267 017 | 555 590 813 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 865 | 1 298 029 | -0,22 | 67,90 | -194 523 | 88 131 626 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -494 | 256 277 | -0,19 | 67,90 | -33 541 | 17 400 311 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 165 862 | -0,17 | 67,90 | -19 418 | 11 261 449 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 50 528 | -0,04 | 67,90 | -1 494 | 3 430 674 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -320 | 180 404 | -0,18 | 67,90 | -21 727 | 12 248 800 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 863 | 8 201 569 | -0,52 | 68,72 | -2 945 370 | 563 578 195 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 581 | 1 300 894 | -0,50 | 68,72 | -452 219 | 89 392 102 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 134 | 256 771 | -0,44 | 68,72 | -77 924 | 17 644 250 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -658 | 166 148 | -0,39 | 68,72 | -45 215 | 11 417 009 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 50 550 | -0,10 | 68,72 | -3 436 | 3 473 589 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -734 | 180 724 | -0,40 | 68,72 | -50 437 | 12 418 612 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 116 | 8 244 432 | -0,26 | 68,63 | -1 449 147 | 565 798 055 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 242 | 1 307 475 | -0,25 | 68,63 | -222 492 | 89 729 264 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 257 905 | -0,22 | 68,63 | -38 363 | 17 699 479 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -324 | 166 806 | -0,19 | 68,63 | -22 235 | 11 447 545 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 50 600 | -0,05 | 68,63 | -1 716 | 3 472 572 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -362 | 181 458 | -0,20 | 68,63 | -24 843 | 12 453 081 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 784 | 8 265 548 | -0,80 | 66,64 | -4 450 459 | 550 812 813 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 253 | 1 310 717 | -0,78 | 66,64 | -683 256 | 87 345 657 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 768 | 258 464 | -0,68 | 66,64 | -117 819 | 17 223 938 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 025 | 167 130 | -0,61 | 66,64 | -68 306 | 11 137 476 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -78 | 50 625 | -0,15 | 66,64 | -5 198 | 3 373 630 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 145 | 181 820 | -0,63 | 66,64 | -76 302 | 12 116 412 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -80 146 | 8 332 332 | -0,95 | 68,90 | -5 521 963 | 574 087 676 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 305 | 1 320 970 | -0,92 | 68,90 | -847 800 | 91 013 248 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 121 | 260 232 | -0,81 | 68,90 | -146 134 | 17 929 673 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 230 | 168 155 | -0,73 | 68,90 | -84 746 | 11 585 678 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -93 | 50 703 | -0,18 | 68,90 | -6 408 | 3 493 376 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 374 | 182 965 | -0,75 | 68,90 | -94 667 | 12 606 069 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4 161 | 89 233 | 4,89 | 2,59 | 10 777 | 231 113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4 161 | 89 233 | 4,89 | 2,59 | 10 777 | 231 113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4 161 | 4 288 031 | 0,10 | 2,59 | 10 777 | 11 106 000 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8 412 478 | 0,00 | 66,84 | 19 918 | 562 290 030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8 412 478 | 0,00 | 66,84 | 19 918 | 562 290 030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 1 507 172 | 0,02 | 66,84 | 19 918 | 100 739 376 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 436 250 | 0,07 | 66,84 | 19 918 | 29 158 950 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 343 282 | 0,09 | 66,84 | 19 918 | 22 944 969 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 224 693 | 0,13 | 66,84 | 19 918 | 15 018 480 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811 082 | 0,03 | 86,01 | 18 922 | 69 761 163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811 082 | 0,03 | 86,01 | 18 922 | 69 761 163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811 082 | 0,03 | 86,01 | 18 922 | 69 761 163 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 678 | 8 412 180 | -0,55 | 74,71 | -3 487 122 | 628 439 478 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 167 | 1 332 977 | -0,53 | 74,71 | -535 417 | 99 581 246 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 235 | 262 055 | -0,47 | 74,71 | -92 262 | 19 577 055 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -716 | 169 087 | -0,42 | 74,71 | -53 489 | 12 631 797 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55 | 50 498 | -0,11 | 74,71 | -4 109 | 3 772 499 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -800 | 184 041 | -0,43 | 74,71 | -59 765 | 13 748 949 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 281 | 8 458 858 | -0,49 | 74,34 | -3 068 962 | 628 858 572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 338 | 1 340 144 | -0,47 | 74,34 | -471 187 | 99 630 593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 092 | 263 290 | -0,41 | 74,34 | -81 183 | 19 573 821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169 803 | -0,37 | 74,34 | -47 134 | 12 623 698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50 553 | -0,09 | 74,34 | -3 568 | 3 758 272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184 841 | -0,38 | 74,34 | -52 561 | 13 741 671 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -86 620 | 8 500 139 | -1,01 | 74,63 | -6 464 529 | 634 373 024 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 298 | 1 346 482 | -0,98 | 74,63 | -992 442 | 100 489 163 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 293 | 264 382 | -0,86 | 74,63 | -171 129 | 19 731 067 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 329 | 170 437 | -0,77 | 74,63 | -99 184 | 12 719 867 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -101 | 50 601 | -0,20 | 74,63 | -7 538 | 3 776 398 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 485 | 185 548 | -0,79 | 74,63 | -110 827 | 13 847 614 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -90 251 | 8 586 759 | -1,04 | 74,19 | -6 695 487 | 637 029 325 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 856 | 1 359 780 | -1,01 | 74,19 | -1 027 941 | 100 878 543 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 388 | 266 675 | -0,89 | 74,19 | -177 160 | 19 783 925 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 385 | 171 766 | -0,80 | 74,19 | -102 750 | 12 742 873 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106 | 50 702 | -0,21 | 74,19 | -7 864 | 3 761 450 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 547 | 187 033 | -0,82 | 74,19 | -114 768 | 13 875 492 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -413 | 8 677 010 | 0,00 | 74,56 | -30 795 | 647 001 251 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 1 373 636 | 0,00 | 74,56 | -4 698 | 102 425 168 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 269 063 | 0,00 | 74,56 | -820 | 20 062 683 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 173 151 | 0,00 | 74,56 | -447 | 12 911 004 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 188 580 | 0,00 | 74,56 | -522 | 14 061 468 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 124 | 8 677 423 | -0,48 | 74,50 | -3 138 238 | 646 468 014 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 467 | 1 373 699 | -0,47 | 74,50 | -481 792 | 102 340 576 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 115 | 269 074 | -0,41 | 74,50 | -83 068 | 20 046 013 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -647 | 173 157 | -0,37 | 74,50 | -48 202 | 12 900 196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 50 808 | -0,10 | 74,50 | -3 650 | 3 785 196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -722 | 188 587 | -0,38 | 74,50 | -53 789 | 14 049 732 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 068 | 8 719 547 | -0,04 | 76,57 | -234 915 | 667 649 610 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -471 | 1 380 166 | -0,03 | 76,57 | -36 064 | 105 678 345 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -81 | 270 189 | -0,03 | 76,57 | -6 202 | 20 688 183 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -47 | 173 804 | -0,03 | 76,57 | -3 599 | 13 308 051 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 50 857 | -0,01 | 76,57 | -306 | 3 894 085 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 189 309 | -0,03 | 76,57 | -3 982 | 14 495 258 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 281 | 8 458 858 | -0,49 | 74,34 | -3 068 962 | 628 858 572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 338 | 1 340 144 | -0,47 | 74,34 | -471 187 | 99 630 593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 092 | 263 290 | -0,41 | 74,34 | -81 183 | 19 573 821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169 803 | -0,37 | 74,34 | -47 134 | 12 623 698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50 553 | -0,09 | 74,34 | -3 568 | 3 758 272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184 841 | -0,38 | 74,34 | -52 561 | 13 741 671 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 648 | 8 722 615 | -0,02 | 76,03 | -125 301 | 663 197 864 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1 380 637 | -0,02 | 76,03 | -19 236 | 104 972 592 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 270 270 | -0,02 | 76,03 | -3 345 | 20 549 169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 173 851 | -0,01 | 76,03 | -1 901 | 13 218 239 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50 861 | 0,00 | 76,03 | -152 | 3 867 064 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 189 361 | -0,01 | 76,03 | -2 129 | 14 397 496 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 987 | 8 724 263 | -0,59 | 76,50 | -3 977 031 | 667 410 482 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 982 | 1 380 890 | -0,57 | 76,50 | -610 627 | 105 638 775 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 375 | 270 314 | -0,51 | 76,50 | -105 188 | 20 679 156 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -798 | 173 876 | -0,46 | 76,50 | -61 047 | 13 301 601 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61 | 50 863 | -0,12 | 76,50 | -4 667 | 3 891 045 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -891 | 189 389 | -0,47 | 76,50 | -68 162 | 14 488 353 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 8 776 250 | 0,00 | 75,40 | -18 624 | 661 729 250 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 1 388 872 | 0,00 | 75,40 | -2 941 | 104 720 949 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 271 689 | 0,00 | 75,40 | -528 | 20 485 351 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174 674 | 0,00 | 75,40 | -302 | 13 170 420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174 674 | 0,00 | 75,40 | -302 | 13 170 420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 50 924 | 0,00 | 75,40 | -75 | 3 839 670 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 047 | 8 776 497 | -0,71 | 75,92 | -4 786 390 | 666 292 344 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 679 | 1 388 911 | -0,69 | 75,92 | -734 808 | 105 443 068 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 668 | 271 696 | -0,61 | 75,92 | -126 631 | 20 626 563 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -967 | 174 678 | -0,55 | 75,92 | -73 413 | 13 261 169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -73 | 50 925 | -0,14 | 75,92 | -5 542 | 3 866 114 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 080 | 190 284 | -0,56 | 75,92 | -81 991 | 14 445 943 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 832 | 8 839 544 | -0,03 | 76,05 | -215 369 | 672 232 294 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -435 | 1 398 590 | -0,03 | 76,05 | -33 081 | 106 360 392 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75 | 273 364 | -0,03 | 76,05 | -5 704 | 20 788 867 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 175 645 | -0,02 | 76,05 | -3 270 | 13 357 504 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 50 998 | -0,01 | 76,05 | -228 | 3 878 311 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 191 364 | -0,03 | 76,05 | -3 726 | 14 552 907 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61 122 | 8 842 376 | -0,69 | 75,63 | -4 622 669 | 668 750 665 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 384 | 1 399 025 | -0,67 | 75,63 | -709 714 | 105 808 541 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 618 | 273 439 | -0,59 | 75,63 | -122 370 | 20 680 246 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -938 | 175 688 | -0,53 | 75,63 | -70 941 | 13 287 319 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 51 001 | -0,14 | 75,63 | -5 370 | 3 857 216 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 047 | 191 413 | -0,54 | 75,63 | -79 185 | 14 476 603 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 296 | 8 903 498 | -0,04 | 74,03 | -244 007 | 659 137 531 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1 408 409 | -0,04 | 74,03 | -37 460 | 104 266 349 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 275 057 | -0,03 | 74,03 | -6 441 | 20 362 827 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 176 626 | -0,03 | 74,03 | -3 776 | 13 075 852 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 51 072 | -0,01 | 74,03 | -296 | 3 780 927 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 192 460 | -0,03 | 74,03 | -4 146 | 14 248 064 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 107 | 8 906 794 | -0,41 | 75,08 | -2 786 101 | 668 747 923 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 697 | 1 408 915 | -0,40 | 75,08 | -427 747 | 105 785 424 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -982 | 275 144 | -0,36 | 75,08 | -73 731 | 20 658 609 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -569 | 176 677 | -0,32 | 75,08 | -42 722 | 13 265 422 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 51 076 | -0,08 | 75,08 | -3 229 | 3 834 934 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -637 | 192 516 | -0,33 | 75,08 | -47 828 | 14 454 660 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 703 | 8 943 901 | -0,21 | 73,55 | -1 375 551 | 657 797 981 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 872 | 1 414 612 | -0,20 | 73,55 | -211 227 | 104 040 610 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -495 | 276 126 | -0,18 | 73,55 | -36 406 | 20 308 267 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 177 246 | -0,16 | 73,55 | -21 108 | 13 035 929 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 51 119 | -0,04 | 73,55 | -1 618 | 3 759 654 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -321 | 193 153 | -0,17 | 73,55 | -23 609 | 14 205 843 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 647 | 8 962 604 | -0,02 | 73,72 | -121 421 | 660 745 573 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1 417 484 | -0,02 | 73,72 | -18 652 | 104 500 464 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 276 621 | -0,02 | 73,72 | -3 244 | 20 393 192 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 177 533 | -0,01 | 73,72 | -1 843 | 13 088 177 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51 141 | 0,00 | 73,72 | -147 | 3 770 242 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 193 474 | -0,01 | 73,72 | -2 138 | 14 263 387 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 486 | 8 964 251 | -0,09 | 77,04 | -653 755 | 690 598 726 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 303 | 1 417 737 | -0,09 | 77,04 | -100 382 | 109 221 324 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -225 | 276 665 | -0,08 | 77,04 | -17 334 | 21 314 050 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -130 | 177 558 | -0,07 | 77,04 | -10 015 | 13 678 926 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51 143 | -0,02 | 77,04 | -770 | 3 940 016 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 193 503 | -0,08 | 77,04 | -11 248 | 14 907 316 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 914 | 8 972 737 | -0,25 | 76,49 | -1 752 680 | 686 320 167 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 518 | 1 419 040 | -0,25 | 76,49 | -269 090 | 108 541 660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -607 | 276 890 | -0,22 | 76,49 | -46 429 | 21 179 178 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -352 | 177 688 | -0,20 | 76,49 | -26 924 | 13 591 266 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51 153 | -0,05 | 76,49 | -2 065 | 3 912 667 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -393 | 193 649 | -0,20 | 76,49 | -30 060 | 14 812 115 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -58 412 | 8 995 651 | -0,65 | 77,15 | -4 506 626 | 694 036 064 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 968 | 1 422 558 | -0,63 | 77,15 | -691 903 | 109 753 764 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 546 | 277 497 | -0,55 | 77,15 | -119 278 | 21 409 560 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -896 | 178 040 | -0,50 | 77,15 | -69 129 | 13 736 213 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 51 180 | -0,13 | 77,15 | -5 246 | 3 948 660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 001 | 194 042 | -0,51 | 77,15 | -77 230 | 14 970 806 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 909 | 9 054 063 | -0,08 | 77,64 | -536 386 | 702 919 424 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 060 | 1 431 526 | -0,07 | 77,64 | -82 294 | 111 137 666 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -183 | 279 043 | -0,07 | 77,64 | -14 207 | 21 663 727 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -107 | 178 936 | -0,06 | 77,64 | -8 307 | 13 891 840 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51 248 | -0,02 | 77,64 | -621 | 3 978 679 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 195 043 | -0,06 | 77,64 | -9 161 | 15 142 319 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9 060 972 | -0,01 | 76,20 | -37 565 | 690 423 414 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1 432 586 | -0,01 | 76,20 | -5 791 | 109 159 472 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 279 226 | 0,00 | 76,20 | -991 | 21 276 323 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 179 043 | 0,00 | 76,20 | -610 | 13 642 629 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51 256 | 0,00 | 76,20 | -76 | 3 905 579 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 195 161 | 0,00 | 76,20 | -686 | 14 870 780 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -742 | 9 061 465 | -0,01 | 76,20 | -56 540 | 690 483 633 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 1 432 662 | -0,01 | 76,20 | -8 687 | 109 168 844 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20 | 279 239 | -0,01 | 76,20 | -1 524 | 21 278 012 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 179 051 | -0,01 | 76,20 | -838 | 13 643 686 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51 257 | 0,00 | 76,20 | -76 | 3 905 783 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 195 170 | -0,01 | 76,20 | -991 | 14 871 954 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31 482 | 9 062 207 | -0,35 | 76,66 | -2 413 501 | 694 735 069 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 833 | 1 432 776 | -0,34 | 76,66 | -370 512 | 109 840 763 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -833 | 279 259 | -0,30 | 76,66 | -63 860 | 21 408 805 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -484 | 179 062 | -0,27 | 76,66 | -37 105 | 13 727 412 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 51 258 | -0,07 | 76,66 | -2 837 | 3 929 587 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -539 | 195 183 | -0,28 | 76,66 | -41 321 | 14 963 295 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 9 093 689 | -0,01 | 77,81 | -48 239 | 707 539 019 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 1 437 609 | -0,01 | 77,81 | -7 392 | 111 853 887 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 280 092 | -0,01 | 77,81 | -1 245 | 21 792 698 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 179 546 | -0,01 | 77,81 | -778 | 13 969 666 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51 295 | 0,00 | 77,81 | -78 | 3 991 033 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 195 722 | -0,01 | 77,81 | -856 | 15 228 248 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 506 | 9 094 309 | -0,07 | 78,13 | -508 342 | 710 577 468 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -999 | 1 437 704 | -0,07 | 78,13 | -78 056 | 112 333 996 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -172 | 280 108 | -0,06 | 78,13 | -13 439 | 21 886 043 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -100 | 179 556 | -0,06 | 78,13 | -7 813 | 14 029 482 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51 296 | -0,02 | 78,13 | -625 | 4 007 977 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112 | 195 733 | -0,06 | 78,13 | -8 751 | 15 293 461 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 9 100 815 | 0,09 | 17,59 | 145 118 | 160 083 336 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 9 100 815 | 0,09 | 17,59 | 145 118 | 160 083 336 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 29 288 793 | 0,07 | 2,80 | 56 000 | 82 008 620 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 29 288 793 | 0,07 | 2,80 | 56 000 | 82 008 620 | |
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1 818 475 | 8 837 349 | 25,91 | ||||
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 181 525 | 916 043 | 24,71 | ||||
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 634 | 9 092 565 | -0,15 | 70,55 | -961 887 | 641 485 916 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 093 | 1 430 453 | -0,15 | 70,55 | -147 662 | 100 919 317 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -361 | 280 280 | -0,13 | 70,55 | -25 469 | 19 773 922 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -210 | 179 656 | -0,12 | 70,55 | -14 816 | 12 674 839 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51 304 | -0,03 | 70,55 | -1 129 | 3 619 528 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 195 845 | -0,12 | 70,55 | -16 509 | 13 816 982 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 660 | 9 106 199 | -0,27 | 71,35 | -1 759 553 | 649 750 064 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 786 | 1 432 546 | -0,26 | 71,35 | -270 141 | 102 215 738 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -653 | 280 641 | -0,23 | 71,35 | -46 593 | 20 024 437 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -378 | 179 866 | -0,21 | 71,35 | -26 971 | 12 833 889 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 51 320 | -0,06 | 71,35 | -2 069 | 3 661 810 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -423 | 196 079 | -0,22 | 71,35 | -30 182 | 13 990 727 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75 736 | 9 130 859 | -0,82 | 72,20 | -5 468 397 | 659 279 065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 627 | 1 436 332 | -0,80 | 72,20 | -839 509 | 103 708 054 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 004 | 281 294 | -0,71 | 72,20 | -144 696 | 20 310 383 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 162 | 180 244 | -0,64 | 72,20 | -83 900 | 13 014 230 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51 349 | -0,17 | 72,20 | -6 426 | 3 707 572 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 298 | 196 502 | -0,66 | 72,20 | -93 720 | 14 188 113 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65 426 | 9 206 595 | -0,71 | 72,02 | -4 711 967 | 663 057 131 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 044 | 1 447 959 | -0,69 | 72,02 | -723 367 | 104 281 718 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 732 | 283 298 | -0,61 | 72,02 | -124 738 | 20 403 065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 004 | 181 406 | -0,55 | 72,02 | -72 308 | 13 064 824 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 51 438 | -0,15 | 72,02 | -5 474 | 3 704 554 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 121 | 197 800 | -0,56 | 72,02 | -80 734 | 14 245 516 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 648 | 9 272 021 | -0,02 | 73,46 | -121 054 | 681 076 303 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1 458 003 | -0,02 | 73,46 | -18 584 | 107 097 610 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 285 030 | -0,02 | 73,46 | -3 232 | 20 936 879 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 182 410 | -0,01 | 73,46 | -1 836 | 13 398 927 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51 514 | 0,00 | 73,46 | -147 | 3 783 961 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 198 921 | -0,01 | 73,46 | -2 057 | 14 611 742 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 260 | 9 273 669 | -0,31 | 70,52 | -2 063 313 | 653 946 680 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 492 | 1 458 256 | -0,31 | 70,52 | -316 760 | 102 831 109 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -774 | 285 074 | -0,27 | 70,52 | -54 580 | 20 102 421 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -450 | 182 435 | -0,25 | 70,52 | -31 732 | 12 864 678 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34 | 51 516 | -0,07 | 70,52 | -2 398 | 3 632 728 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -502 | 198 949 | -0,25 | 70,52 | -35 399 | 14 029 187 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 521 | 9 302 929 | -0,45 | 71,00 | -3 018 995 | 660 508 889 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 529 | 1 462 748 | -0,44 | 71,00 | -463 560 | 103 855 254 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 125 | 285 848 | -0,39 | 71,00 | -79 875 | 20 295 237 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -652 | 182 885 | -0,36 | 71,00 | -46 292 | 12 984 853 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 51 550 | -0,10 | 71,00 | -3 550 | 3 660 055 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -729 | 199 451 | -0,36 | 71,00 | -51 759 | 14 161 041 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 547 | 9 345 450 | -0,11 | 71,61 | -755 298 | 669 251 973 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 619 | 1 469 277 | -0,11 | 71,61 | -115 941 | 105 218 746 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -279 | 286 973 | -0,10 | 71,61 | -19 980 | 20 550 883 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -162 | 183 537 | -0,09 | 71,61 | -11 601 | 13 143 562 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 | 51 600 | -0,02 | 71,61 | -859 | 3 695 210 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -181 | 200 180 | -0,09 | 71,61 | -12 962 | 14 335 410 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 595 | 9 355 997 | -0,15 | 72,23 | -981 964 | 675 781 792 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 087 | 1 470 896 | -0,14 | 72,23 | -150 744 | 106 242 524 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 287 252 | -0,13 | 72,23 | -26 003 | 20 748 155 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 183 699 | -0,11 | 72,23 | -15 096 | 13 268 542 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51 612 | -0,03 | 72,23 | -1 156 | 3 727 924 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 200 361 | -0,12 | 72,23 | -16 830 | 14 472 035 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132 363 | 9 369 592 | -1,39 | 72,79 | -9 634 226 | 681 978 871 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20 322 | 1 472 983 | -1,36 | 72,79 | -1 479 165 | 107 213 130 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 503 | 287 612 | -1,20 | 72,79 | -254 971 | 20 934 242 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 031 | 183 908 | -1,09 | 72,79 | -147 829 | 13 386 001 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -155 | 51 628 | -0,30 | 72,79 | -11 282 | 3 757 816 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 268 | 200 594 | -1,12 | 72,79 | -165 080 | 14 600 515 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -149 754 | 9 501 955 | -1,55 | 70,79 | -10 601 295 | 672 656 697 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 991 | 1 493 305 | -1,52 | 70,79 | -1 627 565 | 105 713 152 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 963 | 291 115 | -1,34 | 70,79 | -280 546 | 20 608 438 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 298 | 185 939 | -1,22 | 70,79 | -162 679 | 13 162 882 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -175 | 51 783 | -0,34 | 70,79 | -12 388 | 3 665 791 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 566 | 202 862 | -1,25 | 70,79 | -181 651 | 14 360 885 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9 651 709 | -0,01 | 70,07 | -34 545 | 676 311 658 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1 516 296 | -0,01 | 70,07 | -5 325 | 106 249 438 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 295 078 | 0,00 | 70,07 | -911 | 20 676 617 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 188 237 | 0,00 | 70,07 | -561 | 13 190 087 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51 958 | 0,00 | 70,07 | -70 | 3 640 785 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 205 428 | 0,00 | 70,07 | -631 | 14 394 689 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23 462 | 9 652 202 | -0,24 | 70,22 | -1 647 574 | 677 807 546 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 602 | 1 516 372 | -0,24 | 70,22 | -252 944 | 106 484 343 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -621 | 295 091 | -0,21 | 70,22 | -43 609 | 20 722 205 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 188 245 | -0,19 | 70,22 | -25 280 | 13 219 147 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51 959 | -0,05 | 70,22 | -1 896 | 3 648 722 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -402 | 205 437 | -0,20 | 70,22 | -28 230 | 14 426 423 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 392 | 9 675 664 | -0,09 | 70,28 | -589 772 | 679 985 347 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 288 | 1 519 974 | -0,08 | 70,28 | -90 518 | 106 820 581 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -222 | 295 712 | -0,08 | 70,28 | -15 602 | 20 782 018 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 188 605 | -0,07 | 70,28 | -9 066 | 13 254 763 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51 986 | -0,02 | 70,28 | -703 | 3 653 467 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -144 | 205 839 | -0,07 | 70,28 | -10 120 | 14 465 933 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 658 | 85 072 | 4,49 | 3,52 | 12 876 | 299 453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 658 | 85 072 | 4,49 | 3,52 | 12 876 | 299 453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 658 | 85 072 | 4,49 | 3,52 | 12 876 | 299 453 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295 934 | 0,10 | 64,41 | 19 967 | 19 061 109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295 934 | 0,10 | 64,41 | 19 967 | 19 061 109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295 934 | 0,10 | 64,41 | 19 967 | 19 061 109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 1 695 159 | 0,02 | 64,41 | 19 967 | 109 185 191 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 225 893 | 0,14 | 64,41 | 19 967 | 14 549 768 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 362 631 | 0,09 | 64,41 | 19 967 | 23 357 063 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810 862 | 0,04 | 63,59 | 18 950 | 51 562 715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810 862 | 0,04 | 63,59 | 18 950 | 51 562 715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 29 421 884 | 0,00 | 63,59 | 18 950 | 1 870 937 604 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 243 | 9 683 746 | -0,16 | 73,09 | -1 114 047 | 707 744 323 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 340 | 1 520 952 | -0,15 | 73,09 | -171 021 | 111 159 994 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -403 | 295 624 | -0,14 | 73,09 | -29 454 | 21 605 917 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 188 424 | -0,12 | 73,09 | -17 102 | 13 771 119 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 51 686 | -0,03 | 73,09 | -1 316 | 3 777 513 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -262 | 205 673 | -0,13 | 73,09 | -19 148 | 15 031 776 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 627 | 9 698 989 | -0,13 | 71,81 | -906 797 | 696 524 166 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 939 | 1 523 292 | -0,13 | 71,81 | -139 248 | 109 393 844 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -334 | 296 027 | -0,11 | 71,81 | -23 986 | 21 258 913 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -194 | 188 658 | -0,10 | 71,81 | -13 932 | 13 548 304 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 | 51 704 | -0,03 | 71,81 | -1 077 | 3 713 076 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 205 935 | -0,10 | 71,81 | -15 512 | 14 789 037 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34 794 | 9 711 616 | -0,36 | 74,88 | -2 605 510 | 727 243 681 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 342 | 1 525 231 | -0,35 | 74,88 | -400 030 | 114 215 246 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -921 | 296 361 | -0,31 | 74,88 | -68 968 | 22 192 667 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -534 | 188 852 | -0,28 | 74,88 | -39 988 | 14 141 974 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 | 51 719 | -0,08 | 74,88 | -3 070 | 3 872 920 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -597 | 206 151 | -0,29 | 74,88 | -44 706 | 15 437 391 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 718 | 9 746 410 | -0,08 | 73,83 | -569 813 | 719 568 679 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 185 | 1 530 573 | -0,08 | 73,83 | -87 487 | 113 000 827 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 297 282 | -0,07 | 73,83 | -15 061 | 21 948 063 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 189 386 | -0,06 | 73,83 | -8 712 | 13 982 198 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 51 760 | -0,02 | 73,83 | -664 | 3 821 394 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132 | 206 748 | -0,06 | 73,83 | -9 745 | 15 264 019 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84 418 | 9 754 128 | -0,86 | 76,15 | -6 428 768 | 742 815 864 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 961 | 1 531 758 | -0,84 | 76,15 | -987 032 | 116 649 499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 234 | 297 486 | -0,75 | 76,15 | -170 128 | 22 654 749 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 296 | 189 504 | -0,68 | 76,15 | -98 696 | 14 431 488 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99 | 51 769 | -0,19 | 76,15 | -7 539 | 3 942 416 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 447 | 206 880 | -0,69 | 76,15 | -110 195 | 15 754 740 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 364 | 9 838 546 | -0,77 | 75,46 | -5 762 481 | 742 423 568 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 724 | 1 544 719 | -0,75 | 75,46 | -884 701 | 116 565 577 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 021 | 299 720 | -0,67 | 75,46 | -152 506 | 22 617 081 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 172 | 190 800 | -0,61 | 75,46 | -88 440 | 14 397 902 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51 868 | -0,17 | 75,46 | -6 716 | 3 913 996 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 309 | 208 327 | -0,62 | 75,46 | -98 778 | 15 720 501 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 538 | 9 914 910 | -0,03 | 77,75 | -197 318 | 770 839 635 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -390 | 1 556 443 | -0,03 | 77,75 | -30 321 | 121 006 439 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -67 | 301 741 | -0,02 | 77,75 | -5 209 | 23 459 005 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 191 972 | -0,02 | 77,75 | -3 032 | 14 924 959 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 51 957 | -0,01 | 77,75 | -233 | 4 039 423 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 209 636 | -0,02 | 77,75 | -3 343 | 16 298 256 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 493 | 9 917 448 | -0,06 | 73,81 | -405 449 | 732 025 680 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -843 | 1 556 833 | -0,05 | 73,81 | -62 223 | 114 912 802 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 301 808 | -0,05 | 73,81 | -10 777 | 22 277 022 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84 | 192 011 | -0,04 | 73,81 | -6 200 | 14 172 697 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 51 960 | -0,01 | 73,81 | -443 | 3 835 266 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 209 679 | -0,05 | 73,81 | -7 012 | 15 476 805 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 604 | 9 922 941 | -0,19 | 75,83 | -1 410 758 | 752 465 547 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 856 | 1 557 676 | -0,18 | 75,83 | -216 573 | 118 119 973 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -492 | 301 954 | -0,16 | 75,83 | -37 309 | 22 897 444 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 192 095 | -0,15 | 75,83 | -21 688 | 14 566 737 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 51 966 | -0,04 | 75,83 | -1 592 | 3 940 629 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -319 | 209 774 | -0,15 | 75,83 | -24 190 | 15 907 351 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -371 | 9 941 545 | 0,00 | 77,11 | -28 608 | 766 592 535 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57 | 1 560 532 | 0,00 | 77,11 | -4 395 | 120 332 623 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 302 446 | 0,00 | 77,11 | -771 | 23 321 611 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192 381 | 0,00 | 77,11 | -463 | 14 834 499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192 381 | 0,00 | 77,11 | -463 | 14 834 499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51 987 | 0,00 | 77,11 | -77 | 4 008 718 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1 569 | 1 569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1 569 | 1 569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | -10 731 | 0 | -100,00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71 647 | 71 647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71 647 | 71 647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -489 977 | 0 | -100,00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11 178 823 | 35 976 940 | 45,08 | 17,00 | 190 039 991 | 611 607 980 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 585 882 | 3 736 902 | 18,59 | 17,00 | 9 959 994 | 63 527 334 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 9 941 916 | 0,00 | 76,62 | -18 925 | 761 724 749 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 1 560 589 | 0,00 | 76,62 | -2 911 | 119 568 428 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 302 456 | 0,00 | 76,62 | -460 | 23 173 423 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192 387 | 0,00 | 76,62 | -306 | 14 740 211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192 387 | 0,00 | 76,62 | -306 | 14 740 211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51 988 | 0,00 | 76,62 | -77 | 3 983 191 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -32 598 | 9 942 163 | -0,33 | 77,52 | -2 527 147 | 770 762 210 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 005 | 1 560 627 | -0,32 | 77,52 | -388 011 | 120 986 984 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -863 | 302 462 | -0,28 | 77,52 | -66 904 | 23 448 246 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -500 | 192 391 | -0,26 | 77,52 | -38 762 | 14 915 035 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 51 989 | -0,07 | 77,52 | -2 946 | 4 030 426 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 210 103 | -0,27 | 77,52 | -43 336 | 16 288 151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 047 | 9 974 761 | -0,88 | 78,05 | -6 950 074 | 778 525 109 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 671 | 1 565 632 | -0,87 | 78,05 | -1 067 015 | 122 196 795 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 357 | 303 325 | -0,77 | 78,05 | -183 963 | 23 674 365 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 367 | 192 891 | -0,70 | 78,05 | -106 694 | 15 055 046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -104 | 52 027 | -0,20 | 78,05 | -8 117 | 4 060 681 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 526 | 210 662 | -0,72 | 78,05 | -119 104 | 16 442 064 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 659 | 10 063 808 | -0,44 | 80,09 | -3 576 721 | 806 006 357 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 856 | 1 579 303 | -0,43 | 80,09 | -549 094 | 126 485 746 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 182 | 305 682 | -0,39 | 80,09 | -94 666 | 24 481 949 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -685 | 194 258 | -0,35 | 80,09 | -54 861 | 15 558 046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 52 131 | -0,10 | 80,09 | -4 165 | 4 175 151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -765 | 212 188 | -0,36 | 80,09 | -61 269 | 16 994 052 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 121 | 10 108 467 | -1,26 | 79,07 | -10 209 675 | 799 282 551 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 824 | 1 586 159 | -1,23 | 79,07 | -1 567 496 | 125 418 544 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 417 | 306 864 | -1,10 | 79,07 | -270 184 | 24 263 921 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 981 | 194 943 | -1,01 | 79,07 | -156 639 | 15 414 260 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -151 | 52 183 | -0,29 | 79,07 | -11 940 | 4 126 141 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 214 | 212 953 | -1,03 | 79,07 | -175 062 | 16 838 321 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 591 | 10 237 588 | -0,39 | 79,63 | -3 152 536 | 815 194 562 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 078 | 1 605 983 | -0,38 | 79,63 | -483 977 | 127 880 572 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 048 | 310 281 | -0,34 | 79,63 | -83 450 | 24 706 931 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -608 | 196 924 | -0,31 | 79,63 | -48 414 | 15 680 586 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 | 52 334 | -0,09 | 79,63 | -3 663 | 4 167 231 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -678 | 215 167 | -0,31 | 79,63 | -53 988 | 17 133 232 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30 257 | 10 277 179 | -0,29 | 77,61 | -2 348 376 | 797 656 054 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 646 | 1 612 061 | -0,29 | 77,61 | -360 596 | 125 118 986 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -801 | 311 329 | -0,26 | 77,61 | -62 169 | 24 163 582 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -465 | 197 532 | -0,23 | 77,61 | -36 091 | 15 331 308 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -35 | 52 380 | -0,07 | 77,61 | -2 717 | 4 065 437 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -518 | 215 845 | -0,24 | 77,61 | -40 204 | 16 752 659 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 994 | 10 307 436 | -0,12 | 78,80 | -945 149 | 812 244 510 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 841 | 1 616 707 | -0,11 | 78,80 | -145 074 | 127 399 422 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -317 | 312 130 | -0,10 | 78,80 | -24 980 | 24 596 406 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -184 | 197 997 | -0,09 | 78,80 | -14 500 | 15 602 520 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 52 415 | -0,03 | 78,80 | -1 103 | 4 130 396 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -206 | 216 363 | -0,10 | 78,80 | -16 233 | 17 049 794 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77 976 | 10 319 430 | -0,75 | 76,81 | -5 989 017 | 792 593 109 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 972 | 1 618 548 | -0,73 | 76,81 | -919 520 | 124 314 036 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 064 | 312 447 | -0,66 | 76,81 | -158 527 | 23 997 773 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 197 | 198 181 | -0,60 | 76,81 | -91 937 | 15 221 470 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52 429 | -0,17 | 76,81 | -6 989 | 4 026 857 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 335 | 216 569 | -0,61 | 76,81 | -102 536 | 16 633 777 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 595 | 10 397 406 | -0,13 | 74,01 | -1 006 150 | 769 499 541 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 087 | 1 630 520 | -0,13 | 74,01 | -154 456 | 120 672 829 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 314 511 | -0,11 | 74,01 | -26 643 | 23 276 582 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 199 378 | -0,10 | 74,01 | -15 468 | 14 755 727 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 52 520 | -0,03 | 74,01 | -1 184 | 3 886 942 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 217 904 | -0,11 | 74,01 | -17 244 | 16 126 814 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57 979 | 10 411 001 | -0,55 | 74,71 | -4 331 524 | 777 790 268 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 901 | 1 632 607 | -0,54 | 74,71 | -664 980 | 121 969 620 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 534 | 314 871 | -0,48 | 74,71 | -114 603 | 23 523 540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -890 | 199 587 | -0,44 | 74,71 | -66 491 | 14 910 845 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 52 536 | -0,13 | 74,71 | -5 080 | 3 924 886 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -994 | 218 137 | -0,45 | 74,71 | -74 260 | 16 296 688 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 764 | 10 468 980 | -0,54 | 75,27 | -4 272 831 | 788 037 813 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 715 | 1 641 508 | -0,53 | 75,27 | -656 009 | 123 562 217 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 502 | 316 405 | -0,47 | 75,27 | -113 061 | 23 816 943 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -871 | 200 477 | -0,43 | 75,27 | -65 563 | 15 090 626 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 52 604 | -0,13 | 75,27 | -4 968 | 3 959 692 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -973 | 219 131 | -0,44 | 75,27 | -73 241 | 16 494 779 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36 652 | 10 525 744 | -0,35 | 73,76 | -2 703 294 | 776 333 617 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 627 | 1 650 223 | -0,34 | 73,76 | -415 023 | 121 713 353 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -970 | 317 907 | -0,30 | 73,76 | -71 543 | 23 447 453 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -563 | 201 348 | -0,28 | 73,76 | -41 524 | 14 850 563 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 52 670 | -0,08 | 73,76 | -3 171 | 3 884 713 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -628 | 220 104 | -0,28 | 73,76 | -46 319 | 16 233 925 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77 558 | 10 562 396 | -0,73 | 74,24 | -5 758 092 | 784 177 629 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 907 | 1 655 850 | -0,71 | 74,24 | -884 004 | 122 934 278 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 052 | 318 877 | -0,64 | 74,24 | -152 345 | 23 674 194 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 190 | 201 911 | -0,59 | 74,24 | -88 348 | 14 990 357 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52 713 | -0,17 | 74,24 | -6 756 | 3 913 540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 329 | 220 732 | -0,60 | 74,24 | -98 668 | 16 387 673 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 204 | 10 639 954 | -0,08 | 74,05 | -607 484 | 787 859 866 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 260 | 1 667 757 | -0,08 | 74,05 | -93 300 | 123 492 903 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -217 | 320 929 | -0,07 | 74,05 | -16 068 | 23 763 926 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -126 | 203 101 | -0,06 | 74,05 | -9 330 | 15 039 081 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 52 804 | -0,02 | 74,05 | -740 | 3 909 994 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -141 | 222 061 | -0,06 | 74,05 | -10 441 | 16 443 017 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 487 | 10 648 158 | -0,23 | 74,36 | -1 820 848 | 791 794 899 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 759 | 1 669 017 | -0,22 | 74,36 | -279 518 | 124 107 770 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -648 | 321 146 | -0,20 | 74,36 | -48 185 | 23 880 352 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -376 | 203 227 | -0,18 | 74,36 | -27 959 | 15 111 919 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 52 814 | -0,05 | 74,36 | -2 082 | 3 927 238 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -419 | 222 202 | -0,19 | 74,36 | -31 157 | 16 522 896 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55 365 | 10 672 645 | -0,52 | 76,35 | -4 227 024 | 814 838 302 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 499 | 1 672 776 | -0,51 | 76,35 | -648 884 | 127 713 604 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 466 | 321 794 | -0,45 | 76,35 | -111 927 | 24 568 425 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -850 | 203 603 | -0,42 | 76,35 | -64 896 | 15 544 743 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65 | 52 842 | -0,12 | 76,35 | -4 963 | 4 034 397 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -949 | 222 621 | -0,42 | 76,35 | -72 455 | 16 996 735 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 646 | 10 728 010 | -0,15 | 77,66 | -1 292 763 | 833 159 785 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 556 | 1 681 275 | -0,15 | 77,66 | -198 504 | 130 571 347 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -440 | 323 260 | -0,14 | 77,66 | -34 171 | 25 105 050 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -255 | 204 453 | -0,12 | 77,66 | -19 804 | 15 878 249 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 | 52 907 | -0,04 | 77,66 | -1 476 | 4 108 869 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -285 | 223 570 | -0,13 | 77,66 | -22 134 | 17 362 916 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 330 | 10 744 656 | -0,36 | 79,13 | -3 033 110 | 850 240 746 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 885 | 1 683 831 | -0,35 | 79,13 | -465 689 | 133 244 073 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 014 | 323 700 | -0,31 | 79,13 | -80 239 | 25 614 867 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -588 | 204 708 | -0,29 | 79,13 | -46 529 | 16 198 851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -45 | 52 926 | -0,08 | 79,13 | -3 561 | 4 188 114 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -657 | 223 855 | -0,29 | 79,13 | -51 989 | 17 713 982 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 296 | 10 782 986 | -0,03 | 80,09 | -263 978 | 863 613 662 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1 689 716 | -0,03 | 80,09 | -40 526 | 135 330 030 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 324 714 | -0,03 | 80,09 | -6 968 | 26 006 474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 205 296 | -0,02 | 80,09 | -4 085 | 16 442 239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 52 971 | -0,01 | 80,09 | -320 | 4 242 469 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 224 512 | -0,02 | 80,09 | -4 485 | 17 981 256 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -53 013 | 10 786 282 | -0,49 | 80,07 | -4 244 714 | 863 650 049 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 139 | 1 690 222 | -0,48 | 80,07 | -651 684 | 135 334 892 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 403 | 324 801 | -0,43 | 80,07 | -112 337 | 26 006 589 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -814 | 205 347 | -0,39 | 80,07 | -65 176 | 16 441 991 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62 | 52 975 | -0,12 | 80,07 | -4 964 | 4 241 671 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -908 | 224 568 | -0,40 | 80,07 | -72 703 | 17 981 003 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99 280 | 10 839 295 | -0,91 | 78,09 | -7 752 428 | 846 402 609 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 242 | 1 698 361 | -0,89 | 78,09 | -1 190 194 | 132 619 066 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 628 | 326 204 | -0,80 | 78,09 | -205 211 | 25 472 129 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 524 | 206 161 | -0,73 | 78,09 | -119 004 | 16 098 391 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -115 | 53 037 | -0,22 | 78,09 | -8 980 | 4 141 474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 702 | 225 476 | -0,75 | 78,09 | -132 903 | 17 606 632 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 014 | 10 938 575 | -0,14 | 81,26 | -1 220 038 | 888 868 604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 305 | 1 713 603 | -0,13 | 81,26 | -187 304 | 139 247 380 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -397 | 328 832 | -0,12 | 81,26 | -32 260 | 26 720 888 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -230 | 207 685 | -0,11 | 81,26 | -18 690 | 16 876 483 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53 152 | -0,03 | 81,26 | -1 463 | 4 319 132 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -257 | 227 178 | -0,11 | 81,26 | -20 884 | 18 460 484 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 511 | 10 953 589 | -0,42 | 81,16 | -3 774 912 | 889 011 904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 140 | 1 715 908 | -0,41 | 81,16 | -579 495 | 139 266 010 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 231 | 329 229 | -0,37 | 81,16 | -99 910 | 26 720 785 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -714 | 207 915 | -0,34 | 81,16 | -57 949 | 16 874 735 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -54 | 53 170 | -0,10 | 81,16 | -4 383 | 4 315 368 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -796 | 227 435 | -0,35 | 81,16 | -64 605 | 18 459 011 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 533 | 11 000 100 | -0,07 | 80,51 | -606 473 | 885 604 851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 156 | 1 723 048 | -0,07 | 80,51 | -93 068 | 138 720 527 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -199 | 330 460 | -0,06 | 80,51 | -16 021 | 26 604 938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -116 | 208 629 | -0,06 | 80,51 | -9 339 | 16 796 470 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53 224 | -0,02 | 80,51 | -725 | 4 285 000 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 228 231 | -0,06 | 80,51 | -10 386 | 18 374 604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 877 | 11 007 633 | -0,11 | 80,38 | -954 711 | 884 828 765 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 824 | 1 724 204 | -0,11 | 80,38 | -146 619 | 138 597 035 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -314 | 330 659 | -0,09 | 80,38 | -25 240 | 26 579 429 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -182 | 208 745 | -0,09 | 80,38 | -14 630 | 16 779 591 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 53 233 | -0,03 | 80,38 | -1 125 | 4 279 039 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 228 360 | -0,09 | 80,38 | -16 398 | 18 356 308 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 367 | 11 019 510 | -0,18 | 85,11 | -1 648 296 | 937 853 967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 973 | 1 726 028 | -0,17 | 85,11 | -253 028 | 146 899 654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -513 | 330 973 | -0,15 | 85,11 | -43 661 | 28 168 616 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -297 | 208 927 | -0,14 | 85,11 | -25 277 | 17 781 464 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23 | 53 247 | -0,04 | 85,11 | -1 957 | 4 531 772 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -332 | 228 564 | -0,15 | 85,11 | -28 256 | 19 452 739 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112 010 | 11 038 877 | -1,00 | 82,06 | -9 191 025 | 905 799 468 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17 198 | 1 729 001 | -0,98 | 82,06 | -1 411 189 | 141 873 869 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 964 | 331 486 | -0,89 | 82,06 | -243 212 | 27 200 216 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 720 | 209 224 | -0,82 | 82,06 | -141 135 | 17 167 959 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 53 270 | -0,24 | 82,06 | -10 585 | 4 371 091 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 919 | 228 896 | -0,83 | 82,06 | -157 464 | 18 782 153 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 157 | 11 150 887 | -0,07 | 82,55 | -673 321 | 920 452 198 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 252 | 1 746 199 | -0,07 | 82,55 | -103 347 | 144 140 346 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 334 450 | -0,06 | 82,55 | -17 830 | 27 607 242 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -125 | 210 944 | -0,06 | 82,55 | -10 318 | 17 412 415 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53 399 | -0,02 | 82,55 | -743 | 4 407 831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -140 | 230 815 | -0,06 | 82,55 | -11 556 | 19 052 670 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 120 | 11 159 044 | -0,04 | 83,90 | -345 678 | 936 271 689 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1 747 451 | -0,04 | 83,90 | -53 110 | 146 615 508 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 334 666 | -0,03 | 83,90 | -9 145 | 28 079 314 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 211 069 | -0,03 | 83,90 | -5 286 | 17 709 217 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53 408 | -0,01 | 83,90 | -420 | 4 481 065 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 230 955 | -0,03 | 83,90 | -5 957 | 19 377 702 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62 929 | 11 163 164 | -0,56 | 83,20 | -5 235 598 | 928 758 500 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 661 | 1 748 084 | -0,55 | 83,20 | -803 781 | 145 437 967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 665 | 334 775 | -0,49 | 83,20 | -138 526 | 27 852 778 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -966 | 211 132 | -0,46 | 83,20 | -80 370 | 17 565 866 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 53 413 | -0,14 | 83,20 | -6 157 | 4 443 881 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 078 | 231 026 | -0,46 | 83,20 | -89 688 | 19 221 017 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17 602 | 11 226 093 | -0,16 | 85,87 | -1 511 565 | 964 036 246 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 702 | 1 757 745 | -0,15 | 85,87 | -232 033 | 150 945 649 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -466 | 336 440 | -0,14 | 85,87 | -40 018 | 28 891 650 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -270 | 212 098 | -0,13 | 85,87 | -23 186 | 18 213 831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 53 487 | -0,04 | 85,87 | -1 803 | 4 593 175 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -302 | 232 104 | -0,13 | 85,87 | -25 934 | 19 931 838 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 120 | 11 243 695 | -0,04 | 82,00 | -337 840 | 921 982 990 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1 760 447 | -0,04 | 82,00 | -51 906 | 144 356 654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 336 906 | -0,03 | 82,00 | -8 938 | 27 626 292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 212 368 | -0,03 | 82,00 | -5 166 | 17 414 176 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53 508 | -0,01 | 82,00 | -410 | 4 387 656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 232 406 | -0,03 | 82,00 | -5 822 | 19 057 292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 565 | 11 247 815 | -0,01 | 83,85 | -131 227 | 943 138 286 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -240 | 1 761 080 | -0,01 | 83,85 | -20 124 | 147 667 967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 337 015 | -0,01 | 83,85 | -3 522 | 28 258 977 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 | 212 431 | -0,01 | 83,85 | -2 012 | 17 812 509 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 53 513 | 0,00 | 83,85 | -168 | 4 487 108 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 232 477 | -0,01 | 83,85 | -2 264 | 19 493 382 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 301 | 11 249 380 | -0,08 | 84,84 | -789 121 | 954 426 648 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 428 | 1 761 320 | -0,08 | 84,84 | -121 155 | 149 434 968 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -246 | 337 057 | -0,07 | 84,84 | -20 871 | 28 596 792 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -143 | 212 455 | -0,07 | 84,84 | -12 132 | 18 025 235 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 53 515 | -0,02 | 84,84 | -933 | 4 540 352 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -159 | 232 504 | -0,07 | 84,84 | -13 490 | 19 726 244 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 423 | 11 258 681 | -0,19 | 89,34 | -1 913 901 | 1 005 834 798 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 289 | 1 762 748 | -0,19 | 89,34 | -293 835 | 157 481 438 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -567 | 337 303 | -0,17 | 89,34 | -50 655 | 30 134 178 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -329 | 212 598 | -0,15 | 89,34 | -29 392 | 18 993 208 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 53 526 | -0,05 | 89,34 | -2 233 | 4 781 938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -367 | 232 663 | -0,16 | 89,34 | -32 787 | 20 785 787 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30 555 | 11 280 104 | -0,27 | 85,15 | -2 601 670 | 960 468 143 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 692 | 1 766 037 | -0,26 | 85,15 | -399 510 | 150 372 929 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -809 | 337 870 | -0,24 | 85,15 | -68 884 | 28 768 651 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -470 | 212 927 | -0,22 | 85,15 | -40 019 | 18 130 117 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 53 551 | -0,07 | 85,15 | -3 150 | 4 559 712 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -522 | 233 030 | -0,22 | 85,15 | -44 447 | 19 841 829 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36 174 | 11 310 659 | -0,32 | 85,78 | -3 102 970 | 970 217 018 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 554 | 1 770 729 | -0,31 | 85,78 | -476 417 | 151 891 363 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -957 | 338 679 | -0,28 | 85,78 | -82 091 | 29 051 546 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -555 | 213 397 | -0,26 | 85,78 | -47 607 | 18 304 981 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 53 588 | -0,08 | 85,78 | -3 603 | 4 596 725 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 233 552 | -0,26 | 85,78 | -53 183 | 20 033 857 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 663 | 11 346 833 | -0,03 | 87,30 | -319 780 | 990 579 656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -562 | 1 776 283 | -0,03 | 87,30 | -49 063 | 155 069 684 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -97 | 339 636 | -0,03 | 87,30 | -8 468 | 29 650 257 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 213 952 | -0,03 | 87,30 | -4 889 | 18 678 031 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 53 630 | -0,01 | 87,30 | -349 | 4 681 904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 234 172 | -0,03 | 87,30 | -5 500 | 20 443 239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 306 | 11 350 496 | -0,04 | 88,38 | -380 544 | 1 003 104 624 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -661 | 1 776 845 | -0,04 | 88,38 | -58 416 | 157 029 388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 339 733 | -0,03 | 88,38 | -10 075 | 30 024 040 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 214 008 | -0,03 | 88,38 | -5 833 | 18 913 043 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53 634 | -0,01 | 88,38 | -442 | 4 739 926 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 234 235 | -0,03 | 88,38 | -6 540 | 20 700 612 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 798 | 11 354 802 | -0,14 | 83,94 | -1 326 160 | 953 176 583 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 425 | 1 777 506 | -0,14 | 83,94 | -203 566 | 149 212 386 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -418 | 339 847 | -0,12 | 83,94 | -35 089 | 28 528 388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -242 | 214 074 | -0,11 | 83,94 | -20 315 | 17 970 399 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53 639 | -0,03 | 83,94 | -1 511 | 4 502 715 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -271 | 234 309 | -0,12 | 83,94 | -22 749 | 19 669 022 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -3 660 993 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -294 948 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -4 627 208 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -372 792 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2 248 102 | 8 374 935 | 36,69 | 10,00 | 22 481 020 | 83 749 350 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 251 898 | 770 180 | 48,60 | 10,00 | 2 518 980 | 7 701 800 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 767 427 | 6 126 833 | 14,32 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 86 501 | 518 282 | 20,03 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 732 198 | 5 359 406 | 15,82 | 5,00 | 3 660 990 | 26 797 030 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 58 989 | 431 781 | 15,82 | 5,00 | 294 945 | 2 158 905 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 4 627 208 | 4 627 208 | |||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 372 792 | 372 792 | |||||
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340 265 | 0,08 | 70,18 | 19 931 | 23 879 798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340 265 | 0,08 | 70,18 | 19 931 | 23 879 798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 11 544 497 | 0,00 | 70,18 | 19 931 | 810 192 799 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 1 953 828 | 0,01 | 70,18 | 19 931 | 137 119 649 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 227 554 | 0,12 | 70,18 | 19 931 | 15 969 740 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 388 213 | 0,07 | 70,18 | 19 931 | 27 244 788 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 340 | 81 414 | 2,96 | 8,71 | 20 381 | 709 116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 340 | 81 414 | 2,96 | 8,71 | 20 381 | 709 116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 340 | 4 280 212 | 0,05 | 8,71 | 20 381 | 37 280 647 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810 564 | 0,03 | 69,08 | 18 997 | 55 993 761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810 564 | 0,03 | 69,08 | 18 997 | 55 993 761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 1 269 837 | 0,02 | 69,08 | 18 997 | 87 720 340 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 131 007 | 24 798 117 | 0,53 | 19,09 | 2 501 238 | 473 455 569 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14 555 | 3 151 020 | 0,46 | 19,09 | 277 890 | 60 160 534 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38 207 | 24 667 110 | 0,16 | 19,01 | 726 353 | 468 946 428 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 245 | 3 136 465 | 0,14 | 19,01 | 80 702 | 59 627 336 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 920 495 | 24 628 903 | 3,88 | 18,64 | 17 154 897 | 458 999 014 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 267 | 3 132 220 | 3,38 | 18,64 | 1 905 909 | 58 373 931 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 5 231 900 | 5 250 491 | 28 142,11 | 108,00 | 565 045 200 | 567 053 028 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 582 200 | 600 791 | 3 131,62 | 108,00 | 62 877 600 | 64 885 428 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16 383 | 632 599 | 2,66 | 1,32 | 21 626 | 835 031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16 383 | 632 599 | 2,66 | 1,32 | 21 626 | 835 031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16 383 | 34 222 983 | 0,05 | 1,32 | 21 626 | 45 174 338 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810 289 | 0,03 | 67,00 | 18 961 | 54 289 363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810 289 | 0,03 | 67,00 | 18 961 | 54 289 363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810 289 | 0,03 | 67,00 | 18 961 | 54 289 363 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339 981 | 0,12 | 50,40 | 19 958 | 17 135 042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339 981 | 0,12 | 50,40 | 19 958 | 17 135 042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339 981 | 0,12 | 50,40 | 19 958 | 17 135 042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 1 953 544 | 0,02 | 50,40 | 19 958 | 98 458 618 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 227 270 | 0,17 | 50,40 | 19 958 | 11 454 408 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 387 929 | 0,10 | 50,40 | 19 958 | 19 551 622 | |
| 2018-06-21 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
| 2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2018-06-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34 884 | 34 884 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18 580 | 73 180 602 | 0,03 | ||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18 580 | 73 180 602 | 0,03 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 14 658 102 | 14 658 102 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -14 658 102 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 1 399 516 | 1 399 516 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -1 399 516 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3 284 771 | 7 018 874 | 87,97 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -3 284 771 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 313 621 | 734 518 | 74,51 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -313 621 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3 734 103 | 3 734 103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -3 734 103 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 420 897 | 420 897 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -420 897 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 2 700 597 | 2 700 597 | 18,00 | 48 610 746 | 48 610 746 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 299 403 | 299 403 | 18,00 | 5 389 254 | 5 389 254 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 3 734 103 | 3 734 103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 420 897 | 420 897 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9 260 | 9 260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9 260 | 9 260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 700 | 45 829 686 | 0,01 | 56,77 | 210 049 | 2 601 751 274 | |
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 700 | 45 829 686 | 0,01 | 56,77 | 210 049 | 2 601 751 274 | |
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2 174 | 7 648 080 | 0,03 | ||||
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2 174 | 7 648 080 | 0,03 | ||||
| 2018-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 126 399 | 45 825 986 | 0,28 | 54,02 | 6 828 339 | 2 475 615 998 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129 715 | 45 699 587 | 0,28 | 53,70 | 6 966 305 | 2 454 282 610 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 204 537 | 45 569 872 | 0,45 | 52,68 | 10 775 582 | 2 400 748 453 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 810 006 | 2,53 | 9,92 | 198 400 | 8 035 260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 810 006 | 2,53 | 9,92 | 198 400 | 8 035 260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 810 006 | 2,53 | 9,92 | 198 400 | 8 035 260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9 105 | 45 365 335 | 0,02 | 54,42 | 495 488 | 2 468 749 775 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21 442 | 45 356 230 | 0,05 | 52,26 | 1 120 576 | 2 370 352 865 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37 400 | 45 334 788 | 0,08 | 52,33 | 1 957 022 | 2 372 224 385 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 000 | 45 297 388 | 0,00 | 51,88 | 103 750 | 2 349 802 002 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 951 | 45 295 388 | 0,01 | 52,33 | 311 418 | 2 370 321 243 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37 963 | 45 289 437 | 0,08 | 52,06 | 1 976 213 | 2 357 600 519 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57 270 | 45 251 474 | 0,13 | 51,37 | 2 941 708 | 2 324 369 113 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 500 | 45 194 204 | 0,02 | 51,36 | 539 280 | 2 321 174 317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22 700 | 45 183 704 | 0,05 | 51,30 | 1 164 424 | 2 317 752 317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72 533 | 45 161 004 | 0,16 | 51,26 | 3 717 693 | 2 314 736 292 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100 000 | 45 088 471 | 0,22 | 51,14 | 5 114 000 | 2 305 824 407 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 44 988 471 | 0,02 | 10,08 | 100 800 | 453 483 788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 44 988 471 | 0,02 | 10,08 | 100 800 | 453 483 788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 168 097 | 44 978 471 | 0,38 | 51,25 | 8 614 786 | 2 305 097 162 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 52 700 | 44 810 374 | 0,12 | 51,07 | 2 691 173 | 2 288 282 078 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 248 121 | 44 757 674 | 0,56 | 51,03 | 12 661 069 | 2 283 885 637 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 154 218 | 44 509 553 | 0,35 | 50,90 | 7 849 897 | 2 265 594 110 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 349 | 616 216 | 2,21 | 1,62 | 21 625 | 998 270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 349 | 616 216 | 2,21 | 1,62 | 21 625 | 998 270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 349 | 616 216 | 2,21 | 1,62 | 21 625 | 998 270 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339 585 | 0,19 | 31,29 | 19 963 | 10 625 615 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1 382 967 | 0,05 | 31,29 | 19 963 | 43 273 037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1 382 967 | 0,05 | 31,29 | 19 963 | 43 273 037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1 382 967 | 0,05 | 31,29 | 19 963 | 43 273 037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1 382 967 | 0,05 | 31,29 | 19 963 | 43 273 037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339 585 | 0,19 | 31,29 | 19 963 | 10 625 615 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790 006 | 0,03 | 83,33 | 18 999 | 65 831 200 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 1 249 279 | 0,02 | 83,33 | 18 999 | 104 102 419 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790 006 | 0,03 | 83,33 | 18 999 | 65 831 200 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 999 514 | 7 480 182 | 15,42 | 4,50 | 4 497 813 | 33 660 819 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 111 597 | 845 858 | 15,20 | 4,50 | 502 186 | 3 806 361 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -439 036 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -17 626 445 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -2 250 846 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 439 036 | 602 867 | 267,98 | 0,47 | 206 347 | 283 347 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 17 626 445 | 34 193 251 | 106,40 | 0,47 | 8 284 429 | 16 070 828 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2 250 846 | 4 102 796 | 121,54 | 0,47 | 1 057 898 | 1 928 314 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 338 947 | 2,49 | 18,50 | 152 625 | 6 270 520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 338 947 | 2,49 | 18,50 | 152 625 | 6 270 520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 382 329 | 0,60 | 18,50 | 152 625 | 25 573 086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 382 329 | 0,60 | 18,50 | 152 625 | 25 573 086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 382 329 | 0,60 | 18,50 | 152 625 | 25 573 086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 338 947 | 2,49 | 18,50 | 152 625 | 6 270 520 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 456 543 | 44 355 335 | 8,45 | 52,00 | 179 740 236 | 2 306 477 420 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 389 610 | 5 278 174 | 7,97 | 52,00 | 20 259 720 | 274 465 048 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1 645 148 | 5 121 404 | 47,33 | 101,00 | 166 159 948 | 517 261 804 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 335 050 | 708 025 | 89,83 | 101,00 | 33 840 050 | 71 510 525 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4 136 | 58 131 | -6,64 | 7,91 | -32 715 | 459 799 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -265 708 | 3 734 776 | -6,64 | 7,91 | -2 101 671 | 29 540 958 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -25 517 | 358 671 | -6,64 | 7,91 | -201 832 | 2 836 980 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4 548 | 62 267 | -6,81 | 8,12 | -36 910 | 505 340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -292 168 | 4 000 484 | -6,81 | 8,12 | -2 371 148 | 32 466 728 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -28 058 | 384 188 | -6,81 | 8,12 | -227 710 | 3 117 955 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -3 649 | 66 815 | -5,18 | 8,63 | -31 476 | 576 340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -234 437 | 4 292 652 | -5,18 | 8,63 | -2 022 230 | 37 027 987 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -22 514 | 412 246 | -5,18 | 8,63 | -194 204 | 3 555 993 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 333 | 163 831 | 6,04 | 2,21 | 20 626 | 362 067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 333 | 163 831 | 6,04 | 2,21 | 20 626 | 362 067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 333 | 163 831 | 6,04 | 2,21 | 20 626 | 362 067 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330 697 | 0,18 | 34,20 | 19 973 | 11 309 837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330 697 | 0,18 | 34,20 | 19 973 | 11 309 837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1 374 079 | 0,04 | 34,20 | 19 973 | 46 993 502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1 374 079 | 0,04 | 34,20 | 19 973 | 46 993 502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1 374 079 | 0,04 | 34,20 | 19 973 | 46 993 502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330 697 | 0,18 | 34,20 | 19 973 | 11 309 837 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789 778 | 0,03 | 94,71 | 18 942 | 74 799 874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789 778 | 0,03 | 94,71 | 18 942 | 74 799 874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789 778 | 0,03 | 94,71 | 18 942 | 74 799 874 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -39 378 | 0 | -100,00 | ||||
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1 941 | 489 977 | -0,39 | 28,00 | -54 348 | 13 719 356 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39 378 | 491 918 | 8,70 | 1,38 | 54 342 | 678 847 | |
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 1 618 684 | 1 618 684 | 13,00 | 21 041 273 | 21 041 273 | ||
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 304 392 | 304 392 | 13,00 | 3 956 792 | 3 956 792 | ||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -5 996 | 0 | -100,00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -249 801 | 0 | -100,00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -24 466 | 0 | -100,00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 5 996 | 35 999 | 19,98 | 7,86 | 47 129 | 282 952 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 249 801 | 2 372 218 | 11,77 | 7,86 | 1 963 436 | 18 645 633 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 24 466 | 141 244 | 20,95 | 7,86 | 192 303 | 1 110 178 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 204 652 | 16 557 473 | 77,03 | 1,50 | 10 806 978 | 24 836 210 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 795 348 | 1 842 617 | 75,94 | 1,50 | 1 193 022 | 2 763 926 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -1 426 590 | 0 | -100,00 | ||||
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -55 457 | 23 708 408 | -0,23 | 35,40 | -1 963 178 | 839 277 643 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 426 590 | 23 763 865 | 6,39 | 1,38 | 1 968 694 | 32 794 134 | |
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7 102 | 7 102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7 102 | 7 102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -49 200 | 0 | -100,00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -9 913 242 | 0 | -100,00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -760 829 | 0 | -100,00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 797 191 | 1 878 242 | 73,74 | 17,00 | 13 552 247 | 31 930 114 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 87 809 | 170 778 | 105,83 | 17,00 | 1 492 753 | 2 903 226 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 1 081 051 | 1 081 051 | |||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 82 969 | 82 969 | |||||
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 045 | 154 498 | 6,22 | 2,28 | 20 623 | 352 255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 045 | 154 498 | 6,22 | 2,28 | 20 623 | 352 255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9 045 | 154 498 | 6,22 | 2,28 | 20 623 | 352 255 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330 113 | 0,19 | 32,09 | 19 960 | 10 593 326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330 113 | 0,19 | 32,09 | 19 960 | 10 593 326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1 373 495 | 0,05 | 32,09 | 19 960 | 44 075 455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1 373 495 | 0,05 | 32,09 | 19 960 | 44 075 455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1 373 495 | 0,05 | 32,09 | 19 960 | 44 075 455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330 113 | 0,19 | 32,09 | 19 960 | 10 593 326 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789 578 | 0,02 | 116,74 | 18 912 | 92 175 336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789 578 | 0,02 | 116,74 | 18 912 | 92 175 336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789 578 | 0,02 | 116,74 | 18 912 | 92 175 336 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 029 | 789 416 | 0,26 | 132,00 | 267 828 | 104 202 912 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 85 402 | 29 247 347 | 0,29 | 132,00 | 11 273 064 | 3 860 649 804 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12 569 | 4 386 818 | 0,29 | 132,00 | 1 659 108 | 579 059 976 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 158 279 | 3 476 256 | 4,77 | 71,00 | 11 237 809 | 246 814 176 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 17 777 | 372 975 | 5,00 | 71,00 | 1 262 167 | 26 481 225 | |
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 3 109 063 | 3 109 063 | 8,50 | 26 427 036 | 26 427 036 | ||
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 349 760 | 349 760 | 8,50 | 2 972 960 | 2 972 960 | ||
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11 787 | 145 453 | 8,82 | 1,75 | 20 627 | 254 543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11 787 | 145 453 | 8,82 | 1,75 | 20 627 | 254 543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11 787 | 145 453 | 8,82 | 1,75 | 20 627 | 254 543 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1 372 873 | 0,04 | 32,55 | 19 986 | 44 687 016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 329 491 | 0,19 | 32,55 | 19 986 | 10 724 932 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1 246 660 | 0,01 | 125,91 | 18 886 | 156 966 961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1 246 660 | 0,01 | 125,91 | 18 886 | 156 966 961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 787 387 | 0,02 | 125,91 | 18 886 | 99 139 897 | |
| 2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22 560 | 7 317 906 | 0,31 | 117,95 | 2 660 914 | 863 134 572 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 564 | 647 367 | 0,40 | 117,95 | 302 419 | 76 355 837 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 197 126 | 7 295 346 | 2,78 | 117,51 | 23 163 488 | 857 246 927 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22 399 | 644 803 | 3,60 | 117,51 | 2 632 017 | 75 768 221 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32 172 | 7 098 220 | 0,46 | 117,22 | 3 771 228 | 832 059 027 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 656 | 622 404 | 0,59 | 117,22 | 428 559 | 72 958 695 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 65 264 | 7 066 048 | 0,93 | 117,01 | 7 636 802 | 826 826 541 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7 416 | 618 748 | 1,21 | 117,01 | 867 776 | 72 402 178 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 898 | 7 000 784 | 0,01 | 116,96 | 105 030 | 818 811 697 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 | 611 332 | 0,02 | 116,96 | 11 930 | 71 501 391 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 31 974 | 6 999 886 | 0,46 | 116,71 | 3 731 542 | 816 925 196 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 634 | 611 230 | 0,60 | 116,71 | 424 108 | 71 333 903 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 12 726 | 6 967 912 | 0,18 | 116,37 | 1 480 897 | 810 840 590 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 446 | 607 596 | 0,24 | 116,37 | 168 268 | 70 704 610 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 385 774 | 6 955 186 | 5,87 | 116,37 | 44 891 517 | 809 356 911 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43 835 | 606 150 | 7,80 | 116,37 | 5 100 965 | 70 536 100 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 976 | 6 569 412 | 0,03 | 116,18 | 229 562 | 763 202 753 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 224 | 562 315 | 0,04 | 116,18 | 26 023 | 65 327 058 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 169 897 | 6 567 436 | 2,66 | 115,77 | 19 668 568 | 760 296 304 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19 305 | 562 091 | 3,56 | 115,77 | 2 234 894 | 65 071 926 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 207 814 | 6 397 539 | 3,36 | 115,71 | 24 046 636 | 740 273 952 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 23 614 | 542 786 | 4,55 | 115,71 | 2 732 430 | 62 807 016 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 18 678 | 6 189 725 | 0,30 | 115,06 | 2 149 048 | 712 175 522 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 122 | 519 172 | 0,41 | 115,06 | 244 152 | 59 734 736 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 64 455 | 6 171 047 | 1,06 | 114,33 | 7 369 301 | 705 551 231 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7 324 | 517 050 | 1,44 | 114,33 | 837 371 | 59 115 619 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 160 000 | 980 146 | 19,51 | 117,71 | 18 832 960 | 115 369 065 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103 200 | 820 146 | 14,39 | 117,63 | 12 139 416 | 96 473 774 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32 008 | 716 946 | 4,67 | 117,60 | 3 764 067 | 84 311 201 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 684 938 | 0,04 | 116,75 | 35 025 | 79 966 512 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 747 | 7 645 906 | 0,05 | 116,75 | 437 462 | 892 659 526 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 426 | 684 638 | 0,06 | 116,75 | 49 736 | 79 931 486 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 44 898 | 7 642 159 | 0,59 | 117,50 | 5 275 484 | 897 948 333 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 102 | 684 212 | 0,75 | 117,50 | 599 481 | 80 394 431 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 373 | 7 597 261 | 0,07 | 117,21 | 629 790 | 890 504 591 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 611 | 679 110 | 0,09 | 117,21 | 71 618 | 79 601 132 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 217 305 | 7 591 888 | 2,95 | 117,05 | 25 434 638 | 888 598 604 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24 692 | 678 499 | 3,78 | 117,05 | 2 890 095 | 79 415 458 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8 950 | 7 374 583 | 0,12 | 116,95 | 1 046 720 | 862 471 494 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 017 | 653 807 | 0,16 | 116,95 | 118 940 | 76 463 971 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 39 473 | 7 365 633 | 0,54 | 116,65 | 4 604 506 | 859 197 407 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 485 | 652 790 | 0,69 | 116,65 | 523 173 | 76 147 627 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 310 | 7 326 160 | 0,06 | 116,54 | 502 277 | 853 773 836 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 490 | 648 305 | 0,08 | 116,54 | 57 103 | 75 551 974 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 944 | 7 321 850 | 0,05 | 118,00 | 465 392 | 863 978 300 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 448 | 647 815 | 0,07 | 118,00 | 52 864 | 76 442 170 | |
| 2017-06-14 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
| 2017-06-09 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
| 2017-06-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 328 877 | 2,57 | 18,13 | 149 572 | 5 962 540 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 372 259 | 0,60 | 18,13 | 149 572 | 24 879 056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 372 259 | 0,60 | 18,13 | 149 572 | 24 879 056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 372 259 | 0,60 | 18,13 | 149 572 | 24 879 056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 1 372 259 | 0,60 | 18,13 | 149 572 | 24 879 056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 328 877 | 2,57 | 18,13 | 149 572 | 5 962 540 | |
| 2017-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9 260 | 9 260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9 260 | 9 260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 700 | 40 898 792 | 0,01 | 66,60 | 246 420 | 2 723 859 547 | |
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 700 | 40 898 792 | 0,01 | 66,60 | 246 420 | 2 723 859 547 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 40 895 092 | 0,02 | 10,20 | 102 000 | 417 129 938 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 40 895 092 | 0,02 | 10,20 | 102 000 | 417 129 938 | |
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2 030 | 6 559 338 | 0,03 | ||||
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2 030 | 6 106 592 | 0,03 | ||||
| 2017-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 36 000 | 36 000 | |||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 787 237 | 2,61 | 7,26 | 145 200 | 5 715 341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 787 237 | 2,61 | 7,26 | 145 200 | 5 715 341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 787 237 | 2,61 | 7,26 | 145 200 | 5 715 341 | |
| 2017-04-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (right to buy) |
A - Award | 399 984 | 399 984 | |||||
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 487 | 133 666 | 6,78 | 2,43 | 20 623 | 324 808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 487 | 133 666 | 6,78 | 2,43 | 20 623 | 324 808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 487 | 133 666 | 6,78 | 2,43 | 20 623 | 324 808 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767 237 | 0,02 | 133,67 | 18 981 | 102 556 570 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 1 226 510 | 0,01 | 133,67 | 18 981 | 163 947 592 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767 237 | 0,02 | 133,67 | 18 981 | 102 556 570 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320 627 | 0,20 | 31,49 | 19 965 | 10 096 544 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1 364 009 | 0,05 | 31,49 | 19 965 | 42 952 643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1 364 009 | 0,05 | 31,49 | 19 965 | 42 952 643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1 364 009 | 0,05 | 31,49 | 19 965 | 42 952 643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1 364 009 | 0,05 | 31,49 | 19 965 | 42 952 643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320 627 | 0,20 | 31,49 | 19 965 | 10 096 544 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 151 177 | 4 527 089 | 3,45 | 12,00 | 1 814 124 | 54 325 068 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15 489 | 434 760 | 3,69 | 12,00 | 185 868 | 5 217 120 | |
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -6 050 000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -5 674 000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -243 450 000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -228 326 000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -25 000 000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -25 000 000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 121 672 | 767 095 | 18,85 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 111 514 | 645 423 | 20,89 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4 896 067 | 29 141 653 | 20,19 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4 487 412 | 24 245 586 | 22,71 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 502 779 | 4 353 957 | 13,06 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 491 338 | 3 851 178 | 14,62 | ||||
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 32 051 | 9 764 459 | 0,33 | 17,76 | 569 226 | 173 416 792 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3 389 | 1 169 695 | 0,29 | 17,76 | 60 189 | 20 773 783 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 235 169 | 9 732 408 | 2,48 | 17,60 | 4 138 880 | 171 286 488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 24 871 | 1 166 306 | 2,18 | 17,60 | 437 720 | 20 526 519 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 35 360 | 9 497 239 | 0,37 | 16,31 | 576 555 | 154 855 331 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3 739 | 1 141 435 | 0,33 | 16,31 | 60 966 | 18 611 440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5 006 | 9 461 879 | 0,05 | 15,62 | 78 207 | 147 819 151 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 529 | 1 137 696 | 0,05 | 15,62 | 8 264 | 17 773 770 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15 148 | 9 456 873 | 0,16 | 15,13 | 229 189 | 143 082 488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 602 | 1 137 167 | 0,14 | 15,13 | 24 238 | 17 205 337 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9 143 | 9 441 725 | 0,10 | 16,20 | 148 089 | 152 927 620 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 967 | 1 135 565 | 0,09 | 16,20 | 15 662 | 18 392 746 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 8 671 | 9 432 582 | 0,09 | 15,35 | 133 078 | 144 766 552 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 917 | 1 134 598 | 0,08 | 15,35 | 14 074 | 17 413 243 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 442 | 9 423 911 | 0,03 | 16,85 | 41 156 | 158 823 999 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 258 | 1 133 681 | 0,02 | 16,85 | 4 348 | 19 106 266 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11 305 | 9 421 469 | 0,12 | 15,32 | 173 204 | 144 346 327 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 195 | 1 133 423 | 0,11 | 15,32 | 18 309 | 17 365 174 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5 697 | 9 410 164 | 0,06 | 16,74 | 95 365 | 157 521 440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 603 | 1 132 228 | 0,05 | 16,74 | 10 094 | 18 952 931 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14 169 | 125 179 | 12,76 | 1,50 | 21 254 | 187 768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14 169 | 125 179 | 12,76 | 1,50 | 21 254 | 187 768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14 169 | 125 179 | 12,76 | 1,50 | 21 254 | 187 768 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993 182 | 0,02 | 100,27 | 18 951 | 99 586 359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993 182 | 0,02 | 100,27 | 18 951 | 99 586 359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 533 909 | 0,04 | 100,27 | 18 951 | 53 535 055 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14 045 614 | 0,00 | 29,39 | 19 985 | 412 800 595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14 045 614 | 0,00 | 29,39 | 19 985 | 412 800 595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14 045 614 | 0,00 | 29,39 | 19 985 | 412 800 595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14 045 614 | 0,00 | 29,39 | 19 985 | 412 800 595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 1 363 375 | 0,05 | 29,39 | 19 985 | 40 069 591 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 319 993 | 0,21 | 29,39 | 19 985 | 9 404 594 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1 594 671 | 3 317 977 | 92,54 | 32,00 | 51 029 472 | 106 175 264 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 165 824 | 355 198 | 87,56 | 32,00 | 5 306 368 | 11 366 336 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 664 259 | 6 480 668 | 11,42 | 6,00 | 3 985 554 | 38 884 008 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 69 074 | 734 261 | 10,38 | 6,00 | 414 444 | 4 405 566 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 294 178 | 40 885 092 | 0,72 | 59,46 | 17 493 177 | 2 431 215 642 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32 122 | 4 874 864 | 0,66 | 59,46 | 1 910 122 | 289 881 838 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 667 | 40 590 914 | 0,12 | 58,74 | 2 976 321 | 2 384 423 943 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 533 | 4 842 742 | 0,11 | 58,74 | 325 024 | 284 476 225 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18 616 | 40 540 247 | 0,05 | 55,99 | 1 042 351 | 2 269 937 618 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 039 | 4 837 209 | 0,04 | 55,99 | 114 168 | 270 845 974 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16 854 | 40 521 631 | 0,04 | 56,42 | 950 861 | 2 286 129 117 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 846 | 4 835 170 | 0,04 | 56,42 | 104 147 | 272 788 203 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 143 016 | 40 504 777 | 0,35 | 56,48 | 8 078 001 | 2 287 839 420 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15 662 | 4 833 324 | 0,33 | 56,48 | 884 640 | 273 001 606 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 361 | 40 361 761 | 0,00 | 56,49 | 20 393 | 2 280 035 879 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 | 4 817 662 | 0,00 | 56,49 | 2 203 | 272 149 726 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456 | 40 361 400 | 0,00 | 56,55 | 25 788 | 2 282 558 254 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 | 4 817 623 | 0,00 | 56,55 | 2 828 | 272 451 034 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 341 438 | 40 360 944 | 0,85 | 56,91 | 19 430 383 | 2 296 840 421 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37 392 | 4 817 573 | 0,78 | 56,91 | 2 127 885 | 274 156 035 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95 280 | 40 019 506 | 0,24 | 55,84 | 5 320 673 | 2 234 789 264 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 434 | 4 780 181 | 0,22 | 55,84 | 582 661 | 266 937 257 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 335 | 39 924 226 | 0,01 | 55,87 | 186 336 | 2 230 686 279 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 365 | 4 769 747 | 0,01 | 55,87 | 20 394 | 266 500 074 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6 289 | 39 920 891 | 0,02 | 56,12 | 352 915 | 2 240 208 704 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 689 | 4 769 382 | 0,01 | 56,12 | 38 664 | 267 639 594 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 26 381 | 39 914 602 | 0,07 | 56,13 | 1 480 758 | 2 240 394 636 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 889 | 4 768 693 | 0,06 | 56,13 | 162 159 | 267 665 307 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 289 278 | 39 888 221 | 0,73 | 56,26 | 16 274 202 | 2 244 031 537 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31 679 | 4 765 804 | 0,67 | 56,26 | 1 782 197 | 268 114 601 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 884 | 39 598 943 | 0,01 | 51,83 | 149 479 | 2 052 425 095 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 316 | 4 734 125 | 0,01 | 51,83 | 16 378 | 245 371 119 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 434 | 39 596 059 | 0,01 | 53,33 | 129 815 | 2 111 812 251 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 266 | 4 733 809 | 0,01 | 53,33 | 14 187 | 252 472 496 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32 717 | 39 593 625 | 0,08 | 53,66 | 1 755 578 | 2 124 574 121 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 583 | 4 733 543 | 0,08 | 53,66 | 192 262 | 253 999 551 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40 332 | 39 560 908 | 0,10 | 54,37 | 2 192 976 | 2 151 049 207 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 417 | 4 729 960 | 0,09 | 54,37 | 240 166 | 257 182 588 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 924 | 39 520 576 | 0,00 | 54,51 | 50 365 | 2 154 183 605 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4 725 543 | 0,00 | 54,51 | 5 505 | 257 579 425 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 803 | 39 519 652 | 0,00 | 54,61 | 98 455 | 2 158 021 973 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 197 | 4 725 442 | 0,00 | 54,61 | 10 757 | 258 038 903 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 85 353 | 39 517 849 | 0,22 | 54,93 | 4 688 039 | 2 170 529 712 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9 347 | 4 725 245 | 0,20 | 54,93 | 513 387 | 259 535 499 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 928 596 | 9 309 333 | 45,90 | 2,00 | 5 857 192 | 18 618 666 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 321 404 | 1 003 781 | 47,10 | 2,00 | 642 808 | 2 007 562 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 299 | 111 010 | 8,08 | 2,56 | 21 245 | 284 186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 299 | 111 010 | 8,08 | 2,56 | 21 245 | 284 186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 299 | 111 010 | 8,08 | 2,56 | 21 245 | 284 186 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992 993 | 0,02 | 94,29 | 18 952 | 93 629 310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992 993 | 0,02 | 94,29 | 18 952 | 93 629 310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 533 720 | 0,04 | 94,29 | 18 952 | 50 324 459 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1 362 695 | 0,05 | 28,92 | 19 955 | 39 409 139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 319 313 | 0,22 | 28,92 | 19 955 | 9 234 532 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12 550 | 1 131 625 | 1,12 | 13,15 | 165 029 | 14 880 529 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 476 348 | 9 404 467 | 35,74 | 12,25 | 30 335 263 | 115 204 721 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 294 707 | 1 119 075 | 35,75 | 12,25 | 3 610 161 | 13 708 669 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24 339 | 39 432 496 | 0,06 | 51,55 | 1 254 571 | 2 032 575 609 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 730 | 4 715 898 | 0,06 | 51,55 | 140 720 | 243 084 264 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 58 541 | 39 408 157 | 0,15 | 51,41 | 3 009 341 | 2 025 803 896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6 565 | 4 713 168 | 0,14 | 51,41 | 337 478 | 242 283 700 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39 349 616 | 0,00 | 50,64 | 45 523 | 1 992 546 505 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4 706 603 | 0,00 | 50,64 | 5 114 | 238 328 256 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21 804 | 39 348 717 | 0,06 | 50,42 | 1 099 388 | 1 984 017 399 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 445 | 4 706 502 | 0,05 | 50,42 | 123 280 | 237 308 420 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21 290 | 39 326 913 | 0,05 | 50,41 | 1 073 191 | 1 982 398 896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 388 | 4 704 057 | 0,05 | 50,41 | 120 375 | 237 123 046 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 | 39 305 623 | 0,00 | 50,00 | 4 500 | 1 965 281 150 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 | 4 701 669 | 0,00 | 50,00 | 500 | 235 083 450 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39 305 533 | 0,00 | 49,84 | 44 802 | 1 958 791 237 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4 701 659 | 0,00 | 49,84 | 5 033 | 234 307 176 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8 380 | 39 304 634 | 0,02 | 50,99 | 427 266 | 2 004 001 791 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4 701 558 | 0,02 | 50,99 | 47 927 | 239 715 517 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 338 | 39 296 254 | 0,01 | 50,48 | 118 029 | 1 983 788 861 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 262 | 4 700 618 | 0,01 | 50,48 | 13 227 | 237 300 828 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33 241 | 39 293 916 | 0,08 | 51,25 | 1 703 751 | 2 013 990 018 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 728 | 4 700 356 | 0,08 | 51,25 | 191 077 | 240 914 397 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23 440 | 39 260 675 | 0,06 | 50,33 | 1 179 656 | 1 975 856 286 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 637 | 4 696 628 | 0,06 | 50,33 | 132 711 | 236 365 319 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 652 | 39 237 235 | 0,44 | 50,38 | 8 597 226 | 1 976 720 891 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 201 | 4 693 991 | 0,41 | 50,38 | 967 321 | 236 477 164 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 944 | 39 066 583 | 0,02 | 51,05 | 405 541 | 1 994 349 062 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 894 | 4 674 790 | 0,02 | 51,05 | 45 639 | 238 648 030 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 28 271 | 39 058 639 | 0,07 | 50,55 | 1 428 963 | 1 974 226 720 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 181 | 4 673 896 | 0,07 | 50,55 | 160 784 | 236 243 008 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33 893 | 39 030 368 | 0,09 | 50,48 | 1 710 844 | 1 970 167 110 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 813 | 4 670 715 | 0,08 | 50,48 | 192 472 | 235 767 418 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48 036 | 38 996 475 | 0,12 | 50,10 | 2 406 829 | 1 953 906 681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 405 | 4 666 902 | 0,12 | 50,10 | 270 816 | 233 833 725 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 290 | 38 948 439 | 0,26 | 50,05 | 5 069 433 | 1 949 318 739 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11 397 | 4 661 497 | 0,25 | 50,05 | 570 405 | 233 301 865 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 581 | 38 847 149 | 0,01 | 49,46 | 276 030 | 1 921 337 258 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 628 | 4 650 100 | 0,01 | 49,46 | 31 060 | 229 988 831 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 944 | 38 841 568 | 0,00 | 49,18 | 46 427 | 1 910 267 156 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106 | 4 649 472 | 0,00 | 49,18 | 5 213 | 228 665 682 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 825 | 38 840 624 | 0,04 | 48,61 | 672 033 | 1 888 042 733 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 556 | 4 649 366 | 0,03 | 48,61 | 75 637 | 226 005 681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 12 955 | 38 826 799 | 0,03 | 48,95 | 634 191 | 1 900 703 822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 457 | 4 647 810 | 0,03 | 48,95 | 71 325 | 227 526 102 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 548 | 38 813 844 | 0,00 | 47,27 | 25 904 | 1 834 718 762 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62 | 4 646 353 | 0,00 | 47,27 | 2 931 | 219 631 712 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11 681 | 38 813 296 | 0,03 | 48,16 | 562 550 | 1 869 225 047 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 314 | 4 646 291 | 0,03 | 48,16 | 63 281 | 223 762 587 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8 598 | 38 801 615 | 0,02 | 48,44 | 416 460 | 1 879 426 065 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 967 | 4 644 977 | 0,02 | 48,44 | 46 838 | 224 987 822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 930 | 38 793 017 | 0,02 | 48,29 | 286 332 | 1 873 132 464 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 667 | 4 644 010 | 0,01 | 48,29 | 32 206 | 224 237 416 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 84 331 | 4 643 343 | 1,85 | 46,17 | 3 893 638 | 214 387 325 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 600 | 4 559 012 | 0,08 | 45,10 | 162 369 | 205 623 295 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 35 263 | 4 555 412 | 0,78 | 45,39 | 1 600 457 | 206 753 296 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8 360 | 4 520 149 | 0,19 | 46,10 | 385 414 | 208 388 813 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 735 | 4 511 789 | 0,06 | 44,98 | 123 025 | 202 948 842 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9 074 | 4 509 054 | 0,20 | 45,80 | 415 623 | 206 531 357 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -850 | 9 418 390 | -0,01 | 4,29 | -3 645 | 40 392 649 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -140 | 1 551 387 | -0,01 | 4,29 | -600 | 6 653 433 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -343 583 | 9 419 240 | -3,52 | 4,83 | -1 658 681 | 45 472 323 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -56 417 | 1 551 527 | -3,51 | 4,83 | -272 359 | 7 490 152 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -296 856 | 9 762 823 | -2,95 | 5,25 | -1 559 711 | 51 294 848 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -48 744 | 1 607 944 | -2,94 | 5,25 | -256 106 | 8 448 299 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 834 561 | 10 059 679 | -21,98 | 5,00 | -14 172 805 | 50 298 395 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -465 439 | 1 656 688 | -21,93 | 5,00 | -2 327 195 | 8 283 440 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 89 896 | 11 348 958 | 0,80 | 27,02 | 2 428 621 | 306 602 314 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10 104 | 1 758 289 | 0,58 | 27,02 | 272 969 | 47 501 760 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 169 877 | 22 337 275 | 5,53 | 33,00 | 38 605 941 | 737 130 075 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 133 153 | 3 029 953 | 4,60 | 33,00 | 4 394 049 | 99 988 449 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 038 | 102 711 | 14,54 | 1,63 | 21 252 | 167 419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 038 | 102 711 | 14,54 | 1,63 | 21 252 | 167 419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13 038 | 102 711 | 14,54 | 1,63 | 21 252 | 167 419 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13 937 394 | 0,01 | 26,74 | 19 948 | 372 685 916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13 937 394 | 0,01 | 26,74 | 19 948 | 372 685 916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1 362 005 | 0,05 | 26,74 | 19 948 | 36 420 014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1 362 005 | 0,05 | 26,74 | 19 948 | 36 420 014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318 623 | 0,23 | 26,74 | 19 948 | 8 519 979 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318 623 | 0,23 | 26,74 | 19 948 | 8 519 979 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 23 803 844 | 0,00 | 79,98 | 18 955 | 1 903 831 443 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533 519 | 0,04 | 79,98 | 18 955 | 42 670 850 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533 519 | 0,04 | 79,98 | 18 955 | 42 670 850 | |
| 2016-06-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70 000 | 70 000 | |||||
| 2016-06-13 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 26 500 | 26 500 | |||||
| 2016-06-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2 318 | 30 003 | -7,17 | 9,56 | -22 157 | 286 787 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -158 684 | 2 122 417 | -6,96 | 9,56 | -1 516 797 | 20 287 335 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -9 056 | 116 778 | -7,20 | 9,56 | -86 563 | 1 116 234 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -5 111 | 32 321 | -13,65 | 9,40 | -48 043 | 303 817 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -349 919 | 2 281 101 | -13,30 | 9,40 | -3 289 239 | 21 442 349 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -19 970 | 125 834 | -13,70 | 9,40 | -187 718 | 1 182 840 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2 154 | 37 432 | -5,44 | 9,21 | -19 844 | 344 839 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -147 529 | 2 631 020 | -5,31 | 9,21 | -1 359 096 | 24 238 009 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -8 417 | 145 804 | -5,46 | 9,21 | -77 541 | 1 343 205 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -4 201 | 39 586 | -9,59 | 9,44 | -39 648 | 373 605 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -275 506 | 2 778 549 | -9,02 | 9,44 | -2 600 171 | 26 223 390 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -16 493 | 154 221 | -9,66 | 9,44 | -155 658 | 1 455 507 | |
| 2016-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9 260 | 9 260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9 260 | 9 260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 700 | 38 787 087 | 0,01 | 38,82 | 143 634 | 1 505 714 717 | |
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 700 | 38 787 087 | 0,01 | 38,82 | 143 634 | 1 505 714 717 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 13 932 918 | 0,06 | 10,73 | 88 522 | 149 500 210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8 250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8 250 | 317 877 | 2,66 | 10,73 | 88 522 | 3 410 820 | |
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2 294 | 2 294 | |||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6 104 562 | 0,01 | ||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6 104 562 | 0,01 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -1 232 130 | 0 | -100,00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -101 204 | 0 | -100,00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 179 531 | 976 214 | 22,53 | 18,00 | 3 231 558 | 17 571 852 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 20 469 | 85 906 | 31,28 | 18,00 | 368 442 | 1 546 308 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 796 683 | 796 683 | |||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 65 437 | 65 437 | |||||
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10 788 | 7 110 113 | 0,15 | 1,97 | 21 252 | 14 006 923 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10 788 | 89 673 | 13,68 | 1,97 | 21 252 | 176 656 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10 788 | 89 673 | 13,68 | 1,97 | 21 252 | 176 656 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13 883 418 | 0,01 | 25,48 | 19 976 | 353 749 491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13 883 418 | 0,01 | 25,48 | 19 976 | 353 749 491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13 883 418 | 0,01 | 25,48 | 19 976 | 353 749 491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13 883 418 | 0,01 | 25,48 | 19 976 | 353 749 491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309 627 | 0,25 | 25,48 | 19 976 | 7 889 296 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309 627 | 0,25 | 25,48 | 19 976 | 7 889 296 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533 282 | 0,05 | 72,47 | 18 987 | 38 646 947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533 282 | 0,05 | 72,47 | 18 987 | 38 646 947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533 282 | 0,05 | 72,47 | 18 987 | 38 646 947 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 3 268 830 | 0,00 | 6,74 | 923 | 22 031 914 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -3 479 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -310 003 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 3 479 | 43 787 | 8,63 | 6,74 | 23 448 | 295 124 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 310 003 | 3 054 055 | 11,30 | 6,74 | 2 089 420 | 20 584 331 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 137 | 6,74 | 923 | 923 | ||
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 262 253 | 21 167 398 | 1,25 | 28,55 | 7 486 904 | 604 295 345 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28 647 | 2 896 800 | 1,00 | 28,55 | 817 826 | 82 699 005 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10 818 | 20 905 145 | 0,05 | 27,82 | 300 959 | 581 585 315 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 182 | 2 868 153 | 0,04 | 27,82 | 32 883 | 79 792 590 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 318 969 | 20 894 327 | 1,55 | 27,72 | 8 840 959 | 579 134 330 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 34 844 | 2 866 971 | 1,23 | 27,72 | 965 782 | 79 464 695 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 60 587 | 20 575 358 | 0,30 | 27,56 | 1 669 705 | 567 032 176 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6 618 | 2 832 127 | 0,23 | 27,56 | 182 384 | 78 050 022 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28 433 | 20 514 771 | 0,14 | 26,55 | 755 024 | 544 759 487 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 106 | 2 825 509 | 0,11 | 26,55 | 82 478 | 75 029 979 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 180 122 | 20 486 338 | 0,89 | 26,49 | 4 772 224 | 542 773 234 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19 676 | 2 822 403 | 0,70 | 26,49 | 521 304 | 74 777 874 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13 433 | 20 306 216 | 0,07 | 26,28 | 353 086 | 533 748 888 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 467 | 2 802 727 | 0,05 | 26,28 | 38 560 | 73 669 679 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14 775 | 20 292 783 | 0,07 | 25,61 | 378 343 | 519 637 294 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 614 | 2 801 260 | 0,06 | 25,61 | 41 330 | 71 731 865 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 16 057 | 2 799 646 | 0,58 | 26,35 | 423 057 | 73 762 833 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37 882 | 2 783 589 | 1,38 | 25,98 | 983 985 | 72 303 724 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 408 607 | 2 745 707 | 17,48 | 25,92 | 10 593 014 | 71 181 630 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 92 140 | 38 783 387 | 0,24 | 31,73 | 2 923 547 | 1 230 573 599 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 034 | 4 496 280 | 0,22 | 31,73 | 318 373 | 142 664 267 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 741 | 38 691 247 | 0,05 | 32,41 | 639 713 | 1 253 801 466 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 150 | 4 486 246 | 0,05 | 32,41 | 69 671 | 145 378 148 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 206 421 153 | 0,01 | 3,86 | 77 200 | 796 785 651 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 90 179 | 19 757 285 | 0,46 | 62,59 | 5 644 024 | 1 236 547 221 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9 821 | 3 358 951 | 0,29 | 62,59 | 614 666 | 210 226 330 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 127 964 | 19 667 106 | 0,65 | 61,38 | 7 854 149 | 1 207 123 699 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13 936 | 3 349 130 | 0,42 | 61,38 | 855 361 | 205 562 231 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 24 431 | 19 539 142 | 0,13 | 61,03 | 1 490 975 | 1 192 434 758 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 660 | 3 335 194 | 0,08 | 61,03 | 162 334 | 203 540 219 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20 659 | 19 514 711 | 0,11 | 60,95 | 1 259 178 | 1 189 433 344 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 250 | 3 332 534 | 0,07 | 60,95 | 137 139 | 203 119 947 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 97 484 | 19 494 052 | 0,50 | 60,85 | 5 931 960 | 1 186 224 761 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10 616 | 3 330 284 | 0,32 | 60,85 | 645 990 | 202 649 780 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 533 020 | 3,90 | 3,86 | 77 200 | 2 057 457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 533 020 | 3,90 | 3,86 | 77 200 | 2 057 457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 182 | 19 376 568 | 0,01 | 65,29 | 77 176 | 1 265 142 628 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 129 | 3 299 668 | 0,00 | 65,29 | 8 423 | 215 443 243 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 179 176 | 19 375 386 | 0,93 | 65,80 | 11 789 387 | 1 274 857 773 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19 513 | 3 299 539 | 0,59 | 65,80 | 1 283 912 | 217 102 407 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 180 358 | 19 196 210 | 0,95 | 67,15 | 12 110 607 | 1 288 979 431 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19 642 | 3 280 026 | 0,60 | 67,15 | 1 318 913 | 220 245 874 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198 484 | 38 671 506 | 0,52 | 31,60 | 6 272 531 | 1 222 104 667 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21 616 | 4 484 096 | 0,48 | 31,60 | 683 113 | 141 707 299 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32 810 | 38 473 022 | 0,09 | 31,86 | 1 045 205 | 1 225 608 131 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 573 | 4 462 480 | 0,08 | 31,86 | 113 823 | 142 158 102 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8 627 | 38 440 212 | 0,02 | 31,50 | 271 712 | 1 210 693 697 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4 458 907 | 0,02 | 31,50 | 29 606 | 140 435 505 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 273 381 | 38 431 585 | 0,72 | 31,89 | 8 719 077 | 1 225 717 756 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29 772 | 4 457 967 | 0,67 | 31,89 | 949 533 | 142 180 171 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 145 272 | 38 158 204 | 0,38 | 31,74 | 4 611 296 | 1 211 236 790 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15 821 | 4 428 195 | 0,36 | 31,74 | 502 198 | 140 561 980 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63 560 | 38 012 932 | 0,17 | 31,50 | 2 002 401 | 1 197 563 211 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6 922 | 4 412 374 | 0,16 | 31,50 | 218 071 | 139 007 872 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 387 336 | 37 949 372 | 1,03 | 32,31 | 12 514 051 | 1 226 068 311 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42 182 | 4 405 452 | 0,97 | 32,31 | 1 362 816 | 142 331 343 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 107 260 | 37 562 036 | 0,29 | 33,77 | 3 622 063 | 1 268 432 394 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11 681 | 4 363 270 | 0,27 | 33,77 | 394 456 | 147 343 265 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 128 975 | 6 928 119 | 1,90 | 8,16 | 1 051 920 | 56 505 739 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14 046 | 824 368 | 1,73 | 8,16 | 114 559 | 6 723 545 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 185 413 | 6 799 144 | 2,80 | 7,91 | 1 466 320 | 53 770 350 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20 192 | 810 322 | 2,56 | 7,91 | 159 686 | 6 408 351 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11 840 | 6 613 731 | 0,18 | 7,70 | 91 160 | 50 921 099 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 289 | 790 130 | 0,16 | 7,70 | 9 924 | 6 083 448 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 68 132 | 6 601 891 | 1,04 | 8,03 | 546 807 | 52 984 797 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7 420 | 788 841 | 0,95 | 8,03 | 59 551 | 6 331 001 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 30 986 | 6 533 759 | 0,48 | 7,88 | 244 126 | 51 476 874 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3 374 | 781 421 | 0,43 | 7,88 | 26 582 | 6 156 503 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 874 | 37 454 776 | 0,01 | 32,34 | 157 646 | 1 211 448 511 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 547 | 4 351 589 | 0,01 | 32,34 | 17 692 | 140 749 100 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 147 831 | 37 449 902 | 0,40 | 33,15 | 4 900 997 | 1 241 565 366 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16 608 | 4 351 042 | 0,38 | 33,15 | 550 600 | 144 248 790 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23 289 | 37 302 071 | 0,06 | 32,96 | 767 582 | 1 229 438 958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 616 | 4 334 434 | 0,06 | 32,96 | 86 221 | 142 858 610 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95 682 | 37 278 782 | 0,26 | 32,41 | 3 100 652 | 1 208 048 754 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 749 | 4 331 818 | 0,25 | 32,41 | 348 330 | 140 376 028 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 165 237 | 37 183 100 | 0,45 | 32,30 | 5 337 915 | 1 201 185 172 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18 563 | 4 321 069 | 0,43 | 32,30 | 599 670 | 139 590 406 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 36 589 | 37 017 863 | 0,10 | 31,15 | 1 139 842 | 1 153 202 679 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 111 | 4 302 506 | 0,10 | 31,15 | 128 068 | 134 034 248 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97 272 | 36 981 274 | 0,26 | 32,12 | 3 124 484 | 1 187 879 200 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 927 | 4 298 395 | 0,25 | 32,12 | 350 987 | 138 069 176 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 53 734 | 36 884 002 | 0,15 | 32,47 | 1 744 598 | 1 197 523 958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6 037 | 4 287 468 | 0,14 | 32,47 | 196 005 | 139 202 510 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 286 671 473 | 0,00 | 4,18 | 41 800 | 1 198 286 757 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88 732 | 36 830 268 | 0,24 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9 968 | 4 281 431 | 0,23 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48 996 | 36 741 536 | 0,13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 504 | 4 271 463 | 0,13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 36 692 540 | 0,03 | 4,18 | 41 800 | 153 374 817 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14 157 | 36 682 540 | 0,04 | 33,72 | 477 445 | 1 237 118 662 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 590 | 4 255 959 | 0,04 | 33,72 | 53 623 | 143 532 217 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40 921 | 36 668 383 | 0,11 | 33,68 | 1 378 043 | 1 234 833 465 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 597 | 4 254 369 | 0,11 | 33,68 | 154 807 | 143 268 854 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218 550 | 36 627 462 | 0,60 | 32,49 | 7 101 280 | 1 190 125 135 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23 908 | 4 249 772 | 0,57 | 32,49 | 776 835 | 138 086 567 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 41 104 | 36 408 912 | 0,11 | 31,68 | 1 302 257 | 1 153 507 150 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 496 | 4 225 864 | 0,11 | 31,68 | 142 442 | 133 883 823 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59 492 | 36 367 808 | 0,16 | 32,24 | 1 918 022 | 1 172 498 130 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6 508 | 4 221 368 | 0,15 | 32,24 | 209 818 | 136 096 904 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 301 066 | 36 308 316 | 0,84 | 32,76 | 9 862 139 | 1 189 366 031 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32 934 | 4 214 860 | 0,79 | 32,76 | 1 078 832 | 138 067 855 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21 814 | 36 007 250 | 0,06 | 31,24 | 681 563 | 1 125 021 321 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 386 | 4 181 926 | 0,06 | 31,24 | 74 549 | 130 661 351 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 172 462 | 35 985 436 | 0,48 | 30,34 | 5 232 928 | 1 091 888 092 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18 866 | 4 179 540 | 0,45 | 30,34 | 572 442 | 126 817 692 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 54 439 | 35 812 974 | 0,15 | 30,55 | 1 663 024 | 1 094 029 055 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 955 | 4 160 674 | 0,14 | 30,55 | 181 916 | 127 101 934 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6 022 | 19 015 852 | 0,03 | 74,00 | 445 628 | 1 407 173 048 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 678 | 3 260 384 | 0,02 | 74,00 | 50 172 | 241 268 416 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20 492 | 19 009 830 | 0,11 | 69,70 | 1 428 282 | 1 324 975 646 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 308 | 3 259 706 | 0,07 | 69,70 | 160 866 | 227 199 878 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 23 157 | 18 989 338 | 0,12 | 70,50 | 1 632 684 | 1 338 843 276 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2 608 | 3 257 398 | 0,08 | 70,50 | 183 877 | 229 662 846 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8 111 | 18 966 181 | 0,04 | 71,96 | 583 702 | 1 364 886 043 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 914 | 3 254 790 | 0,03 | 71,96 | 65 775 | 234 228 359 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 815 | 35 758 535 | 0,11 | 30,13 | 1 199 793 | 1 077 554 845 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 485 | 4 154 719 | 0,11 | 30,13 | 135 152 | 125 199 133 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 128 255 | 35 718 720 | 0,36 | 29,86 | 3 830 118 | 1 066 678 851 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14 447 | 4 150 234 | 0,35 | 29,86 | 431 435 | 123 939 683 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 67 407 | 35 590 465 | 0,19 | 28,52 | 1 922 670 | 1 015 157 510 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 593 | 4 135 787 | 0,18 | 28,52 | 216 577 | 117 966 293 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 134 | 35 523 058 | 0,01 | 28,46 | 117 674 | 1 011 163 846 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 466 | 4 128 194 | 0,01 | 28,46 | 13 265 | 117 509 042 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43 056 | 35 518 924 | 0,12 | 29,77 | 1 281 975 | 1 057 561 755 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 850 | 4 127 728 | 0,12 | 29,77 | 144 407 | 122 901 450 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218 768 | 35 475 868 | 0,62 | 30,21 | 6 610 053 | 1 071 899 804 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24 643 | 4 122 878 | 0,60 | 30,21 | 744 586 | 124 572 346 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456 849 | 35 257 100 | 1,31 | 29,20 | 13 339 991 | 1 029 507 320 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49 677 | 4 098 235 | 1,23 | 29,20 | 1 450 568 | 119 668 462 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 226 865 | 34 800 251 | 0,66 | 29,94 | 6 791 816 | 1 041 839 474 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24 669 | 4 048 558 | 0,61 | 29,94 | 738 533 | 121 204 515 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 726 291 | 34 573 386 | 2,15 | 31,25 | 22 694 197 | 1 080 304 220 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78 976 | 4 023 889 | 2,00 | 31,25 | 2 467 739 | 125 733 252 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 902 | 33 847 095 | 0,00 | 29,50 | 26 609 | 998 489 302 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 | 3 944 913 | 0,00 | 29,50 | 2 891 | 116 374 934 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106 444 | 33 846 193 | 0,32 | 29,19 | 3 107 590 | 988 126 066 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11 575 | 3 944 815 | 0,29 | 29,19 | 337 927 | 115 167 296 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151 144 | 33 739 749 | 0,45 | 30,27 | 4 574 645 | 1 021 194 235 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16 435 | 3 933 240 | 0,42 | 30,27 | 497 435 | 119 046 588 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 631 | 33 588 605 | 0,00 | 27,93 | 17 626 | 938 227 145 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 | 3 916 805 | 0,00 | 27,93 | 1 927 | 109 407 722 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72 073 | 33 587 974 | 0,22 | 27,28 | 1 966 043 | 916 229 549 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 909 | 3 916 736 | 0,20 | 27,28 | 215 746 | 106 842 683 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 87 049 | 33 515 901 | 0,26 | 28,07 | 2 443 831 | 940 932 108 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9 551 | 3 908 827 | 0,24 | 28,07 | 268 137 | 109 737 191 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15 187 | 18 958 070 | 0,08 | 69,45 | 1 054 742 | 1 316 643 649 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 651 | 3 253 876 | 0,05 | 69,45 | 114 662 | 225 982 664 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8 250 | 18 942 883 | 0,04 | 70,86 | 584 597 | 1 342 296 478 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 897 | 3 252 225 | 0,03 | 70,86 | 63 562 | 230 453 314 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 67 373 | 18 934 633 | 0,36 | 69,54 | 4 684 923 | 1 316 659 468 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7 326 | 3 251 328 | 0,23 | 69,54 | 509 429 | 226 087 920 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 124 057 | 18 867 260 | 0,66 | 70,21 | 8 710 228 | 1 324 698 625 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13 490 | 3 244 002 | 0,42 | 70,21 | 947 153 | 227 766 246 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 397 079 | 18 743 203 | 2,16 | 71,10 | 28 233 945 | 1 332 718 580 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 43 178 | 3 230 512 | 1,35 | 71,10 | 3 070 133 | 229 702 648 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 149 927 | 18 346 124 | 0,82 | 67,94 | 10 186 595 | 1 246 503 545 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 16 450 | 3 187 334 | 0,52 | 67,94 | 1 117 674 | 216 559 265 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 38 117 | 18 196 197 | 0,21 | 63,98 | 2 438 547 | 1 164 107 162 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 4 183 | 3 170 884 | 0,13 | 63,98 | 267 609 | 202 858 255 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 168 055 | 18 158 080 | 0,93 | 64,87 | 10 902 350 | 1 177 981 834 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 18 441 | 3 166 701 | 0,59 | 64,87 | 1 196 336 | 205 435 611 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 541 340 | 17 990 025 | 3,10 | 65,80 | 35 621 958 | 1 183 803 012 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 59 401 | 3 148 260 | 1,92 | 65,80 | 3 908 782 | 207 165 897 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 49 021 | 17 448 685 | 0,28 | 66,68 | 3 268 823 | 1 163 514 958 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5 379 | 3 088 859 | 0,17 | 66,68 | 358 683 | 205 971 605 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72 894 | 17 399 664 | 0,42 | 67,68 | 4 933 706 | 1 177 666 678 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7 999 | 3 083 480 | 0,26 | 67,68 | 541 399 | 208 700 102 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6 939 | 17 326 770 | 0,04 | 60,85 | 422 220 | 1 054 288 905 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 761 | 3 075 481 | 0,02 | 60,85 | 46 305 | 187 135 023 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 57 865 | 17 319 831 | 0,34 | 61,73 | 3 572 047 | 1 069 165 292 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6 349 | 3 074 720 | 0,21 | 61,73 | 391 928 | 189 804 618 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 136 793 | 17 261 966 | 0,80 | 58,13 | 7 952 133 | 1 003 482 965 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15 010 | 3 068 371 | 0,49 | 58,13 | 872 570 | 178 372 384 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 114 908 | 17 125 173 | 0,68 | 59,01 | 6 780 526 | 1 010 527 346 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12 609 | 3 053 361 | 0,41 | 59,01 | 744 036 | 180 173 642 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65 309 | 17 010 265 | 0,39 | 60,40 | 3 944 513 | 1 027 380 882 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7 166 | 3 040 752 | 0,24 | 60,40 | 432 810 | 183 654 427 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 113 546 | 16 944 956 | 0,67 | 61,40 | 6 971 475 | 1 040 383 019 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12 459 | 3 033 586 | 0,41 | 61,40 | 764 955 | 186 255 507 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 289 755 | 16 831 410 | 1,75 | 62,56 | 18 126 986 | 1 052 967 960 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 31 795 | 3 021 127 | 1,06 | 62,56 | 1 989 086 | 189 000 799 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 176 647 | 16 541 655 | 1,08 | 63,37 | 11 194 368 | 1 048 267 836 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19 383 | 2 989 332 | 0,65 | 63,37 | 1 228 328 | 189 438 154 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 235 734 | 16 365 008 | 1,46 | 64,46 | 15 195 814 | 1 054 916 236 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25 869 | 2 969 949 | 0,88 | 64,46 | 1 667 560 | 191 447 961 | |
| 2016-02-09 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 45 000 | 12 894 240 | 0,35 | 6,33 | 284 656 | 81 565 094 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -56 853 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -2 296 890 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -238 850 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -26 292 961 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -1 912 167 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -582 747 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -44 572 171 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -4 382 118 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1 723 306 | 1 723 306 | 24,00 | 41 359 344 | 41 359 344 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 189 374 | 189 374 | 24,00 | 4 544 976 | 4 544 976 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 56 853 | 639 600 | 9,76 | 0,68 | 38 376 | 431 730 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 2 296 890 | 73 162 022 | 3,24 | 0,68 | 1 550 401 | 49 384 365 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 238 850 | 6 533 135 | 3,79 | 0,68 | 161 224 | 4 409 866 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 26 292 961 | 70 865 132 | 58,99 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 1 912 167 | 6 294 285 | 43,64 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 582 747 | 582 747 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 44 572 171 | 44 572 171 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 4 382 118 | 4 382 118 | |||||
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24 800 | 12 849 240 | 0,19 | 6,65 | 164 915 | 85 444 876 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91 187 | 12 824 440 | 0,72 | 6,29 | 573 311 | 80 629 819 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91 728 | 12 733 253 | 0,73 | 6,52 | 598 360 | 83 061 556 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 000 | 12 641 525 | 0,20 | 6,88 | 172 015 | 86 981 277 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 63 345 | 12 616 525 | 0,50 | 6,98 | 441 971 | 88 028 018 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3 581 | 6 502 773 | 0,06 | 11,00 | 39 377 | 71 504 492 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 395 | 778 047 | 0,05 | 11,00 | 4 343 | 8 555 405 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 66 345 | 6 499 192 | 1,03 | 10,80 | 716 745 | 70 212 721 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7 318 | 777 652 | 0,95 | 10,80 | 79 059 | 8 401 208 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 522 | 6 432 847 | 0,04 | 11,20 | 28 257 | 72 075 548 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 278 | 770 334 | 0,04 | 11,20 | 3 115 | 8 631 053 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4 503 | 6 430 325 | 0,07 | 10,98 | 49 423 | 70 576 032 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 497 | 770 056 | 0,06 | 10,98 | 5 455 | 8 451 750 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 833 | 6 425 822 | 0,04 | 11,23 | 31 822 | 72 178 688 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 312 | 769 559 | 0,04 | 11,23 | 3 505 | 8 644 148 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 25 650 | 6 422 989 | 0,40 | 10,69 | 274 219 | 68 666 891 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 810 | 769 247 | 0,37 | 10,69 | 30 041 | 8 223 866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 156 | 6 397 339 | 0,00 | 10,60 | 1 654 | 67 811 793 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17 | 766 437 | 0,00 | 10,60 | 180 | 8 124 232 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4 021 | 6 397 183 | 0,06 | 10,69 | 42 999 | 68 409 556 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 440 | 766 420 | 0,06 | 10,69 | 4 705 | 8 195 866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17 221 | 6 393 162 | 0,27 | 10,78 | 185 666 | 68 927 237 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 887 | 765 980 | 0,25 | 10,78 | 20 345 | 8 258 337 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 200 | 12 553 180 | 0,03 | 7,00 | 22 389 | 87 829 579 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103 600 | 12 549 980 | 0,83 | 7,29 | 755 368 | 91 504 414 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 734 | 6 375 941 | 0,03 | 8,90 | 15 433 | 56 745 875 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 190 | 764 093 | 0,02 | 8,90 | 1 691 | 6 800 428 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 27 996 | 6 374 207 | 0,44 | 8,96 | 250 766 | 57 095 047 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3 067 | 763 903 | 0,40 | 8,96 | 27 472 | 6 842 432 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 13 789 | 6 346 211 | 0,22 | 8,96 | 123 493 | 56 836 031 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 511 | 760 836 | 0,20 | 8,96 | 13 532 | 6 813 971 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 57 453 | 6 332 422 | 0,92 | 9,89 | 567 934 | 62 597 258 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 6 294 | 759 325 | 0,84 | 9,89 | 62 217 | 7 506 079 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14 313 | 6 274 969 | 0,23 | 9,15 | 131 017 | 57 439 184 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 568 | 753 031 | 0,21 | 9,15 | 14 353 | 6 893 020 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 10 123 | 6 260 656 | 0,16 | 9,21 | 93 282 | 57 691 319 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 109 | 751 463 | 0,15 | 9,21 | 10 219 | 6 924 656 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 45 903 | 6 250 533 | 0,74 | 9,08 | 416 602 | 56 727 962 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5 029 | 750 354 | 0,67 | 9,08 | 45 642 | 6 809 988 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 1 325 | 12 446 380 | 0,01 | 6,94 | 9 197 | 86 396 547 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 51 370 | 12 445 055 | 0,41 | 6,87 | 352 974 | 85 512 462 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 92 200 | 12 393 685 | 0,75 | 7,12 | 656 750 | 88 281 458 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 000 | 12 301 485 | 0,20 | 7,49 | 187 332 | 92 178 718 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 175 000 | 12 276 485 | 1,45 | 7,45 | 1 303 890 | 91 469 634 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47 193 | 6 204 630 | 0,77 | 8,56 | 403 930 | 53 106 049 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5 196 | 745 325 | 0,70 | 8,56 | 44 473 | 6 379 311 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4 949 | 6 157 437 | 0,08 | 8,95 | 44 308 | 55 126 918 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740 129 | 0,07 | 8,95 | 4 879 | 6 626 301 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3 279 | 6 152 488 | 0,05 | 8,82 | 28 937 | 54 295 091 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739 584 | 0,05 | 8,82 | 3 186 | 6 526 755 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20 851 | 6 149 209 | 0,34 | 8,10 | 168 891 | 49 807 978 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 296 | 739 223 | 0,31 | 8,10 | 18 597 | 5 987 632 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 998 | 6 128 358 | 0,05 | 8,08 | 24 213 | 49 495 071 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736 927 | 0,04 | 8,08 | 2 665 | 5 951 717 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12 706 | 6 125 360 | 0,21 | 7,91 | 100 517 | 48 457 723 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 399 | 736 597 | 0,19 | 7,91 | 11 067 | 5 827 219 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90 550 | 6 112 654 | 1,50 | 8,17 | 739 947 | 49 950 775 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9 970 | 735 198 | 1,37 | 8,17 | 81 472 | 6 007 817 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47 193 | 6 204 630 | 0,77 | 8,56 | 403 930 | 53 106 049 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5 196 | 745 325 | 0,70 | 8,56 | 44 473 | 6 379 311 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4 949 | 6 157 437 | 0,08 | 8,95 | 44 308 | 55 126 918 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740 129 | 0,07 | 8,95 | 4 879 | 6 626 301 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3 279 | 6 152 488 | 0,05 | 8,82 | 28 937 | 54 295 091 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739 584 | 0,05 | 8,82 | 3 186 | 6 526 755 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20 851 | 6 149 209 | 0,34 | 8,10 | 168 891 | 49 807 978 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 296 | 739 223 | 0,31 | 8,10 | 18 597 | 5 987 632 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 998 | 6 128 358 | 0,05 | 8,08 | 24 213 | 49 495 071 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736 927 | 0,04 | 8,08 | 2 665 | 5 951 717 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12 706 | 6 125 360 | 0,21 | 7,91 | 100 517 | 48 457 723 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1 399 | 736 597 | 0,19 | 7,91 | 11 067 | 5 827 219 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90 550 | 6 112 654 | 1,50 | 8,17 | 739 947 | 49 950 775 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9 970 | 735 198 | 1,37 | 8,17 | 81 472 | 6 007 817 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 801 161 | 20 278 008 | 9,75 | 29,00 | 52 233 669 | 588 062 232 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785 045 | 2 337 100 | 50,58 | 29,00 | 22 766 305 | 67 775 900 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 801 161 | 20 278 008 | 9,75 | 29,00 | 52 233 669 | 588 062 232 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785 045 | 2 337 100 | 50,58 | 29,00 | 22 766 305 | 67 775 900 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7 082 | 78 885 | 9,86 | 3,00 | 21 246 | 236 655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7 082 | 78 885 | 9,86 | 3,00 | 21 246 | 236 655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7 082 | 6 348 612 | 0,11 | 3,00 | 21 246 | 19 045 836 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513 020 | 0,03 | 108,45 | 18 979 | 55 637 019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513 020 | 0,03 | 108,45 | 18 979 | 55 637 019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 666 111 | 0,03 | 108,45 | 18 979 | 72 239 738 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308 843 | 0,18 | 35,20 | 19 994 | 10 871 274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308 843 | 0,18 | 35,20 | 19 994 | 10 871 274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 482 740 | 0,12 | 35,20 | 19 994 | 16 992 448 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 11 423 179 | 0,00 | 35,20 | 19 994 | 402 095 901 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 196 132 | 0,29 | 35,20 | 19 994 | 6 903 846 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 356 791 | 0,16 | 35,20 | 19 994 | 12 559 043 | |
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5 284 918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9 241 559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4 936 111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5 284 918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9 241 559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4 936 111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5 284 918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9 241 559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4 936 111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5 284 918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9 241 559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4 936 111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5 284 918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9 241 559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4 936 111 | ||||||||
| 2015-12-15 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150 000 | 33 428 852 | 0,45 | 44,00 | 6 600 000 | 1 470 869 488 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31 647 | 33 278 852 | 0,10 | 43,87 | 1 388 259 | 1 459 843 401 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57 461 | 33 247 205 | 0,17 | 43,93 | 2 524 015 | 1 460 406 753 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 75 612 | 33 189 744 | 0,23 | 43,93 | 3 321 363 | 1 457 905 971 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 000 | 33 114 132 | 0,01 | 43,00 | 172 000 | 1 423 907 676 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 638 | 33 110 132 | 0,03 | 43,84 | 466 321 | 1 451 395 880 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9 400 | 33 099 494 | 0,03 | 44,00 | 413 600 | 1 456 377 736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 800 | 33 090 094 | 0,00 | 43,00 | 34 400 | 1 422 874 042 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 407 800 | 33 089 294 | 1,25 | 43,71 | 17 823 388 | 1 446 207 301 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 700 | 32 681 494 | 0,30 | 44,00 | 4 342 800 | 1 437 985 736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 196 490 | 32 582 794 | 0,61 | 41,31 | 8 117 179 | 1 346 024 545 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 221 434 | 32 386 304 | 0,69 | 42,51 | 9 412 318 | 1 376 618 715 | |
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16 392 657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26 372 015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16 392 657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26 372 015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16 392 657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26 372 015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16 392 657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26 372 015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14 293 989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16 392 657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26 372 015 | ||||||||
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 945 | 71 803 | 10,71 | 3,06 | 21 252 | 219 717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 945 | 71 803 | 10,71 | 3,06 | 21 252 | 219 717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 945 | 71 803 | 10,71 | 3,06 | 21 252 | 219 717 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 512 845 | 0,03 | 110,33 | 18 977 | 56 582 189 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 972 118 | 0,02 | 110,33 | 18 977 | 107 253 779 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 16 282 190 | 0,00 | 110,33 | 18 977 | 1 796 414 023 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308 275 | 0,30 | 21,34 | 19 974 | 6 578 588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308 275 | 0,30 | 21,34 | 19 974 | 6 578 588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 11 422 611 | 0,01 | 21,34 | 19 974 | 243 758 519 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 1 911 734 | 0,05 | 21,34 | 19 974 | 40 796 404 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 195 564 | 0,48 | 21,34 | 19 974 | 4 173 336 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 356 223 | 0,26 | 21,34 | 19 974 | 7 601 799 | |
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -892 000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -31 967 000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -7 587 000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -65 000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -64 000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 101 652 | 512 673 | 24,73 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 3 642 962 | 16 128 927 | 29,18 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 864 614 | 2 943 733 | 41,59 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7 406 | 61 049 | 13,81 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7 292 | 58 632 | 14,20 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | -274 | 0 | -100,00 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 139 220 | 2 744 052 | 5,34 | 45,00 | 6 264 900 | 123 482 340 | |
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 10 780 | 170 714 | 6,74 | 45,00 | 485 100 | 7 682 130 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 346 000 | 32 164 870 | 1,09 | 48,44 | 16 761 728 | 1 558 204 612 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 000 | 31 818 870 | 0,16 | 47,40 | 2 370 000 | 1 508 214 438 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 160 453 | 31 768 870 | 0,51 | 48,60 | 7 798 690 | 1 544 100 511 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33 320 | 31 608 417 | 0,11 | 47,98 | 1 598 614 | 1 516 495 987 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14 386 | 31 575 097 | 0,05 | 47,54 | 683 847 | 1 500 941 181 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 600 | 31 560 711 | 0,01 | 47,24 | 75 577 | 1 490 798 589 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20 500 | 31 559 111 | 0,06 | 46,31 | 949 351 | 1 461 496 119 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 950 | 31 538 611 | 0,01 | 44,68 | 87 130 | 1 409 201 909 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89 843 | 31 536 661 | 0,29 | 45,28 | 4 067 696 | 1 427 841 249 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 212 983 | 31 446 818 | 0,68 | 46,81 | 9 969 500 | 1 471 990 959 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9 818 | 31 233 835 | 0,03 | 46,74 | 458 905 | 1 459 906 929 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 331 | 31 224 017 | 0,01 | 45,63 | 106 368 | 1 424 814 344 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 513 | 31 221 686 | 0,01 | 45,43 | 159 601 | 1 418 448 028 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 897 | 31 218 173 | 0,04 | 45,00 | 625 359 | 1 404 805 298 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40 649 | 31 204 276 | 0,13 | 42,14 | 1 713 148 | 1 315 101 092 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8 063 | 31 163 627 | 0,03 | 44,40 | 357 971 | 1 383 565 315 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15 391 | 31 155 564 | 0,05 | 40,67 | 625 950 | 1 267 093 672 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 191 321 | 31 140 173 | 0,62 | 41,06 | 7 856 214 | 1 278 708 924 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88 640 | 30 948 852 | 0,29 | 42,44 | 3 761 802 | 1 313 441 425 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 183 073 | 30 860 212 | 0,60 | 43,28 | 7 923 253 | 1 335 605 287 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 274 814 | 30 677 139 | 0,90 | 44,63 | 12 265 553 | 1 369 188 203 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 100 | 30 402 325 | 0,01 | 40,55 | 125 706 | 1 232 823 399 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11 300 | 30 399 225 | 0,04 | 41,13 | 464 823 | 1 250 466 041 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43 612 | 30 387 925 | 0,14 | 43,60 | 1 901 322 | 1 324 801 095 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 338 927 | 30 344 313 | 12,36 | 41,00 | 136 896 007 | 1 244 116 833 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2 213 469 | 6 022 104 | 58,12 | 15,50 | 34 308 770 | 93 342 612 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 266 563 | 725 228 | 58,12 | 15,50 | 4 131 726 | 11 241 034 | |
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7 220 154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12 371 376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6 628 338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7 220 154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12 371 376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6 628 338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7 220 154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12 371 376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6 628 338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7 220 154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12 371 376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6 628 338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7 220 154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12 371 376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6 628 338 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4 725 965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8 075 935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4 725 965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8 075 935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4 725 965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8 075 935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4 725 965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8 075 935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4 725 965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8 075 935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4 725 965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8 075 935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4 725 965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8 075 935 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2 260 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2 260 | ||||||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2 329 | 2 329 | |||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6 103 727 | 0,01 | ||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6 103 727 | 0,01 | ||||
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -229 436 | 90 538 | -71,70 | 1,09 | -250 659 | 98 913 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9 411 311 | 3 153 539 | -74,90 | 1,09 | -10 281 857 | 3 445 241 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1 359 253 | 467 436 | -74,41 | 1,09 | -1 484 984 | 510 674 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 307 339 | 0,24 | 27,34 | 19 958 | 8 402 648 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 1 350 721 | 0,05 | 27,34 | 19 958 | 36 928 712 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 481 236 | 0,15 | 27,34 | 19 958 | 13 156 992 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 11 421 675 | 0,01 | 27,34 | 19 958 | 312 268 594 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 194 628 | 0,38 | 27,34 | 19 958 | 5 321 130 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 355 287 | 0,21 | 27,34 | 19 958 | 9 713 547 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 826 200 | 0,02 | 104,21 | 18 966 | 86 098 302 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 411 021 | 0,04 | 104,21 | 18 966 | 42 832 498 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 549 414 | 0,03 | 104,21 | 18 966 | 57 254 433 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 260 | 64 858 | 8,83 | 3,66 | 19 252 | 237 380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 260 | 64 858 | 8,83 | 3,66 | 19 252 | 237 380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 260 | 64 858 | 8,83 | 3,66 | 19 252 | 237 380 | |
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 6 103 033 | 6 103 033 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 506 166 | 506 166 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 94 412 | 94 412 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 66 154 | 66 154 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 65 811 | 65 811 | |||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3 000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3 000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15 000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7 500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7 500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7 500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2 750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -9 184 771 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12 250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12 250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12 250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12 250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12 250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -680 187 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -143 462 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -200 526 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7 500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7 500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7 500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15 000 | 0 | -100,00 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 21 196 | 100 523 | 26,72 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -211 614 | 12 250 | -94,53 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 497 | 79 327 | 0,63 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -100 490 | 12 250 | -89,13 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 40 449 | 78 830 | 105,39 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -1 068 128 | 680 187 | -61,09 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 5 543 | 38 381 | 16,88 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -55 479 | 12 250 | -81,91 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 12 500 | 32 838 | 61,46 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -165 213 | 12 250 | -93,10 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 19 318 | 20 338 | 1 893,92 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -206 800 | 12 250 | -94,41 | ||||
| 2015-06-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
| 2015-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2015-06-10 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70 000 | 70 000 | |||||
| 2015-05-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198 802 | 27 005 386 | 0,74 | 43,27 | 8 602 242 | 1 168 533 854 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57 202 | 26 816 266 | 0,21 | 43,29 | 2 476 343 | 1 160 908 335 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16 300 | 26 759 064 | 0,06 | 43,67 | 711 775 | 1 168 493 400 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 155 | 26 742 764 | 0,34 | 43,62 | 3 932 723 | 1 166 567 503 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150 000 | 26 652 609 | 0,57 | 42,93 | 6 439 500 | 1 144 196 504 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9 200 | 26 492 927 | 0,03 | 40,95 | 376 718 | 1 084 821 778 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 52 381 | 26 483 727 | 0,20 | 41,54 | 2 176 038 | 1 100 200 229 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 139 683 | 26 431 346 | 0,53 | 42,68 | 5 961 908 | 1 128 134 781 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 13 352 | 26 291 663 | 0,05 | 42,97 | 573 749 | 1 129 779 051 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 2 300 | 26 278 311 | 0,01 | 42,15 | 96 949 | 1 107 675 482 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 382 | 26 276 011 | 0,03 | 41,24 | 304 410 | 1 083 538 610 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 500 | 26 268 629 | 0,02 | 41,07 | 184 815 | 1 078 852 593 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89 100 | 26 264 129 | 0,34 | 40,57 | 3 614 475 | 1 065 443 789 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 120 529 | 26 175 029 | 0,46 | 41,09 | 4 951 958 | 1 075 406 301 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9 260 | 9 260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9 260 | 9 260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 700 | 26 054 500 | 0,01 | 39,94 | 147 778 | 1 040 616 730 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 700 | 26 054 500 | 0,01 | 39,94 | 147 778 | 1 040 616 730 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 410 839 | 5,12 | 7,68 | 153 600 | 3 155 244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 410 839 | 5,12 | 7,68 | 153 600 | 3 155 244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20 000 | 410 839 | 5,12 | 7,68 | 153 600 | 3 155 244 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 26 050 800 | 0,04 | 5,11 | 51 100 | 133 119 588 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 26 050 800 | 0,04 | 5,11 | 51 100 | 133 119 588 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 100 | 26 040 800 | 0,00 | 37,07 | 40 777 | 965 332 456 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46 617 | 26 039 700 | 0,18 | 37,15 | 1 732 013 | 967 481 618 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8 334 | 25 993 083 | 0,03 | 35,85 | 298 745 | 931 761 050 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129 118 | 25 984 749 | 0,50 | 36,40 | 4 700 515 | 945 969 590 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 137 800 | 25 855 631 | 0,54 | 36,25 | 4 995 250 | 937 266 624 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 155 731 | 25 717 831 | 0,61 | 36,67 | 5 710 048 | 942 972 563 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 23 012 | 25 562 100 | 0,09 | 35,91 | 826 437 | 918 019 366 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 354 300 | 25 539 088 | 1,41 | 34,76 | 12 315 078 | 887 710 606 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59 973 | 25 184 788 | 0,24 | 34,61 | 2 075 833 | 871 716 030 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 330 | 25 124 815 | 0,02 | 33,99 | 147 177 | 853 992 462 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 397 | 25 120 485 | 0,36 | 34,56 | 3 123 949 | 868 116 233 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21 952 | 25 030 088 | 0,09 | 34,52 | 757 888 | 864 158 782 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 470 | 59 598 | 10,11 | 3,52 | 19 254 | 209 785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 470 | 59 598 | 10,11 | 3,52 | 19 254 | 209 785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5 470 | 59 598 | 10,11 | 3,52 | 19 254 | 209 785 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306 609 | 0,21 | 30,43 | 19 962 | 9 330 112 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1 349 991 | 0,05 | 30,43 | 19 962 | 41 080 226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1 349 991 | 0,05 | 30,43 | 19 962 | 41 080 226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1 349 991 | 0,05 | 30,43 | 19 962 | 41 080 226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1 349 991 | 0,05 | 30,43 | 19 962 | 41 080 226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306 609 | 0,21 | 30,43 | 19 962 | 9 330 112 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 880 | 25 008 136 | 0,01 | 34,72 | 99 986 | 868 217 461 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6 439 | 25 005 256 | 0,03 | 34,47 | 221 935 | 861 863 660 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 158 771 | 24 998 817 | 0,64 | 34,69 | 5 507 401 | 867 151 464 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 116 946 | 24 840 046 | 0,47 | 34,62 | 4 049 208 | 860 076 657 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 600 | 24 723 100 | 0,08 | 34,82 | 682 537 | 860 939 928 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 021 | 24 703 500 | 0,02 | 34,79 | 139 882 | 859 380 417 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 213 820 | 24 699 479 | 0,87 | 34,76 | 7 432 169 | 858 529 191 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 211 400 | 24 485 659 | 0,87 | 34,92 | 7 382 532 | 855 090 632 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 000 | 24 274 259 | 0,00 | 35,60 | 35 595 | 864 042 249 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62 650 | 24 273 259 | 0,26 | 34,46 | 2 159 163 | 836 551 171 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 163 054 | 24 210 609 | 0,68 | 33,80 | 5 510 818 | 818 258 058 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 995 | 24 047 555 | 0,02 | 33,60 | 167 830 | 807 985 824 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49 416 | 24 042 560 | 0,21 | 33,65 | 1 662 843 | 809 029 740 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4 898 409 | 6 323 855 | 343,64 | 3,75 | 18 369 034 | 23 714 456 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 434 924 | 625 495 | 228,22 | 3,75 | 1 630 965 | 2 345 606 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 390 935 | 2 604 832 | 17,66 | 20,00 | 7 818 700 | 52 096 640 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 34 065 | 159 934 | 27,06 | 20,00 | 681 300 | 3 198 680 | |
| 2015-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1 000 000 | 9 184 771 | 12,22 | 94,19 | 94 190 000 | 865 113 580 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21 441 | 345 074 | -5,85 | 3,86 | -82 762 | 1 331 986 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -859 988 | 12 589 950 | -6,39 | 3,86 | -3 319 554 | 48 597 207 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118 571 | 1 851 789 | -6,02 | 3,86 | -457 684 | 7 147 906 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21 548 | 366 515 | -5,55 | 3,81 | -82 130 | 1 396 972 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -863 100 | 13 449 938 | -6,03 | 3,81 | -3 289 706 | 51 264 439 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118 652 | 1 970 360 | -5,68 | 3,81 | -452 242 | 7 510 027 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4 554 | 388 063 | -1,16 | 3,55 | -16 184 | 1 379 059 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -182 454 | 14 313 038 | -1,26 | 3,55 | -648 387 | 50 864 243 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -25 092 | 2 089 012 | -1,19 | 3,55 | -89 169 | 7 423 722 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 927 | 54 128 | 7,82 | 4,90 | 19 242 | 265 227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 927 | 54 128 | 7,82 | 4,90 | 19 242 | 265 227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 927 | 1 425 446 | 0,28 | 4,90 | 19 242 | 6 984 685 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 305 953 | 0,20 | 31,97 | 19 949 | 9 781 317 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1 349 335 | 0,05 | 31,97 | 19 949 | 43 138 240 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 11 420 289 | 0,01 | 31,97 | 19 949 | 365 106 639 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1 909 412 | 0,03 | 31,97 | 19 949 | 61 043 902 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 193 242 | 0,32 | 31,97 | 19 949 | 6 177 947 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 353 901 | 0,18 | 31,97 | 19 949 | 11 314 215 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8 415 | 392 617 | -2,10 | 3,65 | -30 711 | 1 432 856 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337 123 | 14 495 492 | -2,27 | 3,65 | -1 230 330 | 52 901 298 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46 362 | 2 114 104 | -2,15 | 3,65 | -169 198 | 7 715 423 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4 746 | 401 032 | -1,17 | 3,68 | -17 447 | 1 474 274 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -190 117 | 14 832 615 | -1,27 | 3,68 | -698 908 | 54 527 659 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -26 137 | 2 160 466 | -1,20 | 3,68 | -96 085 | 7 942 305 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -2 825 | 405 778 | -0,69 | 3,71 | -10 482 | 1 505 680 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -112 855 | 15 022 732 | -0,75 | 3,71 | -418 760 | 55 743 349 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -15 420 | 2 186 603 | -0,70 | 3,71 | -57 217 | 8 113 609 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -16 182 | 408 603 | -3,81 | 4,21 | -68 102 | 1 719 606 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -647 781 | 15 135 587 | -4,10 | 4,21 | -2 726 186 | 63 698 118 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -88 937 | 2 202 023 | -3,88 | 4,21 | -374 291 | 9 267 214 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -3 558 | 424 785 | -0,83 | 4,29 | -15 260 | 1 821 903 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -142 543 | 15 783 368 | -0,90 | 4,29 | -611 367 | 67 694 865 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -19 599 | 2 290 960 | -0,85 | 4,29 | -84 060 | 9 825 927 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -14 753 | 428 343 | -3,33 | 4,31 | -63 571 | 1 845 730 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -590 638 | 15 925 911 | -3,58 | 4,31 | -2 545 059 | 68 624 750 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -81 109 | 2 310 559 | -3,39 | 4,31 | -349 499 | 9 956 199 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 900 | 23 993 144 | 0,02 | 31,97 | 124 679 | 767 036 821 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 500 | 23 989 244 | 0,00 | 30,80 | 15 400 | 738 868 715 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49 685 | 23 988 744 | 0,21 | 31,82 | 1 581 096 | 763 379 407 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 855 894 | 23 939 059 | 8,40 | 31,94 | 59 276 698 | 764 606 363 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 597 000 | 22 083 165 | 2,78 | 31,75 | 18 954 631 | 701 136 072 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 305 532 | 21 486 165 | 1,44 | 31,68 | 9 680 415 | 680 763 355 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 70 867 | 21 180 633 | 0,34 | 31,41 | 2 226 244 | 665 376 877 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -6 874 | 443 096 | -1,53 | 4,27 | -29 358 | 1 892 419 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -274 734 | 16 516 549 | -1,64 | 4,27 | -1 173 361 | 70 540 529 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -37 592 | 2 391 668 | -1,55 | 4,27 | -160 552 | 10 214 575 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9 908 | 449 970 | -2,15 | 4,45 | -44 093 | 2 002 456 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -396 496 | 16 791 283 | -2,31 | 4,45 | -1 764 486 | 74 724 568 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -54 396 | 2 429 260 | -2,19 | 4,45 | -242 073 | 10 810 693 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -5 457 | 459 878 | -1,17 | 4,71 | -25 724 | 2 167 865 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -218 383 | 17 187 779 | -1,25 | 4,71 | -1 029 457 | 81 023 190 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -29 960 | 2 483 656 | -1,19 | 4,71 | -141 231 | 11 707 954 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8 429 | 465 335 | -1,78 | 4,62 | -38 907 | 2 147 940 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337 541 | 17 406 162 | -1,90 | 4,62 | -1 558 056 | 80 345 103 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46 383 | 2 513 616 | -1,81 | 4,62 | -214 099 | 11 602 600 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100 000 | 21 109 766 | 0,48 | 34,95 | 3 495 000 | 737 786 322 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 354 000 | 21 009 766 | 1,71 | 34,27 | 12 131 651 | 720 008 883 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14 772 | 20 655 766 | 0,07 | 34,53 | 510 114 | 713 295 239 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185 378 | 20 640 994 | 0,91 | 34,33 | 6 364 935 | 708 706 465 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30 507 | 107 504 | 39,62 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30 507 | 3 993 087 | 0,77 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -399 208 | 0 | -100,00 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 500 | 20 455 616 | 0,03 | 33,90 | 186 438 | 693 400 380 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 80 430 | 20 450 116 | 0,39 | 34,64 | 2 786 393 | 708 467 684 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42 500 | 20 369 686 | 0,21 | 33,28 | 1 414 515 | 677 958 148 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185 528 | 20 327 186 | 0,92 | 33,31 | 6 180 420 | 677 151 416 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 216 284 | 20 141 658 | 1,09 | 32,56 | 7 043 267 | 655 911 079 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38 614 | 19 925 374 | 0,19 | 33,00 | 1 274 254 | 657 533 357 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24 890 | 19 886 760 | 0,13 | 33,06 | 822 744 | 657 360 829 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -28 086 | 473 764 | -5,60 | 4,55 | -127 671 | 2 153 589 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1 122 584 | 17 743 703 | -5,95 | 4,55 | -5 102 930 | 80 657 551 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -153 618 | 2 559 999 | -5,66 | 4,55 | -698 301 | 11 636 987 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -11 965 | 501 850 | -2,33 | 4,84 | -57 913 | 2 429 054 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -486 800 | 18 866 287 | -2,52 | 4,84 | -2 356 209 | 91 316 602 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -69 153 | 2 713 617 | -2,49 | 4,84 | -334 714 | 13 134 449 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -10 534 | 513 815 | -2,01 | 5,36 | -56 453 | 2 753 586 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -428 583 | 19 353 087 | -2,17 | 5,36 | -2 296 819 | 103 715 129 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -60 883 | 2 782 770 | -2,14 | 5,36 | -326 278 | 14 913 143 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 076 | 19 861 870 | 0,50 | 36,57 | 3 586 737 | 726 368 448 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 639 | 19 763 794 | 0,05 | 36,75 | 390 999 | 726 349 075 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 397 | 19 753 155 | 0,35 | 35,88 | 2 490 291 | 708 836 041 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63 137 | 19 683 758 | 0,32 | 36,74 | 2 319 502 | 723 134 028 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 505 | 19 620 621 | 0,13 | 35,91 | 915 851 | 704 550 993 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22 839 | 19 595 116 | 0,12 | 35,55 | 811 963 | 696 637 726 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 116 | 19 572 277 | 0,07 | 35,56 | 466 413 | 696 001 913 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 17 098 | 19 559 161 | 0,09 | 34,91 | 596 816 | 682 724 250 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 104 140 | 19 542 063 | 0,54 | 35,98 | 3 746 947 | 703 121 473 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29 006 | 19 437 923 | 0,15 | 35,28 | 1 023 471 | 685 863 225 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 500 | 19 408 917 | 0,07 | 34,26 | 462 530 | 664 978 610 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 769 | 19 395 417 | 0,13 | 34,58 | 890 989 | 670 615 938 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 866 669 | 19 369 648 | 4,68 | 33,79 | 29 287 172 | 654 554 641 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4 394 | 18 502 979 | 0,02 | 33,71 | 148 139 | 623 807 584 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38 166 | 18 498 585 | 0,21 | 34,83 | 1 329 390 | 644 339 013 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 252 474 | 18 460 419 | 1,39 | 34,41 | 8 686 949 | 635 173 175 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 914 | 50 201 | 21,59 | 2,16 | 19 254 | 108 434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 914 | 50 201 | 21,59 | 2,16 | 19 254 | 108 434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 914 | 1 421 519 | 0,63 | 2,16 | 19 254 | 3 070 481 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305 329 | 0,23 | 28,54 | 19 978 | 8 714 090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305 329 | 0,23 | 28,54 | 19 978 | 8 714 090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 1 348 711 | 0,05 | 28,54 | 19 978 | 38 492 212 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 11 419 665 | 0,01 | 28,54 | 19 978 | 325 917 239 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 192 618 | 0,36 | 28,54 | 19 978 | 5 497 318 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 353 277 | 0,20 | 28,54 | 19 978 | 10 082 526 | |
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 7 000 | 7 000 | |||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5 500 | 524 349 | 1,06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5 500 | 524 349 | 1,06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5 500 | 524 349 | 1,06 | ||||
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 182 | 41 287 | 17,61 | 2,83 | 17 495 | 116 842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 182 | 41 287 | 17,61 | 2,83 | 17 495 | 116 842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 182 | 1 412 605 | 0,44 | 2,83 | 17 495 | 3 997 672 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 304 629 | 0,24 | 27,86 | 19 948 | 8 486 964 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1 348 011 | 0,05 | 27,86 | 19 948 | 37 555 586 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 11 418 965 | 0,01 | 27,86 | 19 948 | 318 132 365 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1 908 088 | 0,04 | 27,86 | 19 948 | 53 159 332 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 191 918 | 0,37 | 27,86 | 19 948 | 5 346 835 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 352 577 | 0,20 | 27,86 | 19 948 | 9 822 795 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 670 | 416 208 | 0,16 | 39,80 | 26 668 | 16 566 494 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 27 046 | 18 207 945 | 0,15 | 39,80 | 1 076 523 | 724 738 118 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 471 | 415 538 | 0,36 | 39,93 | 58 731 | 16 590 770 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59 400 | 18 180 899 | 0,33 | 39,93 | 2 371 604 | 725 890 573 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 938 | 414 067 | 0,47 | 39,99 | 77 503 | 16 559 036 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78 262 | 18 121 499 | 0,43 | 39,99 | 3 129 791 | 724 700 491 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 155 | 412 129 | 0,28 | 39,84 | 46 021 | 16 421 239 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46 653 | 18 043 237 | 0,26 | 39,84 | 1 858 884 | 718 930 974 | |
| 2014-06-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70 000 | 70 000 | |||||
| 2014-06-10 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
| 2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 534 | 410 974 | 1,36 | 38,96 | 215 578 | 16 009 574 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 223 466 | 17 996 584 | 1,26 | 38,96 | 8 705 163 | 701 060 529 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 534 | 405 440 | 0,13 | 38,56 | 20 591 | 15 633 847 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21 559 | 17 773 118 | 0,12 | 38,56 | 831 319 | 685 334 985 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 477 | 404 906 | 0,12 | 37,52 | 17 895 | 15 190 413 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 223 | 17 751 559 | 0,11 | 37,52 | 721 168 | 665 965 712 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 757 | 404 429 | 0,94 | 37,40 | 140 504 | 15 124 795 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151 530 | 17 732 336 | 0,86 | 37,40 | 5 666 904 | 663 152 128 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 411 | 400 672 | 0,61 | 37,67 | 90 826 | 15 093 995 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97 254 | 17 580 806 | 0,56 | 37,67 | 3 663 724 | 662 298 849 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 496 | 398 261 | 0,12 | 37,63 | 18 667 | 14 988 274 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20 011 | 17 483 552 | 0,11 | 37,63 | 753 100 | 657 981 241 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 534 | 397 765 | 0,39 | 36,04 | 55 281 | 14 334 377 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61 878 | 17 463 541 | 0,36 | 36,04 | 2 229 916 | 629 338 866 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 572 | 396 231 | 0,14 | 36,39 | 20 817 | 14 419 995 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23 058 | 17 401 663 | 0,13 | 36,39 | 839 147 | 633 296 981 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 | 395 659 | 0,00 | 35,27 | 670 | 13 956 001 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 781 | 17 378 605 | 0,00 | 35,27 | 27 548 | 612 992 058 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 137 | 395 640 | 0,54 | 34,38 | 73 479 | 13 603 725 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 86 201 | 17 377 824 | 0,50 | 34,38 | 2 963 944 | 597 520 838 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 270 | 393 503 | 0,07 | 35,11 | 9 481 | 13 817 386 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 896 | 17 291 623 | 0,06 | 35,11 | 382 600 | 607 174 592 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 809 | 393 233 | 0,46 | 34,05 | 61 604 | 13 391 196 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72 980 | 17 280 727 | 0,42 | 34,05 | 2 485 268 | 588 479 605 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 480 | 391 424 | 0,12 | 34,21 | 16 421 | 13 391 046 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 348 | 17 207 747 | 0,11 | 34,21 | 661 916 | 588 695 953 | |
| 2014-05-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11 600 | 11 600 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8 400 | 518 849 | 1,65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8 400 | 518 849 | 1,65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8 400 | 518 849 | 1,65 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10 000 | 390 839 | 2,63 | 7,02 | 70 200 | 2 743 690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10 000 | 390 839 | 2,63 | 7,02 | 70 200 | 2 743 690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10 000 | 390 839 | 2,63 | 7,02 | 70 200 | 2 743 690 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8 750 | 8 750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8 750 | 8 750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8 750 | 8 750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 151 | 390 944 | 0,30 | 34,08 | 39 232 | 13 325 287 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46 460 | 17 188 399 | 0,27 | 34,08 | 1 583 584 | 585 864 861 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 921 | 389 793 | 0,76 | 34,03 | 99 415 | 13 266 449 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 117 879 | 17 141 939 | 0,69 | 34,03 | 4 011 965 | 583 419 037 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 500 | 386 872 | 0,91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 500 | 386 872 | 0,91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3 500 | 17 178 061 | 0,02 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 505 | 383 372 | 0,13 | 34,26 | 17 304 | 13 136 012 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20 395 | 17 020 560 | 0,12 | 34,26 | 698 822 | 583 199 276 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 | 382 867 | 0,00 | 34,10 | 239 | 13 055 765 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 293 | 17 000 165 | 0,00 | 34,10 | 9 991 | 579 705 626 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 382 860 | 2,68 | 7,26 | 72 600 | 2 779 564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 382 860 | 2,68 | 7,26 | 72 600 | 2 779 564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 382 860 | 2,68 | 7,26 | 72 600 | 2 779 564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372 860 | 0,20 | 34,60 | 25 815 | 12 902 522 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30 122 | 16 989 872 | 0,18 | 34,60 | 1 042 348 | 587 920 929 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372 114 | 0,20 | 33,73 | 24 964 | 12 553 191 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29 865 | 16 959 750 | 0,18 | 33,73 | 1 007 490 | 572 133 774 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 069 | 371 374 | 0,29 | 34,31 | 36 673 | 12 740 319 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43 131 | 16 929 885 | 0,26 | 34,31 | 1 479 648 | 580 794 942 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370 305 | 0,21 | 33,92 | 26 559 | 12 560 486 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31 617 | 16 886 754 | 0,19 | 33,92 | 1 072 427 | 572 786 875 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369 522 | 0,09 | 34,74 | 11 430 | 12 837 564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 271 | 16 855 137 | 0,08 | 34,74 | 461 048 | 585 564 315 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 933 | 369 193 | 0,80 | 33,77 | 99 060 | 12 469 235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118 389 | 16 841 866 | 0,71 | 33,77 | 3 998 506 | 568 822 235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366 260 | 0,23 | 33,72 | 28 295 | 12 352 009 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33 868 | 16 723 477 | 0,20 | 34,72 | 1 176 056 | 580 717 722 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 534 | 365 421 | 0,42 | 33,98 | 52 118 | 12 415 252 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61 892 | 16 689 609 | 0,37 | 33,98 | 2 102 793 | 567 032 804 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363 887 | 0,17 | 34,01 | 21 190 | 12 376 779 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 156 | 16 627 717 | 0,15 | 34,01 | 855 623 | 565 553 550 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 228 | 363 264 | 0,34 | 33,40 | 41 020 | 12 134 580 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49 553 | 16 602 561 | 0,30 | 33,40 | 1 655 283 | 554 596 928 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362 036 | 0,27 | 33,54 | 33 007 | 12 143 991 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 710 | 16 553 008 | 0,24 | 33,54 | 1 332 016 | 555 247 479 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372 860 | 0,20 | 34,60 | 25 815 | 12 902 522 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30 122 | 16 989 872 | 0,18 | 34,60 | 1 042 348 | 587 920 929 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372 114 | 0,20 | 33,73 | 24 964 | 12 553 191 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29 865 | 16 959 750 | 0,18 | 33,73 | 1 007 490 | 572 133 774 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 069 | 371 374 | 0,29 | 34,31 | 36 673 | 12 740 319 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43 131 | 16 929 885 | 0,26 | 34,31 | 1 479 648 | 580 794 942 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370 305 | 0,21 | 33,92 | 26 559 | 12 560 486 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31 617 | 16 886 754 | 0,19 | 33,92 | 1 072 427 | 572 786 875 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369 522 | 0,09 | 34,74 | 11 430 | 12 837 564 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 271 | 16 855 137 | 0,08 | 34,74 | 461 048 | 585 564 315 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 933 | 369 193 | 0,80 | 33,77 | 99 060 | 12 469 235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118 389 | 16 841 866 | 0,71 | 33,77 | 3 998 506 | 568 822 235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366 260 | 0,23 | 33,72 | 28 295 | 12 352 009 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33 868 | 16 723 477 | 0,20 | 34,72 | 1 176 056 | 580 717 722 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 534 | 365 421 | 0,42 | 33,98 | 52 118 | 12 415 252 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61 892 | 16 689 609 | 0,37 | 33,98 | 2 102 793 | 567 032 804 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363 887 | 0,17 | 34,01 | 21 190 | 12 376 779 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 156 | 16 627 717 | 0,15 | 34,01 | 855 623 | 565 553 550 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 228 | 363 264 | 0,34 | 33,40 | 41 020 | 12 134 580 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49 553 | 16 602 561 | 0,30 | 33,40 | 1 655 283 | 554 596 928 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362 036 | 0,27 | 33,54 | 33 007 | 12 143 991 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 710 | 16 553 008 | 0,24 | 33,54 | 1 332 016 | 555 247 479 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303 913 | 0,25 | 26,57 | 19 981 | 8 074 968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303 913 | 0,25 | 26,57 | 19 981 | 8 074 968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1 347 295 | 0,06 | 26,57 | 19 981 | 35 797 628 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 11 418 249 | 0,01 | 26,57 | 19 981 | 303 382 876 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1 907 372 | 0,04 | 26,57 | 19 981 | 50 678 874 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 191 202 | 0,39 | 26,57 | 19 981 | 5 080 237 | |
| 2014-03-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 80 000 | 80 000 | |||||
| 2014-03-12 |
|
4 | IDP |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 60 000 | 60 000 | |||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 784 624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3 019 499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1 648 181 | ||||||||
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11 738 | 452 540 | 2,66 | 28,50 | 334 533 | 12 897 390 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 475 644 | 18 476 847 | 2,64 | 28,50 | 13 555 854 | 526 590 140 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38 934 | 1 552 055 | 2,57 | 28,50 | 1 109 619 | 44 233 568 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303 161 | 0,23 | 29,27 | 19 962 | 8 873 522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303 161 | 0,23 | 29,27 | 19 962 | 8 873 522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 11 243 600 | 0,01 | 29,27 | 19 962 | 329 100 172 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 1 732 723 | 0,04 | 29,27 | 19 962 | 50 716 802 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 16 553 | 4,30 | 29,27 | 19 962 | 484 506 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 177 212 | 0,39 | 29,27 | 19 962 | 5 186 995 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 639 | 361 052 | 0,18 | 39,91 | 25 504 | 14 410 344 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25 596 | 16 513 298 | 0,16 | 39,91 | 1 021 590 | 659 080 401 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 280 | 360 413 | 0,36 | 39,92 | 51 100 | 14 388 372 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 51 244 | 16 487 702 | 0,31 | 39,92 | 2 045 758 | 658 220 390 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 063 | 359 133 | 0,30 | 39,65 | 42 153 | 14 241 383 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42 646 | 16 436 458 | 0,26 | 39,65 | 1 691 123 | 651 786 098 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 486 | 358 070 | 0,70 | 39,70 | 98 694 | 14 215 379 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 99 775 | 16 393 812 | 0,61 | 39,70 | 3 961 068 | 650 834 336 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 377 | 355 584 | 0,39 | 39,54 | 54 442 | 14 058 725 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 55 256 | 16 294 037 | 0,34 | 39,54 | 2 184 656 | 644 217 341 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 056 | 354 207 | 0,87 | 39,53 | 120 798 | 14 001 201 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 122 660 | 16 238 781 | 0,76 | 39,53 | 4 848 541 | 641 891 407 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5 492 | 351 151 | 1,59 | 43,98 | 241 512 | 15 441 935 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 219 958 | 16 116 121 | 1,38 | 43,98 | 9 672 697 | 708 709 644 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 553 | 345 659 | 0,16 | 44,00 | 24 332 | 15 208 823 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22 147 | 15 896 163 | 0,14 | 44,00 | 974 457 | 699 423 224 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 863 | 345 106 | 0,84 | 44,05 | 126 102 | 15 200 366 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 114 663 | 15 874 016 | 0,73 | 44,05 | 5 050 389 | 699 178 972 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 | 342 243 | 0,05 | 43,42 | 7 382 | 14 861 800 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6 814 | 15 759 353 | 0,04 | 43,42 | 295 896 | 684 345 176 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 512 | 342 073 | 0,74 | 42,95 | 107 883 | 14 691 043 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100 626 | 15 752 539 | 0,64 | 42,95 | 4 321 595 | 676 525 868 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 340 | 339 561 | 0,10 | 43,72 | 14 864 | 14 845 233 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13 632 | 15 651 913 | 0,09 | 43,72 | 595 976 | 684 284 419 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 011 | 339 221 | 0,30 | 43,01 | 43 479 | 14 588 403 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40 471 | 15 638 281 | 0,26 | 43,01 | 1 740 480 | 672 533 657 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1 818 | 338 210 | 0,54 | 43,20 | 78 547 | 14 612 329 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72 807 | 15 597 810 | 0,47 | 43,20 | 3 145 619 | 673 901 821 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 455 | 336 392 | 0,14 | 43,64 | 19 858 | 14 681 829 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18 232 | 15 525 003 | 0,12 | 43,64 | 795 736 | 677 588 756 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 290 | 335 937 | 0,09 | 42,65 | 12 369 | 14 328 721 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11 617 | 15 506 771 | 0,07 | 42,65 | 495 500 | 661 410 303 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3 551 | 335 647 | 1,07 | 42,56 | 151 129 | 14 284 968 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 142 220 | 15 495 154 | 0,93 | 42,56 | 6 052 812 | 659 466 007 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 632 | 332 096 | 0,80 | 42,41 | 111 631 | 14 085 188 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 105 414 | 15 352 934 | 0,69 | 42,41 | 4 470 924 | 651 163 990 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2 816 | 329 464 | 0,86 | 42,31 | 119 144 | 13 939 556 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 112 797 | 15 247 520 | 0,75 | 42,31 | 4 772 419 | 645 119 522 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -127 000 | 892 000 | -12,46 | 432,60 | -54 940 390 | 385 880 538 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -4 567 000 | 31 967 000 | -12,50 | 432,60 | -1 975 691 050 | 13 828 972 150 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -1 084 000 | 7 587 000 | -12,50 | 432,60 | -468 940 026 | 3 282 147 580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -2 459 000 | 1 019 000 | -70,70 | 425,88 | -1 047 233 756 | 433 969 580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -88 153 000 | 36 534 000 | -70,70 | 425,88 | -37 542 414 519 | 15 559 023 199 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -20 922 000 | 8 671 000 | -70,70 | 425,88 | -8 910 217 424 | 3 692 787 271 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 170 000 | 6 050 000 | 2,89 | 104,52 | 17 768 043 | 632 333 295 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 6 830 000 | 243 450 000 | 2,89 | 104,52 | 713 857 257 | 25 444 882 755 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 242 000 | 5 880 000 | 4,29 | 104,25 | 25 228 500 | 612 990 000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 9 758 000 | 236 620 000 | 4,30 | 104,25 | 1 017 271 500 | 24 667 635 000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 61 000 | 5 638 000 | 1,09 | 103,75 | 6 328 750 | 584 942 500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 2 439 000 | 226 862 000 | 1,09 | 103,75 | 253 046 250 | 23 536 932 500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 121 000 | 5 577 000 | 2,22 | 104,75 | 12 674 750 | 584 190 750 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 4 879 000 | 224 423 000 | 2,22 | 104,75 | 511 075 250 | 23 508 309 250 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5 456 000 | 5 456 000 | 100,00 | 545 600 000 | 545 600 000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 5 456 000 | 5 456 000 | 100,00 | 545 600 000 | 545 600 000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 219 544 000 | 219 544 000 | 100,00 | 21 954 400 000 | 21 954 400 000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 219 544 000 | 219 544 000 | 100,00 | 21 954 400 000 | 21 954 400 000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 25 000 000 | 25 000 000 | 100,00 | 2 500 000 000 | 2 500 000 000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 25 000 000 | 25 000 000 | 100,00 | 2 500 000 000 | 2 500 000 000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 133 000 | 5 674 000 | 2,40 | 104,09 | 13 844 090 | 590 611 767 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5 367 000 | 228 326 000 | 2,41 | 104,09 | 558 655 860 | 23 766 658 833 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 85 000 | 5 541 000 | 1,56 | 104,12 | 8 850 625 | 576 956 625 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 3 415 000 | 222 959 000 | 1,56 | 104,12 | 355 586 875 | 23 215 605 875 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 8 721 | 40 308 | 27,61 | 17,50 | 152 618 | 705 390 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 346 965 | 2 213 897 | 18,58 | 17,50 | 6 071 888 | 38 743 198 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 44 314 | 125 869 | 54,34 | 17,50 | 775 495 | 2 202 708 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 302 479 | 0,22 | 30,33 | 19 957 | 9 174 188 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 11 242 918 | 0,01 | 30,33 | 19 957 | 340 997 703 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 1 732 041 | 0,04 | 30,33 | 19 957 | 52 532 804 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 15 871 | 4,33 | 30,33 | 19 957 | 481 367 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 176 530 | 0,37 | 30,33 | 19 957 | 5 354 155 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 196 794 | 0,34 | 30,33 | 19 957 | 5 968 762 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 21 410 | 510 449 | 4,38 | 3,62 | 77 504 | 1 847 825 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 1 854 058 | 19 767 770 | 10,35 | 3,62 | 6 711 690 | 71 559 327 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 882 323 | 2 829 753 | 45,31 | 3,62 | 3 194 009 | 10 243 706 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 21 410 | 510 449 | 4,38 | 3,62 | 77 504 | 1 847 825 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 1 854 058 | 19 767 770 | 10,35 | 3,62 | 6 711 690 | 71 559 327 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 882 323 | 2 829 753 | 45,31 | 3,62 | 3 194 009 | 10 243 706 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24 705 | 145 533 | 20,45 | 4,40 | 108 702 | 640 345 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 991 161 | 4 832 285 | 25,80 | 4,40 | 4 361 108 | 21 262 054 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 120 498 | 1 642 513 | 7,92 | 4,40 | 530 191 | 7 227 057 | |
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 030 | 3 030 | |||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
81 555 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
1 866 932 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
31 587 | ||||||||
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301 821 | 0,20 | 32,85 | 19 907 | 9 914 820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301 821 | 0,20 | 32,85 | 19 907 | 9 914 820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301 821 | 0,20 | 32,85 | 19 907 | 9 914 820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 1 731 383 | 0,04 | 32,85 | 19 907 | 56 875 932 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 15 213 | 4,15 | 32,85 | 19 907 | 499 747 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 175 872 | 0,35 | 32,85 | 19 907 | 5 777 395 |
P
Открытый рынок или частная покупка непроизводных или производных ценных бумаг
S
Открытый рынок или частная продажа непроизводных или производных ценных бумаг
A
Предоставление, награждение или иное приобретение ценных бумаг у компании (например, опцион)
C
Конвертация производной
D
Продажа или передача ценных бумаг обратно компании
F
Оплата цены исполнения или налогового обязательства с использованием части ценных бумаг, полученных от компании
G
Дарение ценных бумаг инсайдером или ему
K
Обмен акциями и аналогичные операции хеджирования
M
Исполнение или конвертация производных ценных бумаг, полученных от компании (например, опциона)
V
Сделка, добровольно зарегистрированная в Форме 4.
J
Другое (сопровождается сноской с описанием транзакции)
